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Malassezia pachydermatis, a lipophilic, unipolar-budding yeast is a commensal on
canine skin and it can be isolated from the skin and ear canals of healthy dogs. A
dermatitis associated with elevated cutaneous populations of M. pachydermatis has
been increasingly recognised in the last two decades and one of the most common
underlying causes ofMalassezia overgrowth in dogs is atopic dermatitis. The aim of
these studies was to investigate two aspects of the host's protective responses against
the organism - activation of a humoral immune response and thickening of the skin
by epidermal hyperplasia.
The interaction between M. pachydermatis and the host's immune system has not
been widely studied either in normal or atopic dogs. To investigate antibody
responses to M. pachydermatis, Western blotting techniques were used to detect
Malassezia-specific IgG and IgE binding proteins from M. pachydermatis in atopic
dogs with or without Malassezia dermatitis and normal dogs. By comparing the
binding activity on the immunoblots, atopic dogs with Malassezia dermatitis showed
much greater IgG and IgE responses to M. pachydermatis than normal dogs. The IgG
in sera from the majority of the atopic dogs with Malassezia dermatitis recognised a
25 kDa protein, which was only seen in less than 25 % of the atopic dogs without
Malassezia dermatitis and none of the normal dogs. Proteins of 45, 52, 56, and 63
kDa were recognised by IgE in more than 50 % of the atopic dogs with Malassezia
dermatitis, but only recognised by a minority of normal dog sera, and therefore
represented major allergens. These results suggest that Malassezia dermatitis in
atopic dogs is associated with an IgG and IgE response to the organism, with the
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above proteins being most relevant in the immunological reaction.
In addition to mounting immunological responses, the skin also undergoes biological
changes in response to environmental insults. Epidermal hyperplasia is one of the
major characteristics of skin biopsies from dogs with Malassezia dermatitis. The
mechanisms by which M. pachydermatis induces epidermal lesions are not fully
understood. To investigate the role of M. pachydermatis in the pathogenesis of
epidermal hyperplasia associated with Malassezia dermatitis, a colourimetric cell
proliferation assay was developed to evaluate the effect of extracts and culture
supernatants from M. pachydermatis on proliferation of canine keratinocytes in vitro.
Malassezia extracts, either with or without protease inhibitors, and culture
supernatants from the yeast, did not affect the proliferation of normal canine
keratinocytes in vitro. To further investigate the response of a direct interaction
between canine keratinocytes and live Malassezia organisms, an in vitro co-culture
system was developed. The proliferative response of the keratinocytes was assessed
using direct manual counting and immunohistochemistry techniques. Malassezia
organisms did not cause keratinocyte proliferation, but they induced keratinocyte
detachment from the substratum and cell death. These results suggest that the
epidermal hyperplasia seen in dogs with Malassezia dermatitis is unlikely to be
caused by a direct effect of the organism on the keratinocyte cell cycle, but is likely
to involve other mechanisms.
These studies provide further information regarding the host response to M.
pachydermatis, and suggest possible mechanisms by which overgrowth of




Malassezia pachydermatis is a lipophilic budding yeast that colonises the skin and
mucosal sites of healthy dogs (Guillot & Bond 1999). Despite being part of the
normal cutaneous microflora, it has been suggested that the yeast may become a
pathogen under some circumstances. As with other Malassezia spp. that have been
recognised to cause various skin diseases in human beings, M. pachydermatis has
been associated with cutaneous disease in dogs. "Malassezia dermatitis", a term used
to describe inflammation associated with elevated populations ofM. pachydermatis
on the skin of dogs, has been recognised with increasing frequency and its
importance in canine dermatology can be illustrated by the rise in the number of
review articles on this condition in the last few years (Charach 1997; Bruner &
Blakemore 1999; Morris 1999; Bond 2002; Matousek & Campbell 2002).
The interaction between M. pachydermatis and canine skin in Malassezia dermatitis
is not fully understood. Atopic dermatitis is one of the most common underlying
causes ofMalassezia overgrowth in dogs. However, the antigens of the yeast that are
recognised by the atopic host thus triggering humoral immune responses have not
been reported. Furthermore, the effect of M. pachydermatis on epidermal
proliferation, one of the characteristic histopathological changes in the skin of dogs
with Malassezia dermatitis, has not been extensively studied. The deficiencies in the
understanding of these important factors of Malassezia dermatitis stimulated the
studies described in this thesis.
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1.1 History and taxonomy of the genus Malassezia
The taxonomy and nomenclature of the yeasts currently classified within the genus
Malassezia have been controversial since the fungus was first described by Eichstedt
in 1846 in scales from lesions of pityriasis (tinea) versicolor (cited by Ingham &
Cunningham 1993). Due to the presence of filaments associated with the yeasts, the
organism was primarily considered as a new species of dermatophyte and designated
Microsporum furfur by Robin in 1853 (Gueho et al. 1994). Baillon renamed this
filamentous fungus Malassezia furfur in 1889 (cited by Assaf & Weil 1996; Ashbee
& Evans 2002). On the other hand, Malassez in 1874 described ovoid-shaped cells
without hyphae in scales from humans with dandruff and this organism was named
Pityrosporum malassezii by Sabouraud in 1904 and later referred to as Pityrosporum
ovale by Castellani and Chambers in 1913 (cited by Sloof 1970). These were initially
considered as two different organisms because hyphal forms were rarely observed in
dandruff cases and Pityrosporum did not produce hyphae in cultures.
The yeast and mycelial forms were later thought to be related and were first
classified into the same genus by Panja in 1927 (cited by Ashbee & Evans 2002). In
1951, Gordon (1951) cultured a round-shaped organism from patients with pityriasis
versicolor, which he named Pityrosporum orbiculare. By using a variety of culture
conditions, induction of P. ovale and P. orbiculare to produce hyphae was
demonstrated in the 1970's and the produced hyphae were indistinguishable from
those seen in the cases of pityriasis versicolor (Dorn & Roehnert 1977; Nazzaro-
Porro et al. 1977). This confirmed the dimorphic nature ofMalassezia organisms and
led to the suggestion that round and oval yeast forms and hyphae represented
different stages of the life cycle (Salkin & Gordon 1977). The two genera were later
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unified with the acceptance of the species name Malassezia furfur (including P. ovale,
P. orbiculare, and M. furfur) by the International Commission on the Taxonomy of
Fungi in 1986 (Cannon 1986). Despite this, many workers continued to differentiate
strains on the basis of cellular and colonial morphologies, and the names P. ovale and
P. orbiculare were still widely used in the literature. Due to the heterogeneity of this
organism, Midgley (1989) maintained two species, P. ovale and P. orbiculare, and
subdivided the former into three forms (P. ovale forms 1-3). Based on the serological
differences determined by cell surface antigens, Cunningham et al. (1990) designated
three serovars A, B, and C within the taxon M. furfur.
Malassezia pachydermatis was first identified in 1925 from scales of an Indian
rhinoceros with exfoliative dermatitis (Weidman 1925). Due to its resemblance to P.
ovale but smaller size, Weidman proposed the name Pityrosporum pachydermatis for
this organism. In 1955, round or oval-shaped yeasts showing unipolar budding were
isolated from dogs with otitis externa by Gustafson (1955), and he related them to the
genus Pityrosporum. In contrast to the lipid dependency of P. ovale and P. orbiculare,
these strains did not require lipid supplementation for growth. Gustafson therefore
named his isolates Pityrosporum canis. Non-lipid dependent yeasts were also
isolated from the ear canals of both healthy dogs and dogs with otitis externa by
Fraser (1961) and he termed them P. pachydermatis because of the similarity to the
isolates described by Weidman (1925). Subsequently, all strains ofPityrosporum that
were able to grow on media without lipid supplementation were assigned to a single
species P. pachydermatis by Sloof (1970). After unification of the two genera
Pityrosporum and Malassezia in 1986 (Cannon 1986), the name Malassezia
pachydermatis was adopted.
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Since 1990, the use of genomic analysis has lead to a much clearer classification of
the yeasts under the genus Malassezia. Another lipid-dependent budding yeast
Malassezia sympodialis was defined by Simmons and Gueho in 1990 based on the
difference in the percentage of guanine and cytosine in the DNA (% GC) compared
to M. furfur (Simmons & Gueho 1990). Using genomic comparison and ribosomal
large subunit sequencing, lipid-dependent Malassezia yeasts were further classified
into six distinct taxa by Gueho et al. in 1996, including M. furfur, M. sympodialis,
and four new species, M. globosa, M. obtusa, M. restricta, and M. slooffiae, resulting
in seven species under the genus Malassezia including M. pachydermatis (Gueho et
al. 1996). Seven sequence types were also detected within the species M.
pachydermatis using ribosomal large subunit sequencing (Guillot et al. 1997).
In addition to the currently accepted seven Malassezia species, two novel species
were recently reported to be genetically different from the existing species. Nell et al.
(2002) isolated Malassezia species yeasts from the skin of healthy horses and they
proposed the name M. equi for this new species that required lipid for growth on
Sabouraud's dextrose agar. The other new species was found on the skin of human
patients with atopic dermatitis and the name M. dermatis was proposed for the
isolates (Sugita et al. 2002). The clinical significance of this species is currently
unknown.
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1.2 Characteristics of Malassezia organisms
1.2.1 Structure
A characteristic feature of the genus Malassezia is its cell wall structure. The cell
wall of Malassezia species is relatively thick (up to 0.25 pm) compared to other
yeasts and it is multi-layered (Swift & Dunbar 1965; Nishimura et al. 1991; Mittag
1995). It constitutes 26 to 37 % of the cell volume (Keddie & Barajas 1972). Around
the cell wall there is an outer lamella layer, the structure of which varies depending
on the lipid sources in the medium. It is suggested that this lamellar layer contains
lipid and may play a role in the adhesion process (Mittag 1995).
The inner surface of the cell wall is corrugated, which corresponds to the
invagination of the closely adhered plasma membrane (Barfatani et al. 1964; Swift &
Dunbar 1965; Mittag 1995). Cytoplasmic organelles that have been described include
a nucleus, vacuoles containing lipid, and mitochondria (Barfatani et al. 1964; Swift
& Dunbar 1965). It was found that the number of mitochondria possessed by round
cells (P. obiculare) was different from that of oval cells (P. ovale). The former
contained approximately three mitochondria per cell, which increased in volume
rather than number during growth. In contrast, there were approximately 23
mitochondria in an oval cell and they increased in number rather than size during
growth (Keddie & Barajas 1972). However, electron microscopic observations did
not reveal noticeable differences in the mitochondrial appearance between P. ovale
and P. canis (M. pachydermatis) (Swift & Dunbar 1965).
1.2.2 Reproduction
Yeasts of the genus Malassezia reproduce by unipolar or sympodial (M. sympodialis)
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budding and the budding process described for P. ovale, P. orbiculare, and M.
pachydermatis is very similar (Swift & Dunbar 1965; Keddie & Barajas 1972;
Simmons & Gueho 1990; Nishimura et al. 1991). However, the budding base ofM.
pachydermatis (0.9-1.1 pm in diameter) is broader than that of P. ovale and P.
orbiculare (0.5-0.7 pm) (Keddie & Barajas 1972; Nishimura et al. 1991). Nishimura
et al. (1991) precisely described the budding process ofM. pachydermatis in stages.
The budding yeast first forms an ear-like structure separating from the cell wall. This
structure grows outwards and protrusion of the cytoplasm as well as dimpling of the
cell wall takes place. The cell wall of the daughter cell then becomes thicker, layered
and serrated as it grows. When the daughter cell is as long as the mother cell, a
narrow lumen forms in the cross-wall and fission takes place. The bud is then
completely released leaving the ear-like structure as a bud scar.
1.2.3 Biochemistry
Lipid-dependent Malassezia species have been reported to elaborate a range of
enzymes. Lipase activity has been demonstrated within the cell wall and at the
membrane sites of the yeast in vitro using histochemical techniques and electron
microscopy, suggesting that this enzyme is synthesized intracellularly and exported
to the cell surface (Catterall et al. 1978). It has also been found that the fatty acid
composition of the cell varies depending on the lipid supplementation present in the
medium, indicating that fatty acids are required for membrane synthesis (Nazzaro-
Porro et al. 1976). The lipoxygenase activity of the yeast was proposed to be
involved in the pathological changes associated with pityriasis versicolor (Nazzaro-
Porro et al. 1986; De Luca et al. 1996). Increased levels of lipoperoxides were
detected in lipids from lesional but not non-lesional skin of patients with pityriasis
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versicolor (Nazzaro-Porro et al. 1986). The by-products of lipoperoxidation induced
by lipoxygenase activity of the yeast were considered to cause damage to
melanocytes, resulting in the hypopigmentation seen in pityriasis versicolor (De Luca
et al. 1996). In vitro, M. furfur also produces phospholipases (Riciputo et al. 1996;
Muhsin et al. 1997), the activity of which was demonstrated to cause the release of
arachidonic acid from human epithelial cell lines, a mechanism by which Malassezia
organisms may trigger inflammation in the skin (Plotkin et al. 1998). In addition to
the enzymes described above, Malassezia organisms produce azelaic acid in cultures
supplemented with oleic acid (Nazzaro-Porro & Passi 1978). Azelaic acid is an
inhibitor of tyrosinase, an enzyme involved in the production of melanin, indicating
that the production of azelaic acid by Malassezia organisms may also play a role in
the pathological changes ofpityriasis versicolor (Nazzaro-Porro & Passi 1978).
M. pachydermatis has also been demonstrated to produce various enzymes in vitro,
including alkaline and acid phosphatase, chondroitin-sulphatase, esterase, esterase
lipase, galactosidase, glucosidase, hyaluronidase, leucine arylamidase, lipase,
lecithinase, peroxidase, phosphoamidase, phospholipase, phosphohydrolase, protease,
and urease (Dworecka-Kaszak et al. 1994; Kiss et al. 1996; Mathieson et al. 1998;
Guillot & Bond 1999; Coutinho & Paula 2000; Bond 2002). Lipase was found to be
predominantly associated with the cell membrane of M. pachydermatis, whereas
protease is secreted by the yeast (Mathieson et al. 1998). No significant difference
was found in the production of chondroitin-sulphatase, hyaluronidase, phospholipase,
and protease by M. pachydermatis strains isolated from dogs with otitis or dermatitis
(Coutinho & Paula 2000). When cultured in liquid media, the activities of alkaline
phosphatase and esterase lipase in the culture supernatants from M. pachydermatis
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were significantly greater than that in the cell suspension. Furthermore, significantly
greater activity of C4 esterase was detected in cell suspensions ofM. pachydermatis
strains obtained from healthy dogs than that from dogs with dermatitis (Bond 2002).
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1.3 Malassezia spp. as pathogens in humans and animals
Although Malassezia spp. can be found on normal human skin, they have been
implicated in a range of both cutaneous and systemic diseases. They are most
frequently associated with pityriasis (tinea) versicolor, which is one of the most
common disorders of pigmentation seen in human dermatological clinics worldwide.
Diseases associated with Malassezia spp. in animals have also been widely reported.
In dogs, a dermatitis caused by overgrowth ofM. pachydermatis on the skin surface
has been recognised with increasing frequency. The pathogenic role of Malassezia
spp. in diseases continues to be a major topic in human and veterinary medical
literature. In the following sections, the diseases associated with Malassezia spp. in
humans and animals are reviewed.
1.3.1 Diseases associated with Malassezia spp. in man
1.3.1.1 Pityriasis versicolor
Pityriasis versicolor is a chronic superficial fungal infection of the skin caused by
Malassezia spp. organisms (Sunenshine et al. 1998; Faergemann 1999). Since the
differentiation of new Malassezia species, several studies on the mycology of
pityriasis versicolor have been documented. The species that have been isolated from
patients with pityriasis versicolor include M. furfur, M. globosa, M. restricta M.
slooffiae, and M. sympodialis, and more than one species can be found in some
patients (Erchiga et al. 1999; Crespo Erchiga et al. 2000; Nakabayashi et al. 2000;
Gupta et al. 2001). Although some investigators suggested that M. globosa was the
causative agent of pityriasis versicolor due to its predominant presence in
populations of affected patients (Crespo Erchiga et al. 2000), it remains to be
determined whether M. globosa is also the predominant species in the lesions of
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individuals.
Pityriasis versicolor most often occurs on the trunk, neck and proximal extremities. It
is characterised by scaly hypo- or hyperpigmented macules and patches with minimal
pruritus (Marcon & Powell 1992). The diagnosis can be made by potassium
hydroxide preparations of skin scrapings or tape strippings, which reveal typical
clusters of yeast with hyphae (Sunenshine et al. 1998; Faergemann 1999). There are
several therapeutic options for treating pityriasis versicolor such as topical treatment
with lotions or creams containing selenium, sodium thiosulfate or specific anti-fungal
agents, or oral medication with ketoconazole, fluconazole or itraconazole. However,
relapse is very common and prophylactic treatment may be required (Sunenshine et
al. 1998).
1.3.1.2 Malassezia folliculitis
Malassezia folliculitis is characterised by follicular papules and pustules localised to
the trunk, upper arms, neck, and less often the face. These lesions are generally
pruritic (Faergemann 1999). The diagnosis is based on clinical signs, cytology and
culture in combination with histopathology. Budding yeasts and rarely hyphae can be
found in cytological samples and in dilated follicles of biopsy sections (Assaf& Weil
1996; Faergemann 1999). Although it has been suggested that follicular occlusion
was the primary cause of Malassezia folliculitis with overgrowth of Malassezia
organisms as a secondary event (Hill et al. 1990), colonisation of normal
pilosebaceous units by these yeasts can also be heavy (Leeming et al. 1984). The
exact role of Malassezia organisms in Malassezia folliculitis therefore awaits further
elucidation. Malassezia folliculitis responds rapidly to anti-fungal therapy. It can be
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treated with topical anti-fungal agents or with oral azole anti-fungal drugs for
patients who do not respond to topical treatment. As with pityriasis versicolor,
recurrence tends to be a common problem (Gueho et al. 1998).
1.3.1.3 Seborrheic dermatitis and dandruff
Seborrheic dermatitis is characterised by inflammation and desquamation in areas
that are rich in sebaceous glands such as the scalp, face, and upper trunk, whereas
dandruff is a non-inflammatory scaling condition of the scalp. It is now generally
considered that the latter is the mildest form or a variant of seborrheic dermatitis
(Hay & Graham-Brown 1997; Gueho et al. 1998; Faergemann 1999). The
importance of Malassezia organisms in these two conditions has been supported by
studies demonstrating correlation of in the number of organisms with the severity of
the diseases (Heng et al. 1990; Pierard-Franchimont et al. 1998). The species that
have been isolated from patients with seborrheic dermatitis include M. furfur, M.
globosa, and M. sympodialis with the first two species showing higher frequency
(Nakabayashi et al. 2000). Seborrheic dermatitis can be treated with anti-fungal
drugs, which can also be used prophylactically to reduce the recurrence rate (Gueho
et al. 1998; Faergemann 1999).
1.3.1.4 Atopic dermatitis
Atopic dermatitis is a chronic multi-factorial inflammatory skin disease associated
with abnormal immunological regulation and Malassezia organisms have been
implicated in its pathogenesis as allergens (Ljubojevic et al. 2002; Scheynius et al.
2002). The IgE response to the organism has been investigated extensively using
several diagnostic methods such as the intradermal test, skin prick test, and ELISA
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(described in further detail in chapter 4, section 4.1.3.2). Five Malassezia species
have been isolated from patients with atopic dermatitis, including M. furfur, M.
globosa, M. restricta, M. slooffiae, and M. sympodialis. However, the most
frequently isolated species reported varies with different investigators (Nakabayashi
et al. 2000; Gupta et al. 2001; Sugita et al. 2001). The respective pathogenic role of
different Malassezia spp. in atopic dermatitis remains to be clarified. For atopic
patients with a hypersensitivity response to Malassezia spp., anti-fungal therapy such
as oral ketoconazole should be included in the treatment regime (Faergemann 1999).
1.3.1.5 Malassezia Fungaemia
Systemic bloodstream infection with Malassezia species has been recognised for
about two decades. It is related to administration of lipids through intravenous
catheters, especially to infants in intensive care units. M. furfur and M.
pachydermatis are the only two species that have been reported to cause systemic
disease, and the latter was considered to have been transferred from a household pet
since it is rarely isolated from normal human skin (Long & Keyserling 1985;
Nicholls et al. 1993; Welbel et al. 1994; Chang et al. 1998). However, other
Malassezia spp. might also be involved but were not recognised before the new
taxonomy was adopted. Many blood culture systems do not effectively support the
growth of lipid-dependent Malassezia spp. and this may also hinder the identification
(Midgley 2000). The catheter has to be removed if anti-fungal therapy is
unsuccessful, possibly due to incomplete access to the organisms embedded in the
catheter (Ingham & Cunningham 1993; Ashbee & Evans 2002).
In addition to the diseases described above, a range of other conditions have also
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been reported to be associated with Malassezia spp. such as psoriasis, otitis and acne
(listed in Midgley 2000; Ashbee & Evans 2002; Erchiga & Florencio 2002).
1.3.2 Diseases associated with Malassezia spp. in other animals
An Indian rhinoceros with exfoliative dermatitis was the first case reported to be
associated with M. pachydermatis (Weidman 1925). More recently, similar lesions
were observed in a southern white rhinoceros (Bauwens et al. 1996). Malassezia
organisms have also been found in a variety of other animals with diseases. Non¬
lipid dependent Malassezia yeasts were recently isolated from a horse showing an
erythematous patch of alopecia on the face, which responded well to a
miconazole/chlorhexidine shampoo (Paterson 2002). M. pachydermatis-associated
dermatitis has also been reported in sea lions (Guillot et al. 1998; Nakagaki et al.
2000). Other than dogs and cats, otitis externa caused by M. pachydermatis has been
described in ferrets, fennecs, pigs, and dromedaries (Dinsdale & Rest 1995; Guillot
& Bond 1999). In contrast, the species that have been isolated from cattle with otitis
are M. globosa, M. sympodialis, M. furfur, and M. slooffiae, with a higher frequency
of the first two species (Duarte et al. 1999; Duarte et al. 2001). A case of non-
cutaneous disease was documented in a bird (macaw) showing an ulcer in the crop
from which M. pachydermatis was isolated (Breuer-Strosberg et al. 1990).
In contrast to dogs, in which Malassezia dermatitis and otitis are frequently
diagnosed, these conditions are less common in cats. The clinical signs in cats
include pruritus, erythema, self-excoriation, and less commonly lichenification
(Morris 1999). M. pachydermatis has also been reported to cause feline chin acne
(White et al. 1997). Although three lipid-dependent Malassezia spp. (M furfur, M.
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globosa, and M. sympodialis) have been isolated from healthy cats (Bond et al.
1996a; Bond et al. 1997; Bensignor et al. 1999; Crespo et al. 1999), to date only M.
sympodialis has been reported to be associated with otitis externa in cats (Crespo et
al. 2000; Crespo et al. 2002). Malassezia overgrowth has also been reported in cats
with thymoma-associated dermatitis and paraneoplastic alopecia, suggesting a
correlation between Malassezia dermatitis and internal neoplasia in cats (Forster-Van
Hijfte et al. 1997; Godfrey 1998; Mauldin et al. 2002).
1.3.3 Malassezia dermatitis in dogs
Malassezia dermatitis in dogs was first reported by Dufait (1983) 20 years ago. It is
associated with elevated cutaneous populations of M. pachydermatis. To date, the
potentially important role of M. pachydermatis in this condition has gained
widespread acceptance due to the recovery ofM. pachydermatis from affected skin
of dogs with more generalised skin diseases and the favourable outcome after anti¬
fungal therapy. The following sections will review the current knowledge of
Malassezia dermatitis associated with M. pachydermatis in dogs, with emphasis on
its predisposing factors, pathogenesis and clinical aspects.
1.3.3.1 Predisposingfactors for overgrowth ofMalassezia pachydermatis
The predisposing factors for Malassezia overgrowth on the skin of dogs are still a
focus of research and debate. Two mechanisms that have been suggested to trigger
overgrowth of the yeast are changes in the cutaneous microenvironment and
alterations in host defense mechanisms (Mason 1993; Matousek & Campbell 2002).
By causing these changes, various diseases have been reported as underlying causes
ofMalassezia dermatitis.
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The cutaneous microenvironment is generally considered to be important in
controlling Malassezia populations. Malassezia dermatitis seems to be more
common in humid climates such as summer and in certain anatomic sites such as
skin folds, suggesting that increased cutaneous humidity favours yeast growth (Scott
et al. 2001a). Additionally, changes in lipids on the skin surface resulting in
increased availability of nutrients and growth factors for Malassezia organisms can
also promote their proliferation. The diseases that can cause changes in sebum
production and are associated with Malassezia dermatitis include endocrine diseases,
bacterial skin diseases (in which the bacteria could release lipase), and keratinization
disorders such as seborrheic dermatitis (Plant et al. 1992; Scott et al. 2001a;
Matousek & Campbell 2002).
The skin forms a physical barrier to resist environmental insults such as invasion by
microorganisms. A disrupted epidermal barrier renders the skin prone to bacterial
and yeast infections. Diseases that can cause a decrease in cutaneous barrier function
and are commonly related to Malassezia dermatitis are hypersensitivity diseases
(especially atopic dermatitis), parasite infestation, and keratinization disorders (Scott
et al. 2001a; Matousek & Campbell 2002). Another defense mechanism of the host is
the skin immune system. Alterations in the immune system caused by
hypersensitivity and endocrine diseases can also predispose to Malassezia dermatitis
(Matousek & Campbell 2002).
Genetic predisposition appears to be important in certain breeds, especially West
Highland white terriers, Basset hounds, Dachshunds, Cocker spaniels, Shih Tzus, and
English setters (Plant et al. 1992; Bond et al. 1996b; Scott et al. 2001a). Furthermore,
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medications such as long-term glucocorticoid therapy may also be predisposing
factors (Scott et al. 2001a). However, some investigators suggested that antibiotic
treatment was associated with increased Malassezia populations (Plant et al. 1992),
whereas others did not support this point of view (Matousek & Campbell 2002).
1.3.3.2 Pathogenesis
The pathogenesis of Malassezia dermatitis in dogs has not been fully elucidated.
Several mechanisms by which M. pachydermatis might cause pathological changes
in the skin of dogs have been proposed. Zymogen in the yeast cell wall is capable of
activating the complement system. This can result in damage to epidermal integrity,
which is considered to cause epidermal spongiosis, inflammation and pruritus. The
damaged epidermal water barrier can also lead to an increase in humidity on the skin
surface thus favouring yeast proliferation (Mason 1993). As proteases are believed to
be the mediator of itch at free nerve endings in the skin, the proteases released by
Malassezia organisms may also contribute to the pruritus (Mason & Evans 1991).
Malassezia organisms produce lipases, which alter sebum production and produce
free fatty acids on the skin surface. Released lipid can be used by the yeast for
nutrition, and free fatty acids provide protection by inhibiting other organisms
(Mason et al. 1996). T cell-mediated immunity is important in prevention and
recovery from fungal infections. A deficient cell-mediated defense system may
predispose the host to overgrowth of Malassezia organisms (Mason 1993).
Additionally, the disrupted epidermal barrier could permit the skin immune system to
be exposed to Malassezia antigens and products, eliciting inflammatory and/or
hypersensitivity reactions (Scott et al. 2001a).
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1.3.3.3 Clinicalfeatures ofMalassezia dermatitis
1.3.3.3.1 Clinical presentation
Malassezia dermatitis occurs in dogs of any age, sex, and breed, but is more often
diagnosed in dogs between one and three years of age (Mason & Stewart 1993).
Some breeds also appear to be predisposed (listed in section 1.3.3.1). The dermatitis
often begins in the summer or highly humid months, which also corresponds to the
allergy season, and then persists into winter. There is a second spike of cases in early
spring (Mason 1993; Scott et al. 2001a).
Skin lesions may be localised or generalised. Regional dermatitis commonly occurs
in the external ear canal, or on the face, ventral neck, axillae, groin, interdigital skin
or intertriginous areas. Skin lesions are characterised by erythema, alopecia, greasy
exudation and varying degrees of scaling. Chronic cases can have marked
hyperpigmentation and lichenification. Pruritus varies from mild to extremely severe.
Dogs with generalised lesions often have an offensive, rancid or yeasty odour.
Malassezia paronychia may occur with or without more generalised Malassezia
dermatitis. It produces a reddish-brown staining of hairs or claws, with inflammation
of the surrounding soft tissue. Most dogs with Malassezia dermatitis have concurrent
dermatoses, especially hypersensitivity disorders, ectoparasitic infestation, bacterial
pyoderma, endocrinopathies, and keratinisation defects (Mason 1993; Mason &
Stewart 1993; Bond 1997; Morris 1999; Scott et al. 2001a).
1.3.3.3.2 Diagnosis
The criteria required for the diagnosis ofMalassezia dermatitis have not been firmly
established. It has been proposed that a diagnosis of "Malassezia dermatitis" is
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appropriate when a dog with elevated M. pachydermatis populations on lesional skin
shows a good clinical and mycological response to appropriate anti-fungal therapy
(Bond & Lloyd 1997). The diagnostic tools used to identify Malassezia yeasts on the
skin include cytological, cultural, and histopathological techniques.
Cytology
Cytological examination is a useful technique allowing Malassezia populations to be
rapidly assessed. A variety ofmethods have been used to collect cytological samples
for the evaluation of the organisms, including vigorously rubbing a cotton swab on
the skin surface, pressing a piece of clear acetate tape onto lesional skin several times,
making a superficial skin scraping, and directly impressing a glass slide onto lesional
skin (Mason 1993; Scott et al. 2001a). Cotton swabs and tape stripping are useful for
interdigital spaces. Tape stripping and skin scraping may be more effective for drier
areas. Direct impression with a glass slide is possible for flat surfaces with grease
and wax (Morris 1999; Scott et al. 2001a; Matousek & Campbell 2002). It is difficult
to determine which sampling method is the best since each has its own benefits and
disadvantages. It has been found that swabs, skin scrapings and impression smears
gave similar results in normal dogs (Kennis et al. 1996). Using dogs with elevated
cutaneous Malassezia populations as sampling subjects, Bond and Sant (1993)
observed relatively higher numbers of Malassezia organisms on materials prepared
by tape stripping and dry scraping than by damp swabs. Some investigators reported
that direct impression with a glass slide was the most reliable technique for
producing uniform cytological preparations (Plant et al. 1992).
With the exception of tape strips, the samples collected are transferred to a glass slide,
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heat-fixed, and stained with Diff-Quik®, Giemsa, Gram's or methylene blue. The
tape is dipped into Diff-Quik® solution II or stained with methylene blue without heat
fixation and applied to a glass slide with the sticky side down (Matousek &
Campbell 2002). The slides are examined under high power or with an oil immersion
lens on a light microscope. Microscopic examination reveals round to oval yeasts (3
to 8 pm in diameter) with monopolar budding (Figure 1.1). Yeasts are often seen in
clusters or adhered to keratinocytes (Scott et al. 2001a). As M. pachydermatis can be
found in a small number on healthy dog skin, it is difficult to define the amount of
yeast that is pathogenic. It has been suggested that populations should be considered
elevated if the yeast is readily identified (Bond 1997). Some investigators also
suggested that an elevated population is more likely when a certain number of yeast
is found (Scott et al. 2001a). The various criteria proposed include greater than 10
organisms in 15 randomly chosen oil-immersion microscopic fields (xlOOO) using
tape stripping samples, an average of greater than or equal to four organisms per oil-
immersion microscopic field, an average of greater than or equal to one organism in
10 oil-immersion microscopic fields, and greater than two organisms per high power
field (x400) with specimens obtained using any of the commonly used sampling
techniques.
Culture
Four methods have been described to culture Malassezia organisms from the skin,
including cotton swabs (Bond et al. 1995a), adhesive tapes (Noble & Somerville
1974; Kennis et al. 1996), contact plates (Bond et al. 1994a), and detergent scrubs
(Bond et al. 1995b). M. pachydermatis grows well on both Sabouraud's dextrose
agar and modified Dixon's agar at 32°C to 37°C. However, an atmosphere
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Figure 1.1 Cytological examination of a Diff-Quik® stained tape strip
obtained from the skin of a dog with Malassezia dermatitis (xlOOO)
Numerous round to oval or peanut-shaped budding yeasts are present.
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containing 5 to 10 percent carbon dioxide significantly increases the frequency of
isolation and colony counts on Sabouraud's dextrose agar, but not on modified
Dixon's agar (Bond & Lloyd 1996a). Nevertheless, modified Dixon's agar, a lipid-
supplemented medium, may be advantageous for diagnostic purposes because it
supports the growth ofmore lipid-dependent variants ofM. pachydermatis (Bond &
Anthony 1995) and the lipid-dependent Malassezia spp. that may be found on cats
(Bond et al. 1996a; Bond et al. 1997; Bensignor et al. 1999; Crespo et al. 1999).
Since Malassezia spp. are commensal organisms and elevated populations can be
readily found on cytology, culturing is not usually necessary and is of little practical
diagnostic value (Scott et al. 2001a; Matousek & Campbell 2002).
Histopathology
Malassezia organisms may also be demonstrated by microscopic examination of skin
biopsy specimens (Figure 1.2 A-C). The yeasts are located in the stratum corneum
(Figure 1.2 C) and are occasionally seen in the follicular infundibulum. Due to the
possible loss or disruption of the stratum corneum during processing, skin biopsy is
generally considered to be less sensitive and reliable than other diagnostic tools.
There are several characteristics in skin biopsy samples from dogs with Malassezia
dermatitis (Scott & Miller 1989; Yager 1994; Mauldin et al. 1997; Muse 2000; Nett
et al. 2001; Scott et al. 2001a). The epidermis is characterised by marked irregular
hyperplasia with formation of deep rete ridges (Figure 1.2 A). Hyperplasia can also
be seen in the follicular infundibula. Orthokeratotic hyperkeratosis with focal
parakeratosis is frequently observed. Spongiosis is marked in active lesions (Figure
1.2 B). The dermal inflammation is usually superficial perivascular to interstitial with
lymphocyte exocytosis and focal accumulations of neutrophils. Eosinophils are
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Figure 1.2 A-C Histopathology of canine Malassezia dermatitis (x40, x250,
x400)
A: Irregular epidermal hyperplasia and hyperkeratosis. B: The epidermis shows
marked spongiosis and orthokeratotic hyperkeratosis with focal parakeratosis.
Malassezia yeasts are visible in the stratum corneum (thin arrow). Some
keratinocytes show multiple nucleoli, indicating mitotic activity (bold arrows). C:
Budding yeasts showing characteristic morphology of Malassezia spp. (thin
arrows). Scale bars for A, B, and C are 100, 10, and 10 pm, respectively. The glass
slide was kindly provided by Dr. S. Rhind, University of Edinburgh.
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present occasionally. Linear alignment of mast cells at the dermoepidermal juction
can also be observed in some affected dogs (Mauldin et al. 1997; Beningo et al.
2000). Scott and Miller (1989) described a hyperplastic dermatosis associated with
secondary M. pachydermatis infection in West Highland White Terriers. The
epidermal hyperplasia in these dogs took the form of round bottomed rete ridges,
which the investigators described as epidermal dysplasia.
1.3.3.3.3 Treatment
The treatment of Malassezia dermatitis is currently based on topical and systemic
anti-fungal therapy (Morris 1999). A combination of topical and systemic therapy
can speed resolution of the disease and increase efficacy (Scott et al. 2001a;
Matousek & Campbell 2002).
Topical agents that can be used for Malassezia dermatitis include chlorhexidine,
clotrimazole, enilconazole, ketoconazole, miconazole, nystatin and selenium sulfide
(Mason 1993; Scott et al. 2001a). It has been reported that M. pachydermatis showed
sensitivity, in decreasing order of efficacy, to ketoconazole, econazole, clotrimazole,
miconazole, and nystatin in vitro (Kiss et al. 1997). These agents are used in various
forms of topical anti-fungal products such as sprays, ointments, and shampoos. A
double-blind study demonstrated that a shampoo containing 2 % chlorhexidine and 2
% miconazole (Malaseb®, Leo Animal Health) when used every three days for three
weeks was effective for treating Malassezia dermatitis in dogs due to its degreasing,
anti-Malassezia, and anti-bacterial properties (Bond et al. 1995c).
The commonly used systemic agents forMalassezia dermatitis in dogs are the azoles.
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Ketoconazole or itraconazole are usually given at 5-10 mg/kg/day PO for 21-30 days
(Morris 1999; Matousek & Campbell 2002). However, adverse effects including
anorexia, vomiting, diarrhoea, and hepatotoxicity have been reported (Morris 1999).
A recent study demonstrated that itraconazole given at 5 mg/kg q 24h PO on 2
consecutive days per week for 3 weeks (pulse administration) was as effective as
when given at 5 mg/kg q 24h PO daily for 21 days in treating canine Malassezia
dermatitis (Pinchbeck et al. 2002).
Clinical improvement usually occurs within 7 to 14 days after initiation of anti¬
fungal therapy. As Malassezia dermatitis in dogs is usually associated with an
ongoing disorder, the dog should be evaluated for concurrent diseases. For frequently
recurring cases, shampoo therapy or pulse oral medication may be used
prophylactically (Bond 1997; Morris 1999; Scott et al. 2001a).
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1.4 Cutaneous responses to Malassezia organisms
The skin is continually challenged by a variety of environmental hazards. The first
line of defense and protection is provided by the epidermis, the outermost skin layer
(Eckert et al. 1997). The epidermis protects the body from water loss, UV damage,
mechanical injury, microbiological invasion, and immunological insults. The
predominant cell type of the epidermis, the keratinocyte, provides mechanical
protection from parasites and microorganisms, and it also forms the first line of
immunological defense against environmental or microbiological antigens and
allergens (Blumenberg & Tomic-Canic 1997).
The skin tends to respond to environmental insults by activating the skin immune
system and increasing the thickness of the skin. The latter results from increased
proliferation of cells in the basal layer of the epidermis, leading to epidermal
hyperplasia, hyperkeratosis and lichenification as seen clinically. Inflammation and
lichenification are generally seen in the skin of dogs with Malassezia dermatitis
(section 1.3.3.3.1), indicating that both protective mechanisms are involved in the
disease process. Aspects of these two mechanisms were investigated in the studies
described in chapters 3-6, and the two mechanisms are discussed in detail in the
following two sections.
1.4.1 The immune response to Malassezia organisms
The skin immune system consists of cells residing in the skin, including
keratinocytes, Langerhans' cells, dermal dendrocytes, and mast cells, as well as skin-
seeking T lymphocytes and endothelial cells of cutaneous post-capillary venules
(Yager 1993). It functions in conjunction with humoral substances, such as secretory
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immunoglobulins and cytokines, to deal with challenges from both exogenous and
endogenous antigens, to mount effector responses of various types, and to balance
the response to minimise tissue damage while eliminating the original insult (Yager
1993). Defects in both innate and acquired immune responses may lead to the
development of skin diseases. In sections 1.4.1.1 and 1.4.1.2, the literature regarding
the immunological responses to Malassezia organisms in both humans and dogs are
reviewed.
1.4.1.1 Non-allergic immunological responses to Malassezia organisms
Immunoglobulins specific to the yeast phase of Malassezia organisms have been
studied in normal human individuals with no history of skin disease at various age
ranges. Sohnle et al. (1983) measured IgM, IgG and IgA antibodies against
Malassezia organisms by ELISA in sera from 21 young subjects (aged 23-44) and 20
elderly subjects (aged 70-88), none ofwhom had a history of "significant" superficial
fungal infections. It was found that all three classes of immunoglobulins to
Malassezia organisms were present in both the young and elderly groups, and the
responses of the two groups were very similar, except for the IgM response. The
level of Malassezia-specific IgM in the elderly group was significantly lower than
that in the young subjects. In another study investigating Malassezia-specific IgG in
the sera of normal individuals aged from 29 to 81, the antibody titers were shown to
decline with increasing age, which paralleled the decreasing populations of
Malassezia organisms detected on the skin of elderly people (Bergbrant &
Faergemann 1988). Lower titers ofMalassezia-specific IgG have also been reported
in healthy children. Substantially lower levels of Malassezia-specific IgG were
detected in sera from five healthy 6 month-old children compared to 10 healthy
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adults, but no statistical analysis was performed on the results in this study
(Johansson & Faergemann 1990). Cunningham et al. (1992) studied IgM, IgG and
IgA responses to M. furfur serovar A, B and C in normal individuals divided into 5
age groups, including 2-3 years, 7-10 years, 20-24 years, 33-40 years, and 60-64
years. There was no significant difference in the titers of the three immunoglobulins
between age groups as measured by ELISA, except that the subjects aged between 60
and 64 had significantly lower Malassezia-specific IgM titers than the others. The
Malassezia-specific IgA level was found to be low in all groups, suggesting that
mucosal sensitisation by the yeast might not be important. Due to the difficulties in
producing the mycelial phase of Malassezia organisms in vitro, very few
investigators have studied the humoral responses to the mycelium of the yeast. One
study reported that healthy adults had detectable IgM, IgG, IgG subclasses and IgA
to mycelial antigens of Malassezia organisms in their sera, with the highest titers
being found for IgG (cited in Ashbee & Evans 2002).
Considerably fewer studies have been carried out on cell-mediated immunity to
Malassezia organisms in healthy human individuals at various ages. In order to gain
a clearer picture of cell-mediated immunity to the yeast, Ashbee and Evans (2002)
collated data from control subjects in various studies ranging from 8 to 61 years of
age. They concluded that Malassezia organisms could elicit significant cell-mediated
immune responses in healthy individuals as measured by lymphocyte transformation
assays or a leucocyte migration inhibition assay. Also, the responses were similar in
different age groups, suggesting that the level of cell-mediated immunity to
Malassezia organisms remains fairly constant throughout life. One recent study
looking at cell-mediated immunity to the mycelial phase of Malassezia organisms
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reported that positive responses were detected in 75 % of the healthy individuals
studied using a leucocyte migration inhibition assay (Saadatzadeh et al. 2001).
Bond et al. (1998) studied the humoral and cell-mediated immune responses to M.
pachydermatis in healthy dogs and dogs with Malassezia dermatitis using ELISA
and a lymphocyte proliferation assay. Serum titers of Malassezia-specific IgG and
IgA in seborrheic Basset hounds with high cutaneous populations of M.
pachydermatis and affected dogs of various breeds were found to be significantly
greater than those of healthy Basset hounds and healthy Beagles. The investigators
concluded that high serum titers of IgG and IgA do not prevent seborrheic dermatitis
associated with M. pachydermatis in either Basset hounds or other breeds. The
peripheral blood mononuclear cell (PBMC) proliferative responses to M.
pachydermatis antigens at a concentration of 500 pg/ml in seborrheic Basset hounds
and Irish setters with gluten-sensitive enteropathy were significantly lower than those
in healthy Basset hounds. There was no significant difference between the PBMC
responses of the first two groups and healthy Beagles. The responses to Malassezia
antigens at 50 pg/ml in the four groups of dogs, however, did not vary significantly.
The role of reduced PBMC responses to M. pachydermatis in the pathogenesis of
Malassezia dermatitis in seborrheic Basset hounds is yet unclear.
1.4.1.2 Immunological responses to Malassezia organisms in atopic dermatitis
Elevated cutaneous populations ofMalassezia organisms have been associated with
atopic dermatitis both in man and dogs. The immune response to the yeast in human
patients with atopic dermatitis has been studied extensively, and their role as an
allergen in some atopic patients has been reviewed (Faergemann 1999; Scheynius et
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al. 2002). In contrast, relatively few studies have been documented in dogs. Based on
information from the existing literature, a hypothesis to explain the mechanisms by
which overgrowth of M. pachydermatis might cause hypersensitivity reactions in
dogs with atopic dermatitis can be formulated (summarised in Figure 1.3). It is
postulated that M. pachydermatis on the skin surface releases antigens that penetrate
the skin and are captured by epidermal Langerhans' cells or dermal dendritic
antigen-presenting cells. These cells would then migrate to regional lymph nodes and
present the antigen to a T lymphocyte through a major histocompatibility complex
(MHC) class II molecule, which in cooperation with different environmental
cytokines stimulates T helper (Th) 0 precursor cells to differentiate into Thl cells or
Th2 cells. A cytokine environment dominated by IL-12 favours Thl cell
development, whereas IL-4 and IL-13 stimulate the development of Th2 cells. Th
cells would active B lymphocytes and stimulate them to differentiate into antibody-
forming plasma cells. By secreting IL-2 and IFN-y, Thl cells promote IgG
production, whereas Th2 cells produce IL-4 and IL-13 that promote immunoglobulin
class switching to IgE. The role ofMalassezia-specific IgG antibodies in atopic dogs
with Malassezia dermatitis is currently unclear. The IgG antibodies might provide
some protective immunity against Malassezia organisms. Alternatively, they might
activate the complement system causing epidermal damage and inflammation. The
allergen-specific IgE antibodies would bind to the receptors on the surface of mast
cells and thus sensitise them. Subsequent exposure to Malassezia allergens would
cross-link surface-bound IgE and trigger the release of a variety of inflammatory
mediators from mast cells, resulting in clinical symptoms of Type I hypersensitivity
reactions (Figure 1.3). The evidence in the literature that supports this proposed



























Figure 1.3 Possible pathways for immunological responses stimulated by
Malassezia organisms in atopic dermatitis
Malassezia organisms on the skin surface might release antigens (Ag) that
penetrate the skin and be captured by an antigen-presenting cell (APC). The APC
would then present the antigens to a T lymphocyte. The cytokines present in the
environment determines which T cell subset is produced from ThO cells. IL-12
stimulates development of T helper 1 (Thl) cells. IL-4 and IL-13 favour the
production of T helper 2 (Th2) cells. Thl cells secrete IL-2 and IFN- y that induce
IgG responses. Malassezia-specific IgG might be protective or activate
complement provoking inflammation. Th2 cells secrete IL-4 and IL-13 that induce
allergen-specific IgE responses. The IgE antibodies bind to mast cells and cross¬
link upon subsequent encounter with allergens, which triggers mast degranulation
and causes clinical features ofType I hypersensitivity reactions.
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1.4.1.2.1 Antigen release, penetration, and presentation
It has been suggested that entry through the skin is the most likely mechanism by
which Malassezia organisms stimulate the immune system in human patients with
atopic dermatitis (Scheynius et al. 2002). A recent study demonstrated that M. furfur
was able to invade human keratinocytes and resist phagolysosome fusion (Baroni et
al. 2001a). It has also been reported that the first cloned Malassezia allergen (Mai s
1), a major allergen that is localised to the cell wall, can be released into the culture
medium (Scheynius et al. 2002). These findings support the hypothesis that
Malassezia organisms can penetrate the epidermal barrier and probably release
allergens in the skin, where both whole organisms and allergenic components would
come into contact with Langerhans' cells in the epidermis. Uptake ofwhole M. furfur
yeast cells and various allergenic components from the yeast, including M. furfur
extracts, rMal f 5 and M. furfur mannan, has been demonstrated in vitro using
immature monocyte-derived dendritic cells (MDDCs) which reflect Langerhans'
cells in the skin (Buentke et al. 2000). These results suggest that sensitisation of
atopic patients to M. furfur can be mediated by immature dendritic cells in the
absence of IgE in the skin. The intemalisation was shown to occur via binding to the
mannose receptor (other receptors may also be involved) or pinocytosis (Buentke et
al. 2000). The presence of M. furfur was also shown to induce maturation of
immature MDDCs by up-regulation of CD83 expression, and increase in expression
of co-stimulatory molecules, CD80 and CD86 (Buentke et al. 2001). The mature
dendritic cells are poor at antigen uptake, but excellent at presenting antigens. They
would then efficiently present antigen-derived peptides on MHC molecules to T cells
(Banchereau & Steinman 1998).
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There has been some evidence implying that the interaction between Malassezia
antigen-bearing antigen-presenting cells (APCs) and T cells takes place in the skin. It
has been observed that in P. orbiculare patch test-positive atopic dermatitis patients,
an infiltration ofCD4+ T cells was detected at 24 hours at the patch test sites, but was
more pronounced at 72 hours (Tengvall Linder et al. 2000). The expression of
intercelluar adhesion molecules (ICAM)-l and human leucocyte antigen (HLA)-DR
in the dermis of these patients was also up-regulated. At 24 hours post-test, the
former correlated with the scale of the dermal CD3+ infiltrates, with the majority
being CD4+ (Tengvall Linder et al. 2000).
To date, the release, penetration and presentation of Malassezia antigens into/in the
skin of dogs has not been studied. However, there are some data providing indirect
evidence for a transepidermal route of antigen penetration. Higher numbers of
Langerhans' cells have been detected in lesional atopic skin compared to clinically
normal atopic or normal control canine skin (Day 1996; Olivry et al. 1996). These
cells were present in clusters in lesional skin of dogs with atopic dermatitis (Olivry &
Hill 2001). Expression of surface IgE was also observed on epidermal Langerhans'
cells in lesional atopic canine skin (Olivry et al. 1996), and those cells are
responsible for allergen capture and presentation (Olivry & Hill 2001). Moreover,
eosinophils can be seen below the stratum corneum in lesional atopic canine skin, but
not in clinically normal atopic skin (Olivry et al. 1997). Canine atopic skin also
exhibits hyperplasia of T lymphocytes expressing the gamma-delta T-cell receptor
(Olivry et al. 1997). Furthermore, transepidermal penetration of staphylococcus
antigens has been demonstrated in dogs (Mason & Lloyd 1989). Taken together,
these findings indicate that it is likely that M. pachydermatis may be able to release
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antigens that would penetrate the skin of atopic dogs where they are captured by
epidermal APCs, Langerhans' cells, and thus initiate the process of antigen
presentation to T cells and a cascade of immunological responses.
1.4.1.2.2 Cell-mediated immune responses
Cell-mediated immune responses to Malassezia organisms have been investigated
both in man and dogs using lymphocyte proliferation assays. In humans, it has been
shown that immature MDDCs pre-incubated with M. furfur induced a proliferative
response in autologous PBMCs in a dose-dependent manner (Buentke et al. 2001).
The proliferative responses of PBMCs to Malassezia organisms (P. orbiculare or P.
ovale) in human patients with atopic dermatitis have been demonstrated to be
significantly higher than that in healthy individuals in several studies (Rokugo et al.
1990; Tengvall Linder et al. 1996; Tengvall Linder et al. 1998; Savolainen et al.
2001). Furthermore, atopic patients with specific IgE antibodies against P. orbiculare
or P. ovale were shown to have increased synthesis of the Th2-related cytokines, IL-4,
IL-5, and IL-10, by Pityrosporum-stimulated PBMCs (Kroger et al. 1995; Tengvall
Linder et al. 1998). The results of several studies investigating the correlation
between PBMC proliferation and skin test responses to Malassezia antigens are
inconsistent. Some investigators reported that a correlation was not found between
the PBMC proliferation and the skin prick test (SPT) or atopy patch test (APT) in
atopic dermatitis patients (Rokugo et al. 1990; Tengvall Linder et al. 2000). In
contrast, Johansson et al. (2002) showed a correlation between PBMC proliferation
in response to in vitro stimulation with Malassezia extracts and M. furfur APT
reactions in atopic patients with positive SPT reactions to the yeast. Additionally,
both PBMC proliferation and APT reactions to Malassezia extracts were also found
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to correlate with the production of Th2-related cytokines, IL-4, IL-5, and IL-13, by
PBMCs in these patients (Johansson et al. 2002). In one study investigating T
lymphocyte clones isolated from lesional atopic skin, the majority of the T cells that
were reactive for P. orbiculare showed a Th2 or Th2/Th0 like cytokine profile
(Tengvall Linder et al. 1996). By examining T cell receptor usage to determine
whether Malassezia organisms can act as superantigens, no evidence has been found
for superantigenic activity by P. orbiculare in patients with atopic dermatitis
(Johansson et al. 1999).
The PBMC response to M. pachydermatis in atopic dogs has been studied recently.
Atopic dogs with cytological evidence of Malassezia overgrowth had significantly
higher PBMC responses to extracts ofM. pachydermatis than clinically normal dogs.
Atopic dogs without Malassezia overgrowth had PBMC responses that fell between
those of the above two groups (Morris et al. 2002). A significant correlation was not
found between the PBMC proliferation and intradermal test response to M.
pachydermatis in atopic dogs in this study (Morris et al. 2002).
1.4.1.2.3 Humoral immune responses
Using in vitro serological tests such as ELISA and the radioallergosorbent test
(RAST), Malassezia-specific IgE has been detected in human atopic patients for over
a decade. Kroger et al. (1995) studied the effect of Malassezia extracts on IgE
production by PBMCs in vitro. They found that IgE synthesis by PBMCs from atopic
dermatitis patients with specific IgE for Malassezia organisms (RAST+) was
significantly higher compared with RAST(-) atopic dermatitis patients or normal
controls as measured by ELISA. Also, stimulation with Malassezia extracts and IL-4
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led to a dose-dependent increase in IgE synthesis from PBMCs only in RAST(+)
atopic patients, indicating a Th2-type skewed response toward Malassezia organisms
in these patients (Kroger et al. 1995). Several studies comparing the titers of IgE
specific to Malassezia organisms have revealed similar results. Patients with atopic
dermatitis were found to have significantly higher levels ofMalassezia-specific IgE
in their sera compared to those with other atopic diseases or healthy individuals
(Young et al. 1989; Wessels et al. 1991; Nordvall et al. 1992; Savolainen et al. 2001).
Two studies investigating IgE antibodies against Malassezia organisms in children
and young adults (up to 21 years age) also showed that these antibodies were
detected significantly more frequently in those with atopic dermatitis than the other
two groups (Nordvall & Johansson 1990; Broberg et al. 1992). The Malassezia-
specific IgE, but not the total IgE in serum, has been found to correlate with the
degree of APT response to Malassezia extracts at 48 hours post-test in atopic
dermatitis patients (Tengvall Linder et al. 2000). To the author's knowledge, only
one study investigating specific IgE antibodies to M. pachydermatis in atopic dogs
using an in vitro serological test has been documented to date. Significantly higher
levels ofMalassezia-specific IgE, measured by ELISA, were detected in atopic dogs
with or without Malassezia dermatitis and/or otitis than either healthy dogs or non-
atopic dogs with clinical evidence of Malassezia overgrowth in the skin and/or ear
canals (Nuttall & Halliwell 2001). However, the difference between the atopic
groups was not significant (Nuttall & Halliwell 2001). The Malassezia-specific IgE
antibodies in human and canine atopic patients may play a key role in enhancement
of immune responses. The specific IgE antibodies to allergens can bind to
Langerhans' cells in the skin, where the allergen capturing and presenting capacity of
these APCs can be improved by the membrane-bound IgE upon a second encounter
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with the allergen (Mudde et al. 1990; Maurer et al. 1995).
In contrast to the IgE response to Malassezia organisms in atopic human patients, no
significant difference in Malassezia-specific IgG concentrations was found between
adult patients with atopic dermatitis and healthy individuals as measured by in vitro
serological tests (Tengvall Linder et al. 2000; Savolainen et al. 2001). However, one
study reported significantly elevated Malassezia-specific IgG concentrations in
young adult patients with atopic dermatitis aged between 16 and 21 years (Broberg et
al. 1992). The investigators proposed that this probably reflected increased exposure
to the organisms through atopic skin and a tendency for IgG to follow IgE production.
No correlation has been found between Malassezia-specific serum IgG levels and
APT responses to the yeast in patients with atopic dermatitis (Tengvall Linder et al.
2000). It is, therefore, considered that determination of Malassezia-specific IgG
concentrations seems to have little value in the diagnosis ofMalassezia sensitization
in atopic human patients (Tengvall Linder et al. 2000; Scheynius et al. 2002).
It has been demonstrated that atopic dogs with or without cytological evidence ofM.
pachydermatis overgrowth had significantly higher serum titers of Malassezia-
specific IgG than healthy dogs as measured by ELISA (Nuttall & Halliwell 2001).
However, there was no significant difference between atopic dogs with and without
Malassezia overgrowth (Nuttall & Halliwell 2001). The role of the IgG response to
Malassezia organisms in the pathogenesis of atopic dermatitis is yet unclear, both in
humans and in dogs. IgG antibodies are known to be able to act as opsonins coating
microorganisms and to activate phagocytes, which in turn ingest and destroy
extracellular pathogens (Janeway et al. 1999). This could provide protection for the
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host. Nevertheless, IgG antibodies can also activate the complement system, as has
been demonstrated with M. furfur (Belew et al. 1980; Sohnle & Collins-Lech 1983),
and produce inflammatory responses (Janeway et al. 1999). The precise function of
Malassezia-specific IgG antibodies remains to be elucidated.
1.4.1.2.4 Mast cell responses
The mast cell response to Malassezia antigens has been investigated with intradermal
tests (IDT) or SPT in human atopic patients. One study comparing the two test
methods with Malassezia extracts showed that a higher percentage of patients with
atopic dermatitis reacted positively in IDT than in SPT (Young et al. 1989). However,
positive IDT reactions to Malassezia extracts were also seen in some patients with
other atopic diseases, whereas all the atopic controls gave negative results in SPT
(Young et al. 1989). Studies using SPT to detect hypersensitivity to Malassezia
organisms have shown an increased sensitivity in patients with generalised atopic
dermatitis (Young et al. 1989; Rokugo et al. 1990; Broberg et al. 1992) or those with
lesions predominantly in the head and neck (Waersted & Hjorth 1985; Kieffer et al.
1990; Nissen et al. 1998). The SPT results have also been found to correlate with
levels ofMalassezia-specific IgE in the serum (Broberg et al. 1992; Kim et al. 1999),
and with results of basophil histamine release tests (Kieffer et al. 1990), but not with
the severity of atopic dermatitis (Kim et al. 1999).
Positive IDT results to Malassezia extracts have also been reported in atopic dogs.
Immediate hypersensitivity responses to intradermal injections ofM. pachydermatis
extracts at concentrations which caused no reaction in healthy dogs have been
observed in atopic dogs with Malassezia dermatitis, although they were also seen in
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some atopic dogs without Malassezia dermatitis (Morris et al. 1998). Nevertheless,
the reactivity to the extracts in atopic dogs with cytological evidence of Malassezia
overgrowth was significantly higher than that in atopic dogs without (Morris et al.
1998). Bond et al. (2002a) investigated the frequency of IDT reactivity to M.
pachydermatis extracts in atopic dogs and reported similar results. In this study,
atopic dogs were not grouped according to their cytological findings of Malassezia
populations. However, the frequencies of positive reactivity to the extract in atopic
dogs were found to be significantly greater than that in healthy beagles (Bond et al.
2002a). In contrast, the frequency of immediate hypersensitivity responses to M.
pachydermatis extracts in non-atopic dogs with Malassezia dermatitis is low. One
recent study investigating IDT reactivity to M. pachydermatis in 8 healthy basset
hounds, 17 basset hounds with Malassezia dermatitis, and 19 healthy beagles
reported that only two affected basset hounds and one healthy beagle showed
immediate hypersensitivity reactions (Bond et al. 2002b). Additionally, a preliminary
report has demonstrated positive immediate hypersensitivity reactions to extracts
from M. pachydermatis using passive cutaneous anaphylaxis tests (Morris & DeBoer
2002). Non-atopic dogs received pooled sera from atopic dogs with Malassezia
dermatitis that were IDT positive to Malassezia extracts and serum from an atopic
dog with Malassezia dermatitis exhibiting high levels of anti-Malassezia IgE on an
ELISA assay. Positive IDT responses were observed in the recipients following
subsequent injection of the yeast extract, indicating that anti-Malassezia IgE
antibodies are functional in Type I hypersensitivity reactions (Morris & DeBoer
2002). Taken together, these findings suggest that Type I hypersensitivity responses
to M. pachydermatis allergens may be involved in the pathogenesis and contribute to




The evidence in the literature suggests that similar pathogenetic mechanisms may
occur in canine and human atopic patients with Malassezia overgrowth. Although it
has been demonstrated that atopic dogs have elevated levels of Malassezia-specific
IgG and IgE in their serum (Nuttall & Halliwell 2001), the specific IgG or IgE
binding proteins from M. pachydermatis have not been investigated in these dogs.
Hence, the first aim of the studies in this thesis was to characterise the humoral
immune responses to M. pachydermatis by comparing Malassezia-specific IgG and
IgE responses to individual antigens of the yeast in atopic dogs, with or without
Malassezia dermatitis, and normal dogs. The identified allergens could be further
purified, analysed, and cloned as recombinant proteins, which could potentially be
used for diagnostic purposes and immunotherapy in affected dogs in the future.
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1.4.2. Epidermal hyperplasia associated with Malassezia dermatitis
The skin acts as a barrier to prevent invasion of microorganisms and its barrier
function is largely provided by the epidermis. The process by which the stratum
corneum is continually renewed through keratinisation of the epidermal cells may
also provide a form of defense against cutaneous microorganisms. It has been
considered that epidermal proliferation is important in the defense against superficial
mycoses. The renewing process results in continuous shedding of the stratum
corneum, which may remove fungal microorganisms (Wagner & Sohnle 1995).
Similar to other chronic inflammatory dermatoses, Malassezia dermatitis is often
associated with epidermal hyperplasia, which is a protective mechanism seen in the
skin in response to a variety of environmental insults. However, the mechanism by
which epidermal hyperplasia occurs in Malassezia dermatitis is not understood. It
could be due to any of the mechanisms described in Figure 1.4. The organism might
secrete proteins acting as growth factors and/or interact with surface molecules of
keratinocytes, which convey signals to stimulate their proliferation. Alternatively, the
organism might play an indirect role and the epidermal hyperplasia could be caused
by immune responses stimulated by the yeast or other underlying diseases commonly
associated with Malassezia dermatitis (section 1.3.3.1). Many of these underlying
diseases can cause inflammation and self trauma, which could then lead to the
formation of epidermal hyperplasia (Figure 1.4). In the following sections, the
process by which basal epidermal cells undergo continued cell division and move the
resulting keratinocytes toward the skin surface, and the literature regarding the
interaction between keratinocytes and Malassezia organisms, are reviewed.
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Figure 1.4 Possible mechanisms for the formation of epidermal hyperplasia in
Malassezia dermatitis
The epidermal hyperplasia seen in Malassezia dermatitis might be due to a direct
effect of M. pachydermatis or an indirect effect of the organism. Malassezia
organisms might secrete proteins or interact with keratinocytes, which could have a
direct effect on their proliferation. Alternatively, M. pachydermatis might be an
indirect factor in the proliferation of keratinocytes. In this case, the formation of
epidermal hyperplasia could be induced by immune responses stimulated by the
organism, or inflammation and self trauma caused by other underlying diseases
commonly associated with Malassezia dermatitis.
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1.4.2.1 Theprocess ofkeratinocyte differentiation
1.4.2.1.1 The structure of the epidermis
The epidermis can be divided into basal (stratum basale), spinous (stratum spinosum),
granular (stratum granulosum), and cornified (stratum corneum) layers based on the
morphologic features and the state of differentiation the cells assume as they undergo
progressive differentiation to form a stratum corneum (Eckert 1989; Credille 2000;
Scott et al. 2001b). A schematic representation of these layers is shown in Figure 1.5.
There are four distinct cell types in the epidermis, including keratinocytes,
melanocytes, Langerhans' cells and Merkel's cells, with keratinocytes forming the
majority (Scott et al. 2001b). The review below focuses on keratinocytes.
Basal layer
The stratum basale is a single row of columnar cells in direct contact with the
basement membrane that separates the epidermis from the dermis. Most of these cells
are keratinocytes. They contain two different adhesion structures, hemidesmosomes
and desmosomes. Hemidesmosomes are located at the junction between basal cells
and the basement membrane, and desmosomes mediate adhesion between adjacent
basal cells (Eckert 1989). Basal keratinocytes are the only mitotically active
keratinocytes in the normal epidermis, and their mitotic activity provides for
continual renewal of the epidermis, which is termed proliferation (Kwochka 1993).
There is morphologic and functional heterogeneity in basal keratinocytes. Some cells
serve primarily to anchor the epidermis to the basement membrane, and others













Figure 1.5 Schematic representation of the epidermis
During the process of differentiation, keratinocytes undergo morphological and
structural changes. Basal cells are columnar and adhered to the basement membrane.
The adhesion complexes at the basal surface of keratinocytes in the basal layer are
hemidesmosomes, and those at the junction of adjacent cells are desmosomes. The
keratinocytes in the spinous layer are larger and more flattened than basal cells.
Granular layer cells contain lamellar and keratohyalin granules. Corneocytes are
anuclear and characterised by their cornified envelopes.
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Spinous layer
Immediately above the basal layer is the stratum spinosum that is composed of the
daughter cells of the basal layer. The keratinocytes in this layer are morphologically
larger and more flattened than those in the basal layer (Eckert 1989). Spinous cells
contain prominent keratin filament bundles that form a complex intracellular
cytoskeleton and function in conjunction with desmosomes to provide stability
across the cell layers. The keratinocytes in the spinous layer synthesise lamellar
granules (also called membrane-coating granules or Odland bodies) which are filled
with lipid (Scott et al. 2001b). Lamellar granules are evident in the superficial
keratinocytes of the spinous layer although they are more prominent in the cells of
the granular layer (Kwochka 1993). They eventually release the lipid contents into
the intercellular space, which is important in barrier function of the skin and
intercellular cohesion within the stratum corneum (Suter et al. 1997).
Granular layer
Above the spinous layer is the granular layer, in which the keratinocytes are thin and
flattened with keratohyalin granules in the cytoplasm. Keratohyalin granules are
insoluble aggregates of the structural protein profilaggrin, which is synthesised in the
granular layer and is the precursor of filaggrin. Filaggrin, an interfilamentous matrix
protein, aids in aggregation of keratin filaments into macrofilaments in preparation
for the formation of the cornified layer (Suter et al. 1997).
Cornified layer
The outermost layer of the epidermis is the stratum corneum. The cornified cells
(often called corneocytes) represent the end stage of epidermal differentiation. They
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are anuclear, thin, and present in layers (Kwochka 1993). Corneocytes have a highly
specialised structure, the cornified envelope, which is formed beneath the plasma
membrane during terminal differentiation. The cornified envelope provides structural
support to the cell and resists invasion of microorganisms and external injurious
agents. Corneocytes are eventually sloughed from the skin surface, and the gradual
desquamation is balanced by proliferation of the basal cells, which maintains a
constant epidermal thickness (Eckert 1989; Scott et al. 2001b).
1.4.2.1.2 Epidermal kinetics
In order to maintain normal epidermal anatomy and physiology, a balance exists
between the rate at which new keratinocytes are produced through proliferation in
the basal layer and the rate of loss of terminally differentiated cells from the
comified layer. In dogs, the mitotic activity is confined to the basal layer cells that
undergo proliferative kinetic cycles, whereas in human skin suprabasilar cells are
also mitotically active (Kwochka 1993). A major concept of epidermal kinetics is the
"turnover time", which is the amount of time for the whole cell population to replace
itself. This depends both on the time taken for individual cells to divide, the cell
cycle time, and the proportion ofbasal cells dividing, the growth fraction (Eady et al.
1998).
The cell cycle is an orderly sequence of events performed by a cell in order to
reproduce in which the cell duplicates its contents and then divides into two (Alberts
et al. 2002a). The cell cycle time represents the interval between two successive
mitoses (Eady et al. 1998). A proliferating cell goes through a cell cycle which
consists of four phases: Gl, S, G2, and M phases (Figure 1.6). G1 phase is the post-
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mitotic growth phase, in which the cell increases in mass and monitors its
environment. S (S for synthesis) phase is one of the two major events of the cell
cycle, and it is the phase when DNA duplication occurs. Following S phase is the G2
phase, a pre-mitotic growth phase, in which the cell can further increase its mass
before division. M (M for mitosis) phase is the other major phase of the cell cycle in
which mitosis occurs and the cell is divided leading to the formation of two daughter
cells. The two cells then enter the G1 phase. If extracellular conditions are
unfavorable, some cells may delay progress through G1 and enter a resting state
known as GO (Figure 1.6). These cells may be stimulated to re-enter the proliferative
cycle by various stimuli. If the extracellular environment is favorable with the
presence of stimulating factors, cells in early G1 or GO progress through a
commitment point near the end of G1 known as the restriction point. After passing
this point, cells are committed to DNA replication, regardless of whether the
stimulating factors are removed. After several proliferative cycles, some cells leave
the cycle and undergo terminal differentiation (Eady et al. 1998; Hill 2000; Alberts et
al. 2002a).
The growth fraction is the proportion of basal cells that are proliferative at any one
time, which is about 60 % in the normal skin (Eady et al. 1998). In dogs, the turnover
time for the viable epidermis (stratum basale to stratum granulosum) is
approximately 22 days. In wound areas or the skin of dogs with seborrhea, this can
be greatly reduced (Scott et al. 2001b). High rates of cell production can be achieved




Figure 1.6 The phases of the cell cycle
The cell grows continuously in interphase, which consists of three phases, Gl, S,
and G2 phases. Gl: post-mitotic growth phase; S: DNA synthesis; G2: pre-mitotic
phase. In the M phase, the cell undergoes mitosis to generate an identical daughter
cell. The cell may also temporarily leave the cell cycle and enter a resting state
known as GO phase, in which it does not proliferate. The cell in GO phase can re¬
enter the cell cycle following various stimuli. As some keratinocytes in the basal
layer of the epidermis mature, they leave the cell cycle and undergo terminal
differentiation.
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1.4.2.1.3 The regulatory factors of epidermal proliferation and differentiation
There are a number of factors that have been shown to regulate keratinocyte
proliferation and differentiation. These factors are summarised in Table 1.1. The
factors that stimulate keratinocyte proliferation will be discussed in further detail in
chapter 5 (sections 5.1.1 and 5.6.1).
Table 1.1 Factors known to regulate keratinocyte proliferation and differentiation
Stimulation of proliferation Inhibition of proliferation/
stimulation of differentiation
Growth factors Transforming growth factor P (TGF-P)
Epidermal growth factor family Interferon y (IFN-y)
Epidermal growth factor (EGF) High calcium concentration
Transforming growth factor a (TGF-a) Vitamins
Heparin-binding EGF-like growth factor 1,25-dihydroxyvitamin D3




Fibroblast growth factors (FGF) 1, 2, and 7*







Low concentrations of retinoic acid (10"7-106 M)
*FGF 7 is also known as keratinocyte growth factor (KGF)
1.4.2.1.4 Differentiation and desquamation of keratinocytes
Keratinocyte differentiation is the process of re-engineering the basal keratinocyte
into a cell capable of forming a rigid structural unit, the corneocyte (Eckert 1989).
The signal that causes the initiation of differentiation is currently unclear, but it has
been suggested that integrins expressed on basal keratinocytes may play an important
role. When occupied by their ligands, integrins hold keratinocytes to the basement
membrane. Releasing the ligand conveys a signal to the cell indicating that the
attachment to the substratum has been weakened, which could then trigger terminal
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differentiation (Blumenberg & Tomic-Canic 1997; Eady et al. 1998). During the
differentiation process, a basal cell undergoes a series of changes throughout its
journey to the skin surface. In addition to the morphological changes described in
section 1.4.2.1.1, there are biochemical changes which culminate in the production of
corneocytes. Spinous cells produce involucrin, a cornified envelope precursor protein,
which is deposited on the inner surface of the plasma membrane of each cell (Rice &
Green 1979). They also produce lamellar granules, which will subsequently fuse with
the plasma membrane and release lipids into the intercellular spaces of granular and
cornified cells (Fuchs 1990). As the spinous cells reach the upper granular layer, they
start to produce filaggrin, a protein that allows bundling of keratin filaments into
large macro filaments (Suter et al. 1997). Loricrin, a major precursor protein of
cornified envelopes, is also synthesised at this stage (Mehrel et al. 1990). A calcium
influx into the cell activates epidermal transglutaminase, which then catalyses the
cross-linking of precursor proteins to form a cornifed envelope (Kalinin et al. 2001).
The end product of this process is the corneocyte, which consists of a cornifed
envelope enclosing a constellation of keratin macrofibrillar bundles (Eckert 1989).
The major events that occur during the final stages of keratinocyte differentiation are
summarised in Table 1.2.
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Table 1.2 Events during terminal differentiation of keratinocytes
Cleavage ofprofilaggrin Filaggrin binding to Filaggrin-dependent
to filaggrin => keratin fdaments => assembly of keratin
macrofdaments
Activation ofproteolytic Destruction of cellular
and nucleolytic activity => organelles, nucleic acids
and proteins
Increased intracellular Activation of Cross-linking of Formation of
calcium => transglutaminases => envelope precursor => comified
proteins envelope
Fusion of lamellar Release and remodeling Formation of
granules with plasma => of lipid contents => extracellular lipid
membrane waterproofing layer
Activation of hydrolytic Slough of comeocytes
enzymes => from the skin surface
Adapted from (Eckert 1989)
1.4.2.2 The role of Malassezia organisms in the pathogenesis of epidermal
hyperplasia in man and dogs with diseases associated with Malassezia spp.
There are some similarities between the diseases associated with Malassezia
organisms in man and dogs. In man, M. furfur, M. globosa, and M. sympodialis have
been associated with seborrheic dermatitis, a characteristic clinical feature of which
is greasy scales (section 1.3.1.3). Dogs with Malassezia dermatitis have greasy skin
with varying degrees of scaling (section 1.3.3.3.1) and the histopathology is
characterised by marked irregular hyperplasia of the epidermis (section 1.3.3.3.2).
Little is known about the direct interaction between Malassezia organisms and
keratinocytes, either in man or dogs. In a preliminary report, a significant increase in
a cellular proliferation marker was demonstrated in canine keratinocytes co-cultured
with M. pachydermatis compared to control cells in vitro (von Tscharner et al. 1999).
This could indicate that Malassezia organisms might be able to activate the
proliferative cell cycle of canine keratinocytes. Recently, the epidermal dysplasia in
two West Highland White Terriers with cytological evidence of Malassezia
overgrowth was reported to be reversible after anti-fungal therapy (Nett et al. 2001),
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suggesting a possible pathogenic role ofM. pachydermatis in epidermal hyperplasia
associated with Malassezia dermatitis.
1.4.2.3 Aims
As with other chronic inflammatory dermatoses, skin biopsies from dogs with
Malassezia dermatitis are characterised by marked epidermal hyperplasia. Elevated
populations of M. pachydermatis might have a direct effect on the proliferation of
canine keratinocytes. The second aim of the studies in this thesis was to investigate
the direct effect ofM. pachydermatis on the proliferation of canine keratinocytes by
co-culturing keratinocytes with extracts and culture supernatants from the yeast as
well as live Malassezia organisms. The results of these studies will provide a better
understanding of the pathogenesis of epidermal hyperplasia associated with
Malassezia dermatitis.
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1.5 Summary of aims
The studies described in this thesis were performed with a view to improving our
knowledge of the protective mechanisms against M. pachydermatis in dogs. They
were aimed to investigate two specific aspects of the protective response - activation
of a humoral immune response and thickening of the skin by epidermal hyperplasia.
The studies on humoral immune responses were aimed at investigating the antibody
responses to M. pachydermatis by detecting Malassezia-specific IgG and IgE binding
proteins from the yeast in atopic dogs with or without Malassezia dermatitis and
normal dogs. This was achieved using sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blotting techniques. The experiments
designed to investigate the IgG and IgE responses to M. pachydermatis are described
in chapters 3 and 4, respectively.
A second aim of these studies was to investigate the role ofM. pachydermatis in the
proliferation of canine keratinocytes. The direct effect of M. pachydermatis on
keratinocyte proliferation was evaluated in two ways: secretion of proteins by the
yeast and interaction between live organisms and keratinocytes. The former was
evaluated by culturing keratinocytes with extracts and culture supernatants from the
yeast and the latter using an in vitro Malassezia organism-canine keratinocyte co-






Clinical samples used in this project comprised serum for immunological studies and
skin for keratinocyte culture studies.
Serum samples collected from three groups of dogs were studied. Atopic dogs with
Malassezia dermatitis and atopic dogs without Malassezia dermatitis were recruited
from the dermatology clinic at the Royal (Dick) School of Veterinary Studies in
Edinburgh. Blood samples were collected with owners' consent and were used for
diagnostic purposes in addition to use in this study. Sera of clinically normal dogs
were collected from dogs presented for euthanasia at a rescue centre. Most of these
dogs were euthanised for behavioural problems as they were deemed unsuitable for
re-homing. Eighteen atopic dogs with Malassezia dermatitis, 20 atopic dogs without
Malassezia dermatitis and 18 normal dogs were included in the IgG study. Samples
from 28 atopic dogs with Malassezia dermatitis and 22 normal dogs were used in the
IgE study.
Skin for use in keratinocyte cultures was collected from 17 clinically normal rescue
centre dogs immediately post-mortem.
The dogs from which serum and skin were collected comprised a variety of ages,
breeds and sexes, but these factors were not studied independently due to the low
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number of dogs in each sub-group.
2.1.1 Atopic dogs
The diagnosis of atopic dermatitis was based on a combination of consistent history
and clinical signs, exclusion of other causes of pruritic skin disease and the presence
of at least one positive intradermal skin test reaction. Coat brushings, skin scrapings
and trial therapy were used to rule out ectoparasites. A six-week, home cooked diet
trial was conducted to rule out adverse food reactions. No anti-inflammatory
medication was given for at least three weeks prior to examination. The intradermal
skin tests were performed with 57 allergens (Table 2.1). Following clipping, 0.05 ml
of each allergen extract was injected into the lateral flank after sedation with 0.15
mg/kg xylazine intramuscularly. Histamine (1/100,000 w/v) and diluent consisting of
phosphate buffered saline with 0.4 % phenol as preservative were included as
positive and negative controls, respectively. Test sites were assessed after 20 minutes
and scored from 0 to +4 based on erythema, turgidity, elevation of the wheal and
wheal size. Scores were assigned by comparing the test sites with the controls. A
score of+1 was slightly greater than the negative control, and a +4 approximated the
size of the histamine wheal. Reactions > 2 were considered positive (Scott et al.
2001c).
2.1.2 Dogs with Malassezia dermatitis
Malassezia overgrowth was diagnosed by microscopic observation of Diff-Quik®
(Dade AG, Switzerland) stained adhesive tape strips (Mason 1992; Bond & Sant
1993; Charach 1997). Samples were obtained from the groin, axilla and interdigital
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Table 2.1 Allergens employed in the intradermal skin test
Number Allergens Concentration used for skin test Units Source
Dust and Dust mites
1 Dermatophagoides pteronysinus 1/1000 w/v Greer
2 Acaris siro 100 NE/ml ARTU
3 Dermatophagoides farinae 1/1000 w/v Greer
4 Tyrophagus putresceantiae 100 NE/ml ARTU
5 House dust 1000 PNU/ml Greer
Epithelial group
6 Human epithelia 10 pg/ml ARTU
7 Cat epithelia 100 pg/ml Greer
8 Horse dander 500 PNU/ml Greer
9 Sheep epithelia 500 PNU/ml Greer
10 Mixed feathers 100 Hg/ml ARTU
11 Cotton linters 1/1000 w/v Greer
Insects
12 American/German cockroach 500 PNU/ml Greer
13 Flea 1000 w/v Greer
14 Mixed moths 500 PNU/ml Greer
15 Blackfly (Simulidae) 500 w/v Greer
16 Mosquito (Culicidae) 500 PNU/ml Greer
Trees
17 White ash 1000 PNU/ml Greer
18 Ash 1000 NE/ml ARTU
19 Tag alder 1000 PNU/ml Greer
10 Alder 1000 NE/ml ARTU
21 American beech 1000 PNU/ml Greer
22 Beech 1000 NE/ml ARTU
23 White oak 1000 PNU/ml Greer
24 White birch 1000 PNU/ml Greer
25 Birch 1000 NE/ml ARTU
26 American elm 1000 PNU/ml Greer
27 Elm 1000 NE/ml ARTU
28 Box elder 1000 PNU/ml Greer
29 Elder 1000 NE/ml ARTU
30 Plane 1000 NE/ml ARTU
31 White pine 1000 PNU/ml Greer
32 Hawthorn 1000 PNU/ml Greer
Weeds
33 Yellow dock 1000 PNU/ml Greer
34 Jerusalem oak 1000 PNU/ml Greer
35 Lambs quarter 1000 PNU/ml Greer
36 Common mugwort 1000 PNU/ml Greer
37 Nettle 1000 PNU/ml Greer
38 English plantain 1000 PNU/ml Greer
39 Brassica spp. 1000 PNU/ml Greer
40 Chrysanthemum spp. 1000 PNU/ml Greer
41 Red clover 1000 PNU/ml Greer
42 Heather 1000 NE/ml ARTU
Grasses
43 Kentucky blue 1000 PNU/ml Greer
44 Meadow fescue 1000 PNU/ml Greer
45 Orchard/Cocksfoot 1000 PNU/ml Greer
46 Perennial rye 1000 PNU/ml Greer
47 Sweet vernal 1000 PNU/ml Greer
48 Timothy 1000 PNU/ml Greer
49 Velvet/Yorkshire fog 1000 PNU/ml Greer
50 Red top/Bent 1000 PNU/ml Greer
51 Couch 1000 PNU/ml Greer
Moulds/Smuts
52 Aspergillus mix 1000 PNU/ml Greer
53 Alternaria tenuis 1000 PNU/ml Greer
54 Botrytis cinerea 1000 PNU/ml Greer
55 Penicillium mix 1000 PNU/ml Greer
56 Barley smut 1000 w/v Greer
57 Oat smut 1000 PNU/ml Greer
PNU: protein nitrogen units; NE: nitrogen equivalents.
Greer: Greer Laboratories Inc., Lenoir, NC; ARTU: ARTU Biologicals, Lelystad, The Netherlands.
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web and Malassezia overgrowth was characterised as an average of 5 or more
Malassezia organisms per 400X field (Mauldin et al. 1997; Scott et al. 2001a).
Involvement of Malassezia in cases of otitis externa was assessed by sampling the
external ear canal with a cotton swab and transferring the material to a glass slide
prior to heat fixing and staining. The criteria for demonstrating overgrowth were as
described for the tape strips.
2.1.3 Normal dogs
Although a full history was not available, the normal dogs had no clinical signs of
skin disease and had no lesions on dermatological and otic examination.
2.2 Serum sample collection
Blood samples were collected by cephalic or jugular venipuncture from the three
groups of dogs described above and allowed to clot at room temperature. They were
centrifuged at 95Og for 10 minutes at 4 °C. The harvested sera were stored at -20°C
until used.
2.3 Skin sample collection
Skin from clinically normal dogs was collected immediately post-mortem from the
dogs presented for euthanasia. The lateral thorax was clipped and prepared
aseptically prior to removal of a full thickness skin sample approximately 15 cm x 8
cm (described in detail below in section 2.16).
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MALASSEZIA PACHYDERMATIS CULTURE AND PREPARATION
2.4 Culture of Malassezia pachydermatis
A single isolate ofM. pachydermatis was obtained from the ear canal of a dog with
Malassezia otitis and used throughout these studies. This was deemed appropriate
because previous studies have shown that M. pachydermatis was the only Malassezia
species isolated from the skin and external ear canal of dogs with either otitis externa
or skin infections, and all isolates of M. pachydermatis had similar electrophoretic
karyotypes (Senczek et al. 1999). Use of a single isolate also allows comparison of
multiple serum samples, whereas testing of multiple isolates would require large
volumes of serum and reagents. The sample was cultured on Sabouraud Dextrose
agar (Oxoid, Basingstoke, UK) containing 20 mg/ml chloramphenicol (Intramycetin®,
Parke-Davis Veterinary, Pontypool, UK) for 48 hours at 37°C, and the colonies were
identified as M. pachydermatis by microscopic examination. The colonies were then
subcultured onto large numbers of plates in order to obtain enough organisms for
subsequent studies.
Figure 2.1 shows a plate ofM. pachydermatis cultured on Sabouraud dextrose agar
for 72 hours at 37°C. The yeast colonies appeared smooth, small, white and round. In
order to identify the colonies, the following procedures were used to visualise the
organisms microscopically. A minute amount of a colony was spread onto a slide
with an inoculation loop, fixed over a gentle flame and stained with Gram reagents.
Firstly, the slide was stained with crystal violet for 1 minute and then rinsed with
water. After staining with iodine for 1 minute followed by another rinse, it was
decolourised with acetone and washed with water immediately. The slide was
counterstained with 0.1 % basic fuchsin for 30 seconds, rinsed with water and air-
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Figure 2.1 Colonies of Malassezia pachydermatis on a Sabouraud
dextrose agar
A single isolate ofM. pachydermatis was cultured on Sabouraud Dextrose
agar for 72 hours at 37°C. The colonies appeared white, round, and
glistening. They had an unpleasant smell when the lid of the petri dish was
removed.
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Figure 2.2 Gram stained Malassezia pachydermatis organisms (x500)
The yeasts appeared round to oval in shape and about 1-2 x 2-4 pm in size.
Budding yeasts are characterised by a peanut shape and a bud collarette.
Scale bar =10 pm.
72
dried. The stained M. pachydermatis organisms are shown in Figure 2.2.
2.5 Extraction of proteins from M. pachydermatis
2.5.1 Reagents and buffers
All the buffers listed below were prepared using de-ionised water. Chemicals were
purchased either from Sigma, Poole, UK or BDH, Poole, UK. The phosphate
buffered saline (PBS) was autoclaved at 121°C for 1.5 hours if used for tissue culture
purposes. Malassezia extraction buffer was prepared either with or without protease
inhibitors.
PBS Malassezia extraction buffer
8.5g NaCl (Sigma) 988.25 mg NH4HC03 (Sigma)
2.1g Na2HP0412H20 (BDH) Protease inhibitors:
0.4g NaH2P04-2 H20 (BDH) 262.4 mg e-aminocaproic acid (Sigma)
186 mg ethylenediaminetetraacetic acid (Sigma)
17.4 mg phenylmethylsulfonyl fluoride (BDH)
Dissolved in 1 liter water Dissolved in 100 ml water
pH 7.2-7.3 pH 7.4
2.5.2 Optimisation of the extraction procedure
Malassezia colonies were carefully harvested and suspended in PBS for a washing
procedure that consisted of three cycles of centrifiigation at 500 g for 5 minutes
followed by removal of the supernatant and resuspension in PBS. After the last
washing cycle, the cells were resuspended in extraction buffer (pH 7.4) comprising
125 mM NH4HC03 and protease inhibitors (20 mM e-aminocaproic acid, 5 mM
ethylenediaminetetraacetic acid and 1 mM phenylmethylsulfonyl fluoride) (Jensen-
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Jarolim et al. 1992; Morris et al. 1998).
Preliminary experiments were performed using three different methods to determine
the optimum method for protein extraction. First, the Malassezia colonies in the
extraction buffer were mixed vigorously with an equal volume of glass beads (0.4
mm, 40 mesh, BDH, UK) on a vortex mixer for 10 minutes to mechanically disrupt
the cell membranes. A second suspension of Malassezia organisms was subjected to
three cycles of freezing and thawing by alternately immersing the container in a dry
ice-methanol mixture and warm tap water. This was intended to fracture the cell
membranes and allow release of cytoplasmic contents. Thirdly, a Malassezia
suspension was placed in an ultrasonic water bath for 5 minutes in order to
physically fragment the organisms. Ten agar plates were prepared for each method,
and equal weights of colonies (3.07 gm) were added to 5 ml of extraction buffer.
After extraction, the cell suspensions were stored at 4°C overnight to allow
equilibration of cellular proteins. The suspensions were then centrifuged at 6000 g
for 5 minutes and the supernatants were collected. The amount of protein obtained
from each method was measured with BCA Protein Assay Reagent (see section 2.8),
and the extracts were analysed by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) (see section 2.10). The protein concentrations of the
extracts obtained from the three methods (glass beads, freeze/thaw cycles, and
ultrasonification) were 16.35 mg/ml, 0.58 mg/ml, and 0.22 mg/ml, respectively.
Figure 2.3 shows the Coomassie blue stained protein profiles of the three different
extracts on an SDS-PAGE gel (see section 2.11 for Coomassie blue staining). Much
stronger protein bands were seen in the extract obtained by glass bead disruption.











Figure 2.3 Extracts ofM. pachydermatis obtained using three different
methods in a Coomassie blue-stained SDS-PAGE gel
G: Glass beads; F/T: Three freeze/thaw cycles; U: Ultrasonification.
Molecular weights in kilodaltons. The extract produced using glass bead
disruption was selected for the subsequent studies.
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The effect of glass bead disruption was further assessed by examining Leishman's
stained cytospin preparations of the remaining cell pellets. The pellets were
resuspended in PBS and 100 pi of the suspension was centrifuged for 5 minutes at
600 rpm onto a glass slide in a cytocentrifuge (Shandon Cytospin 2, Southern
Instruments LTD., Runcom, UK). The slide was air-dried and then stained with
Leishman's solution (Fisher Scientific, Loughborough, UK) for 2 minutes. An equal
volume of distilled water was added to the slide and it was stained with diluted
Leishman's solution for a further 8 minutes. After rinsing in tap water, the slide was
air-dried and mounted with DPX mountant (Fisher Scientific, UK). Figure 2.4 shows
the Malassezia pellets stained with Leishman's solution. Substantial amounts of cell
debris were present in the pellets. The majority of the organisms were destroyed by
glass beads and showed defective features.
For some experiments, the extract was prepared using buffer without protease
inhibitors. The Malassezia extracts prepared with or without protease inhibitors using
glass bead disruption were compared in an SDS-PAGE gel (see section 2.10 for SDS-
PAGE) and shown in Figure 2.5. The two extracts exhibited very similar protein
profiles with some variations of density shown by individual bands.
2.6 Culture supernatants from M. pachydermatis
Culture supernatants from M. pachydermatis were prepared by inoculating the
organisms into Sabouraud liquid medium (Mast Laboratories Ltd, Merseyside, UK)
and then culturing them for three days at 37°C. The cell suspension was then
centrifuged at 6000 g for 5 minutes and the supernatant collected. It was
concentrated using Centriplus™ concentrators (Millipore Corporation, Bedford, MA,
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Figure 2.4 Leishman's stained Malassezia pachydermatis cell pellets
obtained after glass bead disruption (x500)
Considerable amounts of cell debris resulted from glass bead disruption.
Very few Malassezia organisms retained their intact shape with the
majority exhibiting abnormal morphology.









Figure 2.5 Coomassie brilliant blue stained extracts of Malassezia
pachydermatis on an SDS-PAGE gel
Lane 1: Malassezia extracts produced with protease inhibitors.
Lane 2: Malassezia extracts produced without protease inhibitors.
The molecular weight markers on the left are 200, 116, 97, 66, 45, and 31 kDa.
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USA) to a final volume of 2 ml by repeated centrifugation at 3000g until the required
volume was reached. An equal volume of sterile medium was also incubated and
concentrated in parallel to act as a control. The protein profile of the culture
supernatants was checked using an SDS-PAGE gel (section 2.10) with reducing
sample buffer after sterilisation (see section 2.7) and is shown in Figure 2.6. No
visible bands were present in the sterile medium. On the contrary, culture
supernatants from Malassezia showed faint visible bands between 66 and 45 kDa,
indicating that proteins within this molecular weight range were generated in the
liquid medium or released from Malassezia during culture.
2.7 Sterilisation of Malassezia extracts and supernatants
For experiments requiring sterile materials, extracts and culture supernatants from M.
pachydermatis were sterilised using syringe filters (Nalgene®, Nalge Nunc
International Corp., New York, USA). The Malassezia extracts were centrifuged at
6000 g for 5 minutes and then at 20,000 g for 10 minutes to further purify the
extracts and facilitate filtration. They were then sterilised by passing through syringe
filters with a 0.8, 0.45 and 0.2 pm pore size serially. A 50 pi aliquot of the filtered
extracts was plated on Sabouraud Dextrose agar and the plate was incubated for 3
days at 37°C to check its sterility. No growth of any organisms was observed after
the three-day incubation.
The culture supernatants from Malassezia were sterilised by passing through syringe
filters with a 0.2 pm pore size. The sterility of the cell supernatant and control media












Figure 2.6 Coomassie brilliant blue stained culture supernatants from M.
pachydermatis on an SDS-PAGE gel
Lane 1: culture supernatants from Malassezia. Faint bands are visible.
Lane 2: sterile Sabouraud liquid medium. No bands are visible.
The molecular weight markers on the left are 200, 116, 97, 66, 45, 31, and 21.5 kDa.
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2.8 BCA protein concentration assay
The assay reagent was obtained from Pierce Chemical Company, Rockford, IL, USA.
Protein standards were prepared by two-fold dilution of the 2.0 mg/ml BSA stock
standard with PBS. 10 pi of each standard and sample was added to the wells of a 96
well plate in triplicate followed by 100 pi of working reagent. After incubating for
30 minutes at 37°C, the plate was read at 570 nm in a Dynatech ELISA plate reader
(Dynatech MR5000, Dynatech Laboratories Ltd, Billingshurst, UK). The protein
concentrations of samples were determined using a linear standard curve generated
by analysing the O.D. values ofprotein standards.
GEL ELECTROPHORESIS AND IMMUNOBLOTTING
2.9 Reagents and solutions
The following solutions were prepared with de-ionised water unless stated otherwise.
Chemicals were obtained from various companies including Bio-Rad, Hemel
Hempstead, UK; Fisher Scientific, UK; National Diagnostics, Hessle Hull, UK; and
Sigma, UK.
Resolving buffer (1 M Tris/HCl) Stacking buffer (0.5 M Tris/HCl)
12.lg Tris (Sigma) 6.05g Tris
In 100 ml water In 100 ml water
Adjusted to pH 8.8 with HC1 Adjusted to pH 6.8 with HC1
Sodium dodecyl sulphate (SDS, 10 %) Ammonium persulphate (10 %)
lOg SDS (Fisher Scientific)
In 100 ml water
100 mg Ammonium persulphate (Bio-Rad)
In 1 ml water
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Separating gel Stacking gel
10 % 12 % 4%
Resolving buffer 2.5 ml 2.5 ml
Stacking buffer 1.4 ml
Acrylamide (National Diagnostics) 3.35 ml 4.1 ml 0.72 ml
Water 3.05 ml 2.3 ml 2.95 ml
10 % SDS 1 ml 1 ml 0.28 ml
TEMED (Sigma) 10 pi 10 pi 10 pi
10 % Ammonium persulphate 100 pi 100 pi 100 pi
Sample buffers Reducing Non-reducing
Stacking buffer (see above) 1.25 ml 1.25 ml
Glycerol (BDH) 1 ml 1 ml
10 % SDS 2 ml 2 ml
P- mercaptoethanol (Sigma) 0.5 ml
Distilled water 5 ml 5.5 ml
0.05 % (w/v) Bromophenol blue (Sigma) 0.25 ml 0.25 ml
Running buffer (10X) Tris buffered saline (TBS)
72.05g Glycine (Fisher Scientific) 2.42g Tris
15.14g Tris 29.24g NaCl
5g SDS
In 500 ml water In 1 liter water
pH 8.3 pH 7.5
CAPS transfer buffer Towbin transfer buffer
(10 mM CAPS in 10 % methanol)
1.1065g 3-(Cyclohexylamino)-l-propanesulfonic acid 1.515g Tris
(CAPS, Sigma) 7.2g Glycine
50 ml methanol (Fisher Scientific) 100 ml methanol
In 500 ml water In 500 ml water
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2.10 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE)
The broad range molecular weight standards (Bio-Rad, UK) were diluted 1: 20 in
reducing sample buffer and 10 pi aliquots were stored at -20°C until used. The
separating polyacrylamide gel and stacking gels were prepared as described in
section 2.9. The minigel apparatus (Bio-Rad, UK) was set up as described in the
manufacturer's instructions and the gels were poured between the glass plates. A
minigel was made of 3.5 ml of separating gel solution overlaid by 1.5-2 ml of
stacking gel solution that covered the bottom of the teeth of a comb used to generate
the wells. Two different combs were used in this study. A comb with multiple teeth
was used for experiments that required loading several different samples in the same
gel. For immunoblotting that required strips containing equal amounts ofMalassezia
extracts, a comb with only two teeth was used to generate a regular-sized well for
molecular weight standard and a wide well for Malassezia extracts. The gel was
allowed to set for 30 minutes and the comb was removed. Samples were diluted 1:1
with either reducing or non-reducing sample buffer and then heated at 95°C for 5
minutes along with an aliquot of thawed molecular weight standard. They were then
added into wells on the top of the gel and the gel electrophoresis was performed in
the running buffer at 200 V for either 40 minutes (10 % separating gel) or 60 minutes
(12 % separating gel).
2.11 Coomassie blue staining
Both staining and destaining were performed on a platform rocker. For gels which
were not used for immunoblotting, the separated proteins and molecular weight
standards were visualised by staining gels with Coomassie blue solution comprising
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0.25 % Coomassie brilliant blue R (BDH, UK), 10 % acetic acid (Fisher Scientific,
UK) and 45 % methanol (Fisher Scientific, UK) for 5-10 minutes. The gels were then
destained with 10 % acetic acid and 45 % methanol to remove background. With
several changes of destain solution, it usually took 2-3 hours to obtain clear bands
with a clean background.
2.12 Electrophoretic transfer
After the electrophoresis was completed, the separated proteins and molecular weight
standards were transferred from the gel to a polyvinylidene difluoride microporous
membrane (Millipore Immobilon™-P Transfer Membrane, Millipore Corporation,
Bedford, MA) in a Bio-Rad Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell.
A piece of membrane about the same size as the gel was immersed in 100%
methanol for 3 seconds and then equilibrated in the transfer buffer. CAPS transfer
buffer (LeGendre et al. 1993) was used for 12 % separating gels and Towbin transfer
buffer for 10 % separating gels. Four pieces of Whatman chromatography paper cut
to the same size as the gel were pre-wetted in the transfer buffer. The gel and
membrane were then sandwiched between them as illustrated in Figure 2.7. The
transfer was run at 80 mA per minigel for 1 hour. The quality of transfer was checked
by staining gels and molecular weight standards blotted onto the membrane with
Coomassie brilliant blue R-250 for 5-10 minutes followed by destaining with several
changes of destain solution as described in section 2.11.
2.13 Immunoblotting
Precise details of the reagents, conditions and dilutions used for immunoblotting can








Anode plate on the base
Figure 2.7 Profile of the gel sandwich in a Bio-Rad Trans-Blot® SD semi-dry
electrophoretic transfer cell
Two sheets of pre-soaked paper were placed onto the platinum anode and a tube
was rolled over the surface of the paper to exclude air bubbles. The rolling step
was repeated every time a layer was added to ensure there were no bubbles
between each layer. The pre-wetted membrane was then placed on top of the
paper followed by the gel on the top of the membrane. Another two sheets of
pre-soaked paper were placed on top of the gel and the cathode was carefully
placed onto the stack. The safety cover was placed on the unit before connecting
it to the power supply.
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0.5 cm x 7 cm strips) was pre-wetted in 100% methanol for 3 seconds and rinsed
with water for a few minutes. It was then blocked for 1 hour with blocking reagents
including various concentrations of skimmed milk and goat sera, casein solution
(Vector Laboratories Inc., Burlingame, CA, USA), Tween 20 (Fisher Scientific, UK),
Tween 80 (Sigma, UK), and an avidin/biotin blocking kit (Vector Laboratories Inc.,
Burlingame, CA, USA). After washing with TBS containing 0.05 or 0.1 % Tween 20
(Fisher Scientific, UK) (TTBS) for 15 minutes (3x5 minute rinses), the membrane
was incubated with 1/5 - 1/100 diluted dog serum samples in dilution buffer (1 %
skimmed milk in TTBS) for 30-60 minutes. It was then washed again in TTBS for a
further 15 minutes. Bound IgG or IgE was detected by incubating the membrane for
1 hour with enzyme conjugated anti-dog IgG or IgE antibodies diluted in dilution
buffer followed by a 15-minute wash with TTBS. If the anti-dog IgG or IgE antibody
was not conjugated, a further 1-hour incubation with an enzyme conjugated
secondary antibody was used followed by washing with TTBS for 15 minutes. The
membrane was developed with appropriate substrates either chromogenically or
chemiluminescently. The molecular weights of bands detected were determined
using standard curves generated by analysing the position of molecular weight
markers on Coomassie blue stained membranes (section 2.11).
CULTURE OF CANINE KERATINOCYTES AND FIBROBLASTS
2.14 Reagents and solutions
The following solutions were obtained from Gibco™ Invitrogen life technologies,
Paisley, UK: Penicillin (10,000 units/ml) and Streptomycin (10,000 pg/ml);
Fungizone (250 pg/ml); Dulbecco's Modified Eagle medium with GlutaMAX™ I;
William's Medium E; dispase; 10 x Trypsin/EDTA; Murine epidermal growth factor.
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Foetal calf serum was batch tested and purchased from Gibco™ Invitrogen life
technologies or Sigma, UK. Trypan blue (0.4%), cholera toxin and hydrocortisone
were obtained from Sigma.
2.15 Cell culture plastics and incubation conditions
Unless stated otherwise, cells were cultured in plastic tissue culture treated flasks or
various multi-well plates (see specific sections), all of which were obtained from
Corning Costar, Bucks, UK. All cultures were maintained at 37°C in a humidified
atmosphere with 5 % C02 in air.
2.16 Primary keratinocyte culture
Healthy skin was taken immediately post-mortem from dogs presented for euthanasia.
The flank of dogs was shaved and scrubbed with Hibiscrub (ZENECA Limited,
Macclesfield, UK), painted with Povidone-Iodine and wiped with 70% ethanol. Full-
thickness skin (approximately 15 cm x 8 cm x 0.5 cm) was removed and dipped in
Povidone-Iodine/ PBS solution (1:5) for 10 seconds and then washed with PBS
containing Penicillin (100 units/ml), Streptomycin (100 pg/ml), and Fungizone (2.5
pg/ml) (PSF). The skin was then immersed in Dulbecco's Modified Eagle Medium
(DMEM) containing PSF.
Canine keratinocyte culture was established using a modification of a protocol
published previously (Wilkinson et al. 1987). The subcutaneous tissue and fat were
removed by trimming and the skin was cut into small pieces (approximately 1 cm x 1
cm). The pieces were then incubated in William's Medium E containing 10 mg/ml
dispase and PSF overnight at 4°C. The epidermis was carefully stripped off the
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dermis and placed in a solution of Trypsin/EDTA (0.1 %/0.04 %) at 37°C for 10
minutes. The enzymatic effect of trypsin was stopped by adding an excess of
William's Medium E supplemented with 10% foetal calf serum (FCS), 0.1 nM
cholera toxin, 10 ng/ml murine epidermal growth factor, and PSF (complete
medium). The cell suspension was filtered with a cell strainer (70 pm, Becton
Dickinson, Oxford, UK) to remove hair and cell debris. It was then centrifuged at
700g for 10 minutes and the cells were resuspended in complete medium. For
primary cultures, tissue culture flasks coated with fibronectin (kindly provided by Dr.
R. C. McKenzie, University of Edinburgh, UK) at a concentration of 1 pg/cm2 were
used to enhance cell attachment to the plastic. The cells were counted in a
haemocytometer and the viability was assessed by trypan blue exclusion (section
2.14). Cells were then plated into 25 cm2 tissue culture flasks at a density of 1-3 x 106
viable cells per flask.
2.17 Cell counting and viability
Cells were counted in an improved Neubauer haemocytometer after mixing 10 pi of
cell suspension with an equal volume of trypan blue. This counting procedure is
based on the principle that viable cells exclude the stain and dead cells take it up.
Viability was calculated by dividing the number of viable cells into the total cell
number.
2.18 Primary fibroblast culture
Skin pieces were rinsed with PBS containing PSF after the epidermis was stripped
off. They were then immersed in Trypsin/EDTA (0.1 %/0.04 %) at 37°C for 45
minutes and the container was shaken occasionally during the incubation. Excess
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DMEM supplemented with 10% FCS and hydrocortisone (0.4 pg/ml) was added to
terminate the enzyme reaction and the cells were collected by filtering the
supernatants through a cell strainer. The suspension was centrifuged at 700g for 10
minutes and the cells were resuspended in supplemented DMEM. They were counted
as described above and plated at 1.2 x 105 viable cells/cm2.
2.19 Subculture
In order to obtain more cells for subsequent experiments and avoid early
differentiation, cells were subcultured when they reached approximately 80 %
confluence. The cell monolayer was washed with sterile PBS (warmed to 37°C) after
the media was removed. An appropriate volume of Trypsin/EDTA diluted in PBS
(0.1 %/0.04 %) was added and the cells were incubated at 37°C until they separated
from the plate. By gently tapping the edges of a flask or plate using the palm of a
hand, it usually took 15-30 minutes for the keratinocytes and less than 10 minutes for
the fibroblasts to separate. The completion of trypsinisation was determined by
observation of a single cell suspension (not in strings or clumps) microscopically.
Media containing 10 % FCS was added 1: 1 into the cell suspension and the cells
were spun down by centrifugation at 700g for 10 minutes, resuspended in fresh
media and counted. The suspension was adjusted to a desired cell concentration
before placing into a new container.
CHARACTERISATION OF KERATINOCYTE CULTURES
2.20 Cultivation of cells on cover slips and chamber slides
Keratinocytes and fibroblasts were subcultured onto cover slips or chamber slides for
immunostaining studies to visualise their growth and cellular characteristics. Circular
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glass cover slips with a diameter of 22 mm were obtained from Fisher Life Science,
Loughborough, UK and 8 well Nunc Lab-Tek™ II chamber slides from Merck
Eurolab Ltd, Lutterworth, UK. The latter are tissue culture treated glass slides with a
removable medium chamber. After culturing was complete, the medium chamber
was removed to allow the slides to be processed as standard microscope slides.
Cover slips were sterilised by dipping in 70 % alcohol and air-dried in the tissue
culture hood. They were carefully inserted into wells of a 12 well plate. Each cover
slip was coated with 10 pg of fibronectin (kindly provided by Dr. R. C. McKenzie,
University of Edinburgh, UK) in PBS and left for 30 minutes at room temperature.
Excess solution was aspirated and the cover slips were air dried before use. Skin cells
were plated at a density of 5 x 105 viable cells/well, and confluence occurred in 4-5
days. No coating was applied to chamber slides, and cells were cultured at 2 x 104
viable cells/cm2 (1.4 x 104 cells/well) for immunostaining studies (see section 2.28).
2.21 Fixation
Media was removed from wells and they were washed with PBS three times to
remove non-adherent cells. Cells were then fixed in 4 % paraformaldehyde in PBS
for 20 minutes at room temperature. Excess paraformaldehyde was aspirated and the
cells were washed with PBS three times. Cover slips and chamber slides were
preserved in 70 % alcohol to prevent putrefactive changes and stored at 4°C until
used.
2.22 Preparation of solutions for staining
The following solutions were used for haematoxylin & eosin staining (section 2.23)
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and immunohistochemistry studies (section 2.24, 27- 28). They were prepared using
chemicals obtained from either Fisher Scientific or Sigma.
Citrate buffer (10 mM) Tris buffered saline (TBS) Scott's tap water substitute
2.1g citric acid-H20 6.06g Tris 3.5g NaHC03
8.77g NaCl 20g MgS04
In 1 liter distilled water In 1 liter de-ionised water In 1 liter tap water
Adjusted to pH 6.0 with NaOH Adjusted to pH 7.6 Checked pH 8
2.23 Haematoxylin & Eosin (H & E) staining
H & E staining was carried out on cells cultured on cover slips and preserved in 70 %
alcohol. The cover slip was washed with tap water and soaked in Harris
haematoxylin (Surgipath, Peterborough, UK) for 1 minute followed by Scott's tap
water substitute for 30-60 seconds. It was then washed with tap water three times
and stained with eosin for 30 seconds. After washing again in tap water three times,
the cover slip was dehydrated using absolute ethanol with five changes and then
xylene with two changes. It was then carefully removed from the well and mounted
upside down with DPX mountant (Fisher Scientific, UK).
Figure 2.8 shows the result of keratinocytes stained with H & E. Cells were present
with purple-staining nuclei and pink-staining cytoplasm. They tended to vary in size
depending on the degree of proliferation. Newly reproduced cells were smaller
compared to other cells. Occasional cells showed mitotic features and one or two
cells appeared to be apoptotic or necrotic.
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Figure 2.8 H&E stained canine keratinocytes (xlOO)
Canine keratinocytes were subcultured onto a cover slip coated with fibronectin
and cultured to confluence. Some cells were still undergoing mitosis (thin arrow).
Apoptotic or necrotic-like cells showed dark red staining cytoplasm and pyknotic
nuclei (bold arrows). Newly reproduced cells appeared to be smaller than other
cells (areas around arrows).
Scale bar = 100 pm.
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2.24 Cytoskeleton detection
Canine keratinocyte and fibroblasts were mixed 1: 1 and cultured at 2 x 104 viable
cells/cm2 in chamber slides for three days before fixation. To inhibit intrinsic
peroxidase activity, the cells were treated with 1 % H202 in methanol for 20 minutes.
They were then rinsed with PBS and incubated with 1% SDS in PBS for 5 minutes.
After washing with PBS, the slides were assembled with coverplates and placed in a
slide rack (Sequenza™, Thermo Shandon Inc, Pittsburgh, USA). The reagents of the
Vector Elite ABC mouse IgG kit (Vector Laboratories Ltd., Peterborough, UK) were
added according to the manufacturer's instructions and the immunostaining was
performed at room temperature. Cells were blocked with horse serum diluted in PBS
for 1 hour and then incubated with monoclonal mouse antibody against broad
spectrum keratin, or vimentin (EURO/ DPC Ltd., Gwynedd, UK) for a further one
hour. Cells incubated with universal monoclonal negative control antibody (EURO/
DPC Ltd., Gwynedd, UK) were used as a control. They were washed again in PBS
and then incubated with biotinylated horse anti-mouse IgG for 30 minutes. ABC
reagents were added after another wash with PBS and allowed to react for 30
minutes. The slides were rinsed with PBS and developed using DAB (3, 3'-
diaminobenzidine, Vector Laboratories Ltd., Peterborough, UK) for 7 minutes. The
development was ceased by washing the slides with distilled water and they were
then removed from the slide rack and counterstained with Mayer's haematoxylin
(Sigma, UK) for 5 minutes followed by two rinses in Scott's tap water substitute.
The slides were dehydrated by dipping serially in 70 %, 90 %, 95 % and 100 %
ethanol for 5 minutes each and then clarified in xylene for another 5 minutes. Excess
xylene was wiped off from the back of the slides and they were mounted with DPX
mountant.
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Figure 2.9 shows the cells stained with anti-keratin, anti-vimentin, and control Abs.
Keratinocytes reacted to anti-keratin Ab and exhibited brown staining, but fibroblasts
appeared blue, the colour of the counterstain (Figure 2.9 A). In contrast, the
cytoplasm of fibroblasts stained positively with anti-vimentin Ab unlike
keratinocytes which were negative (Figure 2.9 B). All the cells stained blue if the
primary Ab was replaced with the negative control Ab (Figure 2.9 C) indicating that
the brown staining present was specific.
EVALUATION OF CELL GROWTH
2.25 Keratinocyte proliferation assay
A colourmetric assay reagent (Celltiter 96® AQueous One Solution Cell Proliferation
Assay from Promega, UK) was used to determine the number of viable keratinocytes
in the study assessing the effects of extracts and culture supernatants of M.
pachydermatis on canine keratinocyte proliferation. The validation of this assay is
described in Chapter 5. The assay was performed in 96 well tissue culture plates.
Keratinocyte monolayers were trypsinised, washed and counted in a haemocytometer.
Cells were diluted with media and plated both in the 96 well plates (100 pl/well, 2 x
104 viable cells/cm2) and flasks, in which cells were grown to generate a standard
curve for the cell proliferation assay. Various treatments were applied to the cells in
the plates during culture (see chapter 5). When performing the assay, cells grown in
the flasks were trypsinised, washed and counted in a haemocytometer. A volume of
100 pi of cell suspension (containing two fold dilutions from 2 x 105 to 3125 cells
per well) was added in triplicate to allow generation of a standard curve. Wells with
100 pi of medium only were included as background. After addition of 20 pi of




Figure 2.9 Cytoskeleton staining in canine keratinocytes and fibroblasts
(x500)
A: Anti-keratin Ab stained keratinocytes showing dark brown staining compared
to adjacent fibroblasts.
B: Silk- like vimentin in the cytoplasm of fibroblasts stained with anti-vimentin
Ab. Keratinocytes appeared unstained.
C: Both keratinocytes and fibroblasts were negatively stained using control Ab.
Scale bars = 10 pm
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keratinocytes, background and standards, the plates were incubated at 37°C for a
further 3 hours. The absorbance of the reaction was evaluated using an ELISA reader
(Dynatech MR5000, Dynatech Laboratories Ltd, Billingshurst, UK) at a wavelength
of 490 nm. A reference wavelength of 630 nm was applied simultaneously to reduce
background generated by excess cell debris, fingerprints and other nonspecific
absorbance.
2.26 Statistical analysis
The specific tests employed will be described in the appropriate chapters.
IMMUNOHISTOCHEMISTRY
2.27 Antigen retrieval
Keratinocytes cultured on chamber slides for proliferating cell nuclear antigen
(PCNA) and Ki-67 antigen detection were subjected to antigen retrieval treatments to
improve the immunoreactivity of antigens and to enhance staining. For PCNA
detection, 10 mM Citric buffer (pH 6.0) was boiled by microwaving in a pressure
cooker and slides rinsed with TBS were put in a slide rack and placed in the citric
buffer (see section 2.22 for buffer preparation). The pressure cooker was heated with
the lid on at high power until the pressure valve rose and then it was heated for a
further 5 minutes at pressure.
For Ki-67 antigen detection, slides were rinsed in distilled water with two changes
and immersed in 10 mM citric buffer in a glass beaker that was heated on a hot plate
until it boiled. The buffer was kept boiling for 10 minutes and the beaker was




2.28.1 Proliferating cell nuclear antigen detection
After antigen retrieval treatment (section 2.27), the slides were incubated with 1 %
H202 in distilled water for 5 minutes. They were then rinsed with distilled water and
placed in TBS for a further 5 minutes. The immunostaining was performed in a slide
rack and the slides were incubated with horseradish peroxidase conjugated anti-
PCNA antibody (Dako, Cambridgeshire, UK) for 1 hour at room temperature.
Negative control slides were processed by replacing the anti-PCNA Ab with a
horseradish peroxidase conjugated immunoglobulin negative control (Dako,
Cambridgeshire, UK). They were then rinsed with TBS and developed with DAB for
5 minutes. The counterstain, dehydration and mount were carried out in the manner
described in section 2.24.
2.28.2 Ki-67 antigen detection
The antigen retrieval procedures were first applied to the slides (section 2.27) and
they were then rinsed with PBS and incubated with 1 % H202 in distilled water for 5
minutes. After rinsing with distilled water, the slides were placed in PBS for 5
minutes. The immunostaining was performed in the same way as for the cytoskeleton
in a slide rack. Anti-Ki-67 monoclonal Ab (Zymed, San Francisco, USA) diluted 1:
50 with PBS was used as the primary Ab and a negative control slide was incubated
with mouse primary Ab isotype control (Zymed).
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2.28.3 Apoptosis detection
The slides were immersed in PBS for 5 minutes and then placed in a slide rack for
immunostaining. The apoptotic cells were detected using DermaTacs™, an in situ
apoptosis detection kit for skin cells and tissues (R&D Systems Europe, Oxon, UK).
The staining was performed at room temperature unless stated specifically and the
manufacturer's instructions were followed. The slides were incubated with Cytonin
as a permeabilization and blocking agent for 30 minutes and then rinsed with
distilled water. After incubating with 3 % H202 in methanol for 5 minutes, they were
washed with PBS and incubated with terminal deoxynucleotidyl transferase enzyme
(TdT) labelling buffer for 5 minutes. The labelling reaction mix containing
brominated deoxynucleoside triphosphate (B-dNTP) mix, TdT enzyme and TdT
labelling buffer was then added and allowed to react for 45 minutes at 37°C. A
positive control was generated by adding nuclease into the labelling reaction mix and
a negative control was generated by omitting the TdT enzyme. The labelling reaction
was stopped by adding TdT stop buffer and the slides were washed with PBS after 5
minutes. They were then incubated with biotinylated mouse monoclonal anti-
bromodeoxyuridine (BrdU) antibody for 45 minutes at 37°C and then washed with
PBS. Bound BrdU was detected by incubating the slides with HRP conjugated
streptavidin for 10 minutes and washed with PBS followed by distilled water. The
colour was developed with TACS blue Label™ for 5 minutes and the slides were
rinsed with distilled water before counterstaining in eosin-based Red Counterstain C
for 5 minutes. After further washing in distilled water, the slides were air-dried,
clarified by dipping in xylene for 5 minutes and mounted with DPX mountant.
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2.29 Cell counting
All the slides were counted blind. 100 cells were counted in randomly chosen
confluent areas at high magnification (400X) and the nuclei were regarded as PCNA
or Ki-67 positive if the nuclei showed any specific brown staining. The whole area of
a well on the chamber slide was scanned for apoptotic cells at 100 X magnification
and cells that were condensed and exhibited increased Red Counterstain C uptake or
showing blue nuclear staining were regarded as apoptotic.
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Chapter 3
CHARACTERISATION OF THE IgG RESPONSE TO
MALASSEZIA PACHYDERMATIS ANTIGENS IN
ATOPIC AND NORMAL DOGS
3.1 Introduction
It has been well characterised that atopic diseases are clincial manifestations of Type
I hypersensitivity reactions mediated by IgE antibodies (Platts-Mills 2001). IgG
antibodies may also be involved in the disease process, however, their role in atopic
disease is less well defined in contrast to IgE. Both a pathogenic and a protective role
have been suggested for IgG antibodies in Type I hypersensitivity. This introduction
will focus on the relationship between IgG antibodies and atopic diseases in human
beings and dogs.
3.1.1 Anaphylactic IgG antibodies
The first indications of the existence of a heat-stable anaphylactic IgG antibody were
demonstrated approximately 30 years ago using serum samples from human patients
with food allergy (Parish 1970). These heat-stable antibodies were shown to be able
to sensitise skin mast cells of monkeys and were not removed from the serum by
anti-IgE immunosorbent. Furthermore, they could be precipitated by anti-IgG.
Unlike the long lasting sensitisation seen with IgE, which peaks at 24 hours, the
sensitisation with heat-stable IgG reached maximum in approximately 2 hours and
persisted for less than 24 hours (Parish 1970). They were therefore called "short-term
sensitising IgG", IgG-(S-TS). However, due to the lack of reliable in vitro assays to
detect IgG-(S-TS), its precise identity has not been determined (Van der Zee &
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Aalberse 1991).
In dogs, anaphylactic IgG antibodies (IgGd) with similar properties to IgG-(S-TS) in
man were first reported by Willemse et al. (1985a). Allergen specific IgGd were
detected most frequently against house dust, human dander, grass pollens and spring
tree pollens in atopic dogs using an ELISA technique (Willemse et al. 1985b). In a
later study, an IgGd response to a 90 kDa polypetide in crude extracts from
Dermatophagoides farinae was demonstrated in atopic dogs by Western blotting
(Noli et al. 1996). Nevertheless, high levels of IgGd to allergens of
Dermatophagoides farinae and D. pteronyssinus were also detected in normal dogs
(Lian & Halliwell 1998). It may be concluded from these data that the role of IgGd in
canine atopic disease is still uncertain.
3.1.2 IgG response to environmental allergens
In addition to IgE responses, the correlation between IgE and IgG responses to
specific environmental allergens, as well as allergen recognition by IgG subclasses,
have been studied in man. Using purified allergens of house dust mite and rye grass
pollen in an antigen-binding assay, it has been shown that there is a strong correlation
between IgE and IgG responses to Der p I and Rye I (Chapman & Platts-Mills 1978;
Platts-Mills et al. 1978). Barnes et al. (1993) showed that IgG responses to antigens
of house dust mites were predominately associated with IgGl antibodies in children
with atopic dermatitis as demonstrated by ELISA. However, a similarity of antibody
binding epitopes in grass pollen extracts (Dactylis glomerata) was found to lie
between IgE and IgG4 by Desvaux et al. (1989) using immunoblotting techniques to
characterise specific IgE, IgA, IgM classes and IgG subclasses in patients allergic to
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grass pollen. Furthermore, significantly higher concentrations of total and allergen-
specific IgG4 in sera were observed in patients with atopic dermatitis as compared to
normal individuals (Shakib et al. 1977; Merrett et al. 1984) whereas the levels of
specific IgGl antibodies to house dust mite and grass pollen in atopic patients were
not significantly different from those ofnon-atopic individuals (Kemeny et al. 1989).
Although there are similarities in biological activity between IgG-(S-TS) and IgG4,
there has been no clear evidence to conclude that IgG4 has anaphylactic activity and
is IgG-(S-TS) (Parish 1981).
Both total and allergen-specific IgG responses to environmental allergens have also
been documented in dogs. Significantly higher total IgG concentrations were
observed in atopic dogs than in normal dogs, as measured by radial immunodiffusion
assays (Hill et al. 1995). Atopic dogs were also shown to have higher concentrations
of allergen-specific IgG than non-atopic dogs as detected by ELISA (Hites et al.
1989). Day et al. (1996) showed that allergen-specific IgG antibodies were most
frequently detected to D. farinae, D. pteronyssinus, mould mix, insect mix, and
meadow fescue among 33 allergens included in a commercial ELISA test kit. In the
same study, the IgG subclass profile of allergen-specific antibodies was found to be
allergen-dependent with the IgG response to D. farinae and D. pteronyssinus being
dominated by IgG4 antibodies, and Timothy grass predominantly within the IgGl
and IgG4 subclasses (Day et al. 1996). The literature regarding the humoral immune
response in dogs with flea allergy dermatitis is inconsistent. One study showed that
dogs with flea bite hypersensitivity had higher levels of both IgE and IgG antibodies
to partially purified flea antigen than flea naive dogs and non-atopic dogs exposed
chronically to fleas, as measured by radioimmunoassay (Halliwell & Longino 1985).
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In contrast, McKeon and Opdebeeck (1994) showed that neither IgG nor IgE
reactivity detected using ELISA or western blotting could distinguish between dogs
with and without flea allergy.
3.1.3 IgG response to allergen-specific immunotherapy
IgG antibodies are generally considered important in the treatment of atopic diseases
in regard to allergen-specific immunotherapy. Elevated IgG responses have been
observed in human patients undergoing allergen-specific immunotherapy with IgGl
antibody appearing first and shifting to an IgG4-dominated responses later (Djurup &
Osterballe 1984; McHugh et al. 1990; Peng et al. 1992). However, both positive and
negative correlations between IgG4 responses and clinical improvement during
immunotherapy have been documented (Nakagawa et al. 1983; Djurup & Osterballe
1984; Hedlin et al. 1986; Mailing & Djurup 1988). The protective role of IgG4 as a
blocking antibody that competes for antigen with anaphylactic antibody in Type I
hypersensitivity still remains uncertain.
Although substantially less research on the correlation between IgG responses and
immunotherapy has been done in dogs compared to human beings, similar findings
have been reported. One study showed that atopic dogs not only had higher
concentrations of allergen-specific IgG than non-atopic dogs, it also increased further
after specific allergen immunotherapy (Hites et al. 1989).
3.1.4 Antigen-specific IgG response to cutaneous microorganisms
Cutaneous microorganisms such as Staphylococcus spp. bacteria and Malassezia
yeasts are known to be important in the pathogenesis of atopic dermatitis, both in
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man and in dogs. Higher levels of colonisation of Staphylococcus aureus and
Pityrosporum (Malassezia) species are commonly seen in human patients with atopic
eczema (Ring et al. 1992). Likewise, dogs with atopic dermatitis frequently exhibit
concurrent skin infection with Staphylococcus intermedius or Malassezia yeasts
(DeBoer & Marsella 2001).
The IgG responses to these microorganisms have been studied less extensively in
man than IgE responses. One recent study reported that atopic children under 7 years
of age more frequently had IgG antibodies to Staphylococcus aureus-derived
superantigen, enterotoxin B, than normal controls. Also, the levels of these specific
IgG antibodies measured by ELISA were higher, although they did not correlate with
serum IgE concentrations (Campbell & Kemp 1998). In contrast, no difference in the
levels ofMalassezia-specific IgG was shown between patients with atopic dermatitis
and healthy controls (Tengvall Linder et al. 2000; Savolainen et al. 2001). These two
studies were carried out in patients with a median age of over 25 years. Interestingly,
a study looking at IgG antibody responses to Malassezia organisms on skin of
children and young adults with atopic dermatitis aged between 0-21 years showed
that young adults (16-21 years) had significantly elevated Malassezia-specific IgG
levels (Broberg et al. 1992).
It has been shown that atopic dogs with Staphylococcus intermedius skin infection
(pyoderma) had significantly higher anti-staphylococcal IgG concentrations in their
sera compared to normal dogs, using an ELISA to measure antigen-specific IgG
(Morales et al. 1994; Shearer & Day 1997a). Nine major IgG binding epitopes of
Staphylococcus intermedius ranging between 25 and 120 kDa were identified by
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Western blotting analysis in groups of dog with various skin diseases including
atopic dermatitis with and without pyoderma (Shearer & Day 1997a). Elevated
serum titers ofM. pachydermatis-specific IgG measured by ELISA have also been
found in dogs with skin diseases associated with M. pachydermatis (Bond et al. 1998)
and atopic dogs with Malassezia overgrowth (Nuttall & Halliwell 2001). In addition,
four proteins of 219, 110, 71 and 42 kDa in extracts ofM. pachydermatis have been
demonstrated using Western blotting to be recognised mainly by non-atopic dogs
with Malassezia dermatitis as compared to healthy dogs (Bond & Lloyd 2002).
However, specific IgG binding proteins in M. pachydermatis have not been
investigated using sera of atopic dogs.
3.1.5 Aims
The aim of this part of the study was to characterise one arm of the humoral immune
response to M. pachydermatis by comparing the IgG binding activities to individual
antigens of the yeast in atopic dogs with and without Malassezia dermatitis, and
normal dogs in order to further clarify the role the organism plays in atopic dogs. The
initial objective of the experiments in this chapter was to develop a Western blotting
technique to detect specific IgG binding antigens ofM. pachydermatis. This method
was to be used to analyse all subsequent serum samples. The first part of this chapter
describes the experiments performed to validate and optimise the Western blotting
technique. The second section describes the detection of IgG binding antigens ofM.
pachydermatis in three groups of dogs using the optimal conditions demonstrated in
the former section.
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VALIDATION AND OPTIMISATION OF METHODOLOGY
3.2 Specificity of anti-canine IgG antibody
Aims
In order to characterise the IgG response to Malassezia pachydermatis, it was
essential to demonstrate that the anti-dog IgG used in this study bound to IgG in dog
sera specifically. The aim of the initial experiments in this section was to validate the
feasibility of using a horseradish peroxidase conjugated goat anti-dog IgG heavy and
light chain (Bethyl Laboratories, Montgomery Tx, USA) for immunoblotting.
3.2.1 Binding of anti-canine IgG antibody to purified canine IgG
Methods
Purified dog IgG (Sigma, UK), a normal dog serum sample, and mouse IgGlK
(Sigma, UK) were separated in a 12 % SDS-PAGE gel and blotted onto a membrane
which was then incubated with the goat anti-dog IgG to test its specificity. The
samples were diluted 1/100, 1/100, and 1/10 respectively with PBS and mixed 1:1
with reducing sample buffer before being subjected to electrophoresis. A volume of
20 pi from each sample was loaded into a minigel along with 5 pi of molecular
weight standards, and the SDS-PAGE was performed as described in chapter 2
(sections 2.9 and 2.10). After electrophoresis, one gel was stained with Coomassie
blue (section 2.11) and the other was used for electrophoretic transfer and
immunoblotting (sections 2.12 and 2.13).
The molecular weight standards transferred onto the membrane were cut off and
stained with Coomassie blue. The rest of the membrane was blocked for 1 hour with
1 % skimmed milk in TBS. After washing with TBS containing 0.05 % Tween 20
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(TTBS) for 15 minutes (3x5 minute rinses), the membrane was incubated for 1 hour
with a horseradish peroxidase conjugated goat anti-dog IgG heavy and light chain
(Bethyl Laboratories, Montgomery Tx, USA) diluted 1/5,000 in dilution buffer (1 %
skimmed milk in TTBS). The membrane was washed again in TTBS for a further 15
minutes and then developed with DAB (3, 3'-diaminobenzidine) peroxidase substrate
(Vector Laboratories, Inc., Burlingame, CA, USA) for about 5 minutes. After rinsing
with water to remove excess substrate, the membrane was air-dried.
Results
The protein profiles of purified dog IgG, normal dog serum and mouse IgGlic in an
SDS-PAGE gel are shown in Figure 3.1 A. As the electrophoresis was performed
under reducing condition, purified dog IgG was cleaved into heavy and light chains
which have a molecular weight of approximately 54 and 28 kDa, respectively. These
two bands were also present in the normal dog serum and mouse IgG Ik.
The binding of the anti-dog IgG to heavy and light chains of canine IgG is shown in
Figure 3.1 B. Two bands were seen in the lanes of purified dog IgG and normal dog
serum, which corresponded to the two bands at the same molecular weight range
shown in the gel. However, no bands were in the lane ofMouse IgG or to any of the
other proteins present in the dog serum sample indicating that the anti-dog IgG was














Figure 3.1 A-B Demonstration of specific binding between the horseradish
peroxidase conjugated goat anti-dog IgG and purified canine IgG
A: Purified canine IgG (lane 1), a serum sample from a normal dog (lane 2) and mouse
IgGlK (lane 3) analysed using reducing sample buffer in an SDS-PAGE gel. Purified
canine IgG was cleaved into two distinct bands: a heavy and light chain. Multiple
protein bands were present along with the heavy and light chains of IgG in dog serum.
More than two bands were found in mouse IgG Ik. These may include the heavy chain
ofmouse IgGl, the light chain of IgGl and their breakdown products.
B: Specificity of the horseradish peroxidase conjugated goat anti-dog IgG demonstrated
by immunoblotting. Two bands were detected both in purified canine IgG and dog
serum, whereas no visible bands were detected in mouse IgG Ik, confirming that the
anti-dog IgG was specific for heavy and light chains of canine IgG.
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3.2.2 Specificity of the anti-canine IgG antibody in Malassezia immunoblots
The previous experiment demonstrated that the anti-dog IgG was specific for canine
IgG. However, it was not known at this stage whether the Ab would bind to IgG in
dog sera specifically and not cause non-specific binding to Malassezia extracts.
Since the conclusions of this part of study were to be drawn from the binding shown
on a membrane, it was important to determine that the Ab bound to antigenic
components in Malassezia extracts rather than non-specific binding between the anti-
dog IgG and the extracts.
Methods
The Malassezia extract prepared with glass beads (123 pg, 150 pi of 1/20 dilution)
was mixed with reducing sample buffer and a final volume of 300 pi was added into
a broad well running across the top of the gel. The electrophoresis was run at 200 V
for 60 minutes and the proteins were transferred to a membrane as described in
chapter 2. This allowed the membrane to be cut into narrow strips so that they could
be probed with individual sera or different reagents. The strips were dipped in
methanol for a few seconds and rinsed in de-ionised water. It was found that this step
helped achieve an evenly spread colour development.
An 8-channel incubation tray was used to hold the strips and reagents. Each channel
held a strip and 1 ml of reagents. Eight strips were divided into two groups: the strips
in group one (no. 1-4) were blocked with 1 % skimmed milk in TBS, and strips in
group two (no. 5-8) were incubated with TBS (Figure 3.2). The first two strips in
each group were then incubated with different dilutions of dog sera (1/25 or 1/100),
whereas the other two were used as controls and incubated only with dilution buffer.
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Figure 3.2 Experimental design
Strips 1 2 3 4 5 6 7 8
Blocking 1 % skimmed milk in TBS None
Serum 1/25 1/100 Buffer Buffer 1/25 1/100 Buffer Buffer
Anti-IgG 1/1,000
The strips were incubated with either 1 % skimmed milk in TBS or plain TBS for 1
hour followed by a 15 minute wash (3x5 minute rinses) in TBS containing 0.05 %
Tween 20 (TTBS). A serum sample from an atopic dog with Malassezia dermatitis
was diluted either 1/25 or 1/100 in dilution buffer (1 % skimmed milk in TTBS) and
allowed to react with the strips for 30 minutes. After another 15-minute wash, bound
IgG was detected by incubating the strips for 1 hour with anti-dog IgG diluted
1/1,000 in dilution buffer. The strips were washed again in TTBS and developed with
DAB peroxidase substrate.
Results
The strips incubated with dog sera showed intense staining (Figure 3.3), but the
bands were difficult to interpret due to the dark background. This could stem from
insufficient blocking, high concentrations of serum or anti-dog IgG. Further
optimisation of the reagents was therefore required in order to allow clear
visualisation of the bands. However, despite the high background, no staining
developed in strips incubated only with dilution buffer, regardless of whether or not
they were blocked. This indicated that the anti-dog IgG did not bind to Malassezia
extracts non-specifically, thus confirming that the brown staining obtained was
generated from IgG in dog sera which had bound to Malassezia extracts.
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Figure 3.3 Specificity of the anti-canine IgG in Malassezia immunoblots
Immunoblots showing the effects of blotting and different serum dilutions.
Lanes 1-4 were blocked with 1 % skimmed milk in TBS whereas lanes 5-8
were not blocked. Lanes 1 and 5 were incubated with dog serum diluted 1/25,
and lanes 2 and 6, 1/100. The strips incubated with serum (lanes 1, 2, 5 and 6)
showed intense staining, although distinct bands were not visible. In contrast,
the strips incubated with buffer alone showed no binding (lanes 3, 4, 7 and 8),
indicating that the anti-dog IgG did not bind to Malassezia extracts non-
spec ifically.
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3.3 Optimisation of blocking reagents
Aims
Due to the difficulties in visualising bands on the strips in the previous experiment,
different concentrations ofblocking reagents were used to reduce the background.
Methods
As the anti-dog IgG was purified from goat serum, two different dilutions of normal
goat serum were used as a blocker in addition to skimmed milk. Eight strips with
separated Malassezia proteins were pre-wetted with methanol, rinsed with water and
blocked with either skimmed milk or goat sera diluted 1/100 or 1/20 in TBS for 1
hour (Figure 3.4). They were washed with TTBS for 15 minutes (3x5 minute rinses)
and then incubated with dog sera. Serum samples were used from an atopic dog with
Malassezia dermatitis and a normal dog and included in each blocker group tested.
Due to the intense binding seen in the previous experiment, the dog sera and anti-dog
IgG were used at higher dilutions in this experiment. The strips were incubated with
dog sera diluted 1/100 in dilution buffer for 30 minutes followed by washing in
TTBS for 15 minutes. They were then incubated for 1 hour with anti-dog IgG diluted
1/5,000, washed again in TTBS for 15 minutes and developed with DAB peroxidase
substrate.
Figure 3.4 Experimental design
Strips 1 2 3 4 5 6 7 8
Blocking 1 % milk 5 % milk 1 % goat serum 5 % goat serum
Serum AM 1/100 N 1/100 AM 1/100 N 1/100 AM 1/100 N 1/100 AM 1/100 N 1/100
Anti-IgG 1/5,000
AM: atopic dog with Malassezia dermatitis; N: normal dog.
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Results
The comparison between different blocking reagents is shown in Figure 3.5. There
was substantially less staining shown in strips incubated with the normal dog serum
compared with the atopic dog serum, suggesting that the brown staining shown in the
atopic dog was a specific antibody-antigen reaction rather than non-specific
background. Despite this, no difference was observed between each blocker tested.
The binding present in the atopic dog was indistinct although the normal dog showed
a few clear bands. However, goat serum was not superior to skimmed milk in terms
of enhancing the clarity of bands in the normal or atopic dog. Since skimmed milk
was cheap and easy to obtain, 1 % skimmed milk in TBS was therefore used as a








Figure 3.5 Evaluation of four different blocking reagents
Immunoblots showing the effects of different blotting reagents on different
serum samples. Lanes 1-4 were blocked with skimmed milk in TBS and lanes
5-8, goat serum. The strips in lanes 1, 3, 5 and 7 were incubated with a serum
sample from an atopic dog with Malassezia dermatitis, and the rest of the
strips, a serum sample from a normal dog. There is a clear difference between
the amount of staining shown by atopic dog serum and normal dog serum.
However, no apparent difference was shown between strips blocked with
goat serum and skimmed milk.
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3.4 Optimisation of anti-canine IgG antibody dilution and substrate
incubation time
Aims
With dog serum diluted to 1/100 and anti-dog IgG diluted to 1/5,000, the IgG binding
was sub-optimal in the atopic dog with Malassezia dermatitis as shown in the
previous experiment. The aim of these experiments was to determine the optimal
dilution of anti-dog IgG with a serum dilution of 1/100. In addition, three different
substrate incubation times were evaluated.
Methods
Twenty four pre-wetted strips containing separated Malassezia proteins were divided
into three groups and placed into three 8-channel incubation trays. They were
blocked with 1 % skimmed milk for 1 hour and washed with TTBS for 15 minutes.
Half of the strips were incubated for 30 minutes with a serum sample from an atopic
dog with Malassezia dermatitis and the other half with a serum sample from a
normal dog, both of which were diluted 1/100 in dilution buffer. After further
washing in TTBS for 15 minutes, the strips were incubated for 1 hour with anti-dog
IgG diluted 1/5,000, 1/10,000, 1/20,000 or 1/50,000. Each dilution group included
strips that had been incubated with sera from both the atopic and normal dog (see
Figure 3.6 for experimental design). The strips were then washed in TTBS for a
further 15 minutes, and developed with DAB peroxidase substrate. Three different
incubation times were evaluated: the strips in trays 1, 2, and 3 were incubated with
the substrate for 1,15, and 25 minutes, respectively.
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Figure 3.6 Experimental design
Strips 1 2 3 4 5 6 7 8
Blocking 1 % skimmed milk in TBS
Serum AM 1/100 N 1/100 AM 1/100 N 1/100 AM 1/100 N 1/100 AM 1/100 N 1/100
Anti-IgG 1/50,000 1/20,000 1/10,000 1/5,000
DAB Tray 1 1 minute
Tray 2 15 minutes
Tray 3 25 minutes
AM: atopic dog with Malassezia dermatitis; N: normal dog.
Results
Anti-dog IgG at dilutions of 1/20,000 and 1/50,000 did not generate sufficient
staining, regardless of the incubation time of the DAB peroxidase substrate (Figure
3.7). The binding that developed under these conditions was very faint using the
atopic dog serum compared to the strips incubated with anti-dog IgG diluted
1/10,000 or 1/5,000. No bands were detected with the normal dog serum with the
higher dilutions of anti-dog IgG, whereas a few faint bands were visible when the
anti-dog IgG was used at dilution of 1/10,000 or 1/5,000. The intensity of binding in
the strips incubated with higher concentrations of anti-dog IgG did not differ
noticeably between groups developed with DAB peroxidase substrate for different
periods of time. However, anti-dog IgG at a dilution of 1/5,000 tended to produce a
darker background, and this was more noticeable with the normal dog serum. The
best results were obtained using an anti-dog IgG dilution of 1/10,000 and a 1-minute
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Figure 3.7 Optimisation of anti-dog IgG concentration and DAB peroxidase
substrate development
Four different concentrations of anti-dog IgG, including 1/50,000, 1/20,000, 1/10,000
and 1/5,000, were evaluated. Each dilution group of anti-dog IgG comprised a serum
sample chosen from an atopic dog with Malassezia dermatitis and a normal dog (see
Figure 3.6 for experimental design). The strips in trays 1, 2, and 3 were developed
with DAB peroxidase substrate for 1,15, and 25 minutes, respectively. Comparing the
results from the three trays, anti-dog IgG diluted 1/10,000 and a 1-minute substrate
development were deemed to provide the best outcome (strips 5 and 6 in tray 1) and
therefore used to analyse all subsequent serum samples.
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IgG RESPONSE TO MALASSEZIA PACHYDERMATIS ANTIGENS IN DOGS
3.5 Detection of IgG binding proteins from Malassezia pachydermatis in
atopic dogs with Malassezia dermatitis, atopic dogs without
Malassezia dermatitis and normal dogs
Aims
In this section, the optimal conditions for immunoblotting to detect Malassezia
pachydermatis specific IgG determined from earlier sections in this chapter were
used to analyse individual dog serum samples from three groups of dogs: atopic dogs
with Malassezia dermatitis, atopic dogs without Malassezia dermatitis and normal
dogs.
Methods
The strips containing separated Malassezia proteins were pre-wetted with methanol
and blocked for 1 hour with 1 % skimmed milk in TBS. After washing with TTBS
for 15 minutes (3x5 minute rinses), each strip was incubated with 10 pi of dog
serum diluted to 1 ml in dilution buffer (1 % skimmed milk in TTBS) for 30 minutes.
The strips were then washed again in TTBS for a further 15 minutes. Bound IgG was
detected by incubating the strips for 1 hour with horseradish peroxidase conjugated
goat anti-dog IgG heavy and light chain diluted 1/10,000 in dilution buffer. After
further washing with TTBS for 15 minutes, the strips were developed with DAB
peroxidase substrate for about 1 minute. The molecular weights of IgG binding
proteins were determined using standard curves generated by analysing the position
ofmolecular weight markers on Coomassie blue stained membranes.
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Results
The IgG immunoblots of individual dog sera from the three different groups are
shown in Figure 3.8 A-C. The amount of staining seen in the normal dogs (Figure 3.8
A) was much weaker than that seen in the atopic dogs with cytological evidence of
Malassezia overgrowth (Figure 3.8 B). The binding pattern seen in atopic dogs
without Malassezia dermatitis lay between the previous two groups (Figure 3.8 C).
More than half of the normal dogs showed multiple indistinct bands between 42 and
68 kDa, but clearer bands could be seen at 42 (in 83 % of dogs), 45 (61%), and 82
kDa (67 %) (Figure 3.9 A). Two dogs showed relatively strong binding patterns (No.
9 and 18) and one dog had a prominent band at 27 kDa (No. 15).
In the atopic dogs with Malassezia dermatitis, there was more intense staining of
indistinct bands between 45 and 51 kDa. However, distinct IgG-binding proteins
with molecular weights of 25 (78 %), 29 (67 %), 42 (94 %), 61 (67 %), 82 (89 %),
and 90 kDa (61 %) were recognised by more than 50 % of the atopic dogs with
Malassezia dermatitis (Figure 3.9 B). Some atopic dogs also showed binding to
various low molecular weight proteins between 14 and 42 kDa. Antigens of 28-30
(55 %), 42 (95 %), 45-51 (80 %), 61 (50 %), 82 (65 %) and 90 (55 %) kDa were also
recognised by more than 50 % of the sera from atopic dogs without Malassezia
dermatitis (Figure 3.9 C).
The blots of the three groups demonstrate that most dogs show IgG binding to
multiple Malassezia antigens. However, atopic dogs with Malassezia dermatitis had
a much greater IgG response than the normal dogs, and the majority showed binding
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Figure 3.8 A-C IgG-binding components in extracts of M. pachydermatis
detected by immunoblotting with dog sera from 3 different groups
A: Normal dogs; B: Atopic dogs with Malassezia dermatitis and C: Atopic dogs
without Malassezia dermatitis. The numbers along the bottom signify the strips
probed with individual dog sera. The molecular weight standards on the left are
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Figure 3.9 A-C Percentage of dogs from three different groups showing IgG
binding to individual antigenic components in extracts ofM. pachydermatis
A: Normal dogs; B: Atopic dogs with Malassezia dermatitis and C: Atopic dogs
without Malassezia dermatitis. X axis: molecular weights of the bands detected on
the strips; Y axis: percentage of dogs reacting to those bands.
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3.6 Discussion
In this chapter, specific IgG binding antigens in extracts of Malassezia
pachydermatis were demonstrated with sera of atopic dogs with Malassezia
dermatitis, atopic dogs without Malassezia dermatitis and normal dogs using western
blotting. The results of the immunoblotting with individual dog sera indicate that
most dogs have an IgG response to multiple antigens ofM. pachydermatis.
Approximately half of the normal dogs showed faint IgG binding to multiple
indistinct bands between 42-68 kDa, but clearer bands could be seen at 42, 45, and
82 kDa. These difficulties in distinguishing bands could be overcome using two-
dimensional SDS-PAGE to further separate the antigens by their isoelectronic points
and immunoblotting (Onishi et al. 1999). Nevertheless, our results suggest that the
commensal population of M. pachydermatis is recognised by the dog's immune
system leading to an antibody response. This is in agreement with studies in man,
which showed that Malassezia-specific IgG was detectable in healthy individuals by
ELISA (Tengvall Linder et al. 2000; Savolainen et al. 2001). Whether or not this IgG
response seen in normal dogs is protective in any way remains to be determined.
The degree and intensity of staining on the blots from the atopic dogs with
Malassezia dermatitis was much greater than that seen using sera from the normal
dogs, indicating that the majority of atopic dogs with Malassezia dermatitis had a
greater IgG response to M. pachydermatis. This result is in accordance with a recent
finding that dogs with skin disease associated with M. pachydermatis develop high
serum titers ofM. pachydermatis-specific IgG (Bond et al. 1998). Furthermore, more
numerous IgG-binding proteins were observed on the blots from the atopic dogs with
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Malassezia dermatitis than using normal sera. Some of these proteins were the same
in both groups (molecular weights of 42, 45-51, 82 kDa). However, an antigen of 25
kDa was recognised by the majority of atopic dogs with Malassezia dermatitis but
was not recognised by most dogs in the other two groups. At this stage, the identity
of this protein and its function are not known. Likewise, the significance of the IgG
response to this antigen in the atopic dogs is unknown. It is known that IgG is
required to opsonise staphylococci for phagocytosis by neutrophils (Shearer & Day
1997b). Similarly, the IgG may act as an opsonin to facilitate phagocytosis of
Malassezia antigens. This could have a protective function but the IgG could also
activate the complement system and exacerbate the underlying inflammation. It has
been shown that Pityrosporum orbiculare and P. ovale are capable of activating the
classical and alternative complement pathways (Belew et al. 1980; Sohnle & Collins-
Lech 1983). It has also been suggested that zymogen in the cell wall of M.
pachydermatis might activate complement leading to epidermal damage and
inflammation (Mason 1993). Despite the uncertainty surrounding the role of this
antigen, the IgG response seen in the atopic dogs with Malassezia overgrowth but
not in the normal dogs suggests that it may have some clinical relevance in the
disease.
IgG-binding components in extracts ofM. pachydermatis have also been investigated
with sera of healthy dogs and non-atopic dogs with Malassezia dermatitis (Bond &
Lloyd 2002). Proteins of 132, 66 and 50-54 kDa were recognised by most sera, but
affected dogs showed immunoreactivity mainly to proteins of 219, 110, 71, and 42
kDa (Bond & Lloyd 2002). Comparing the relative positions of bands and molecular
weight standards, we infer that some of these results are likely to represent the same
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bands as those seen in this study. However, the 25 kDa antigen was not recognised
by sera from the non-atopic dogs with Malassezia dermatitis, again suggesting a
degree of specificity for this response in dogs with atopic dermatitis.
The pattern of IgG binding revealed by sera from the atopic dogs without Malassezia
dermatitis lies between that revealed by sera from the normal dogs and atopic dogs
with Malassezia dermatitis. Most of these dogs also recognised antigens of 28-30, 42,
45-51, 61, 82, and 90 kDa. Due to the difficulty of precisely resolving the molecular
weight of proteins on SDS-PAGE gels, it is possible that the bands detected at 28 and
30 kDa are the same as the 29 kDa antigen seen in the group with Malassezia
overgrowth. There are some possible explanations for this intermediate pattern.
White et al. (1996) compared the carriage ofM. pachydermatis on clinically normal
skin of the intradermal test site in atopic dogs and trunkal glabrous skin of healthy
dogs. They found that atopic dogs had significantly higher yeast culture scores than
healthy dogs. Hence, the atopic dogs without Malassezia dermatitis could still have
had elevated populations of the yeast without having cytological evidence of
overgrowth. Also, some of the atopic dogs may have had Malassezia dermatitis or
otitis in the past, leading to a residual IgG response. Finally, the immune system of
atopic dogs may be sensitized to the normal population of the commensal through
their frequent scratching behavior. It has been suggested that disruption of stratum
corneum barrier function by scratching may enhance exposure of the skin immune
system to yeast allergens (Morris et al. 1998). However, the 25 kDa antigen was only
seen in less than 25 % of the atopic dogs without Malassezia overgrowth, suggesting
that an IgG response to this protein is clinically relevant in the disease.
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In contrast to two human studies showing no difference in levels of Malassezia-
specific IgG between patients with atopic dermatitis and healthy controls (Tengvall
Linder et al. 2000; Savolainen et al. 2001), the results of this chapter demonstrated
that atopic dogs generally developed a greater IgG response to M. pachydermatis
than normal dogs, with a higher frequency in atopic dogs with Malassezia dermatitis.
This could indicate that people and dogs with atopic dermatitis might react
differently to Malassezia organisms colonising on their skin. Tengvall Linder et al.
(2000) also showed that the Malassezia-specific serum IgG levels did not correlate
with the patch test responses to Malassezia extracts in patients with atopic dermatitis.
Since intradermal skin testing to Malassezia extracts was not performed in dogs in
the present study, no comparison can be made between human beings and dogs in
this respect. Whether the greater IgG response to M. pachydermatis seen in the atopic
dogs simply reflects higher exposure to the organism, or plays a role in the
pathogenesis of atopic dermatitis is uncertain.
In summary, the experiments in this chapter have identified a number of IgG binding
proteins in M. pachydermatis. The IgG response was greater in atopic dogs with
Malassezia dermatitis and an antigen of 25 kDa appeared to be the most important.
In order to determine the identity of the 25 kDa antigen, the crude Malassezia
extracts could be purified using high-performance liquid chromatography (HPLC)
and separated by electrophoresis. The 25 kDa antigen recognised by the sera of
atopic dogs with Malassezia dermatitis could then be identified by N-terminal
sequencing. It has been suggested that T-cell mediated immune responses are
important in immunity against superficial mycoses (Hay 1992). The purified antigen
could potentially be used to study cell-mediated immune responses to M.
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pachydermatis in the future, which would further elucidate the antigen recognition
and cellular responses in atopic dogs with Malassezia dermatitis. The cellular
location of this 25 kDa antigen is unknown and awaits further investigation. The
Malassezia extract used in this study was produced by grinding the organisms with
glass beads and therefore consisted of fragmented cell walls and various intracellular
components. The 25 kDa antigen could possibly be intracellular, on the cell wall, or
both. Determination of its location and identity may help us further understand the
mechanisms by which M. pachydermatis triggers immune responses in the host.
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Chapter 4
IDENTIFICATION OF MAJOR ALLERGENS OF
MALASSEZIA PACHYDERMATIS IN DOGS WITH ATOPIC
DERMATITIS AND MALASSEZIA OVERGROWTH
4.1 Introduction
Atopic diseases represent clinical presentations of Type I hypersensitivity reactions
that are generally triggered by an increased production of IgE in response to
environmental allergens (Platts-Mills 2001). Exposure to antigens leads to
production of antigen-specific IgE that binds to mast cells, resulting in the individual
being sensitised. Subsequent re-encounter with the allergens cross-links mast cell
bound IgE, bringing about mast cell degranulation, release of inflammatory
mediators and clinical signs of atopic diseases (Platts-Mills 2001). The association
between atopic diseases and IgE concentrations, both total and allergen-specific, has
therefore been investigated extensively.
4.1.1 Total serum IgE in patients with atopic diseases
Total serum IgE levels are often raised in human patients with atopic diseases such as
allergic rhinitis, asthma and atopic dermatitis (O'Loughlin et al. 1977; Zetterstrom &
Johansson 1981; Platts-Mills 2001). It has also been found that there is a positive
correlation between the severity of atopic dermatitis and increased serum IgE levels
in atopic individuals (Clendenning et al. 1973). Determination of total serum IgE
concentrations has been used to provide additional evidence for diagnosis of
suspected atopic diseases, especially in children, in which elevated IgE levels can
also be helpful to predict subsequent development of atopic diseases (Kjellman 1976;
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Lindberg & Arroyave 1986; Fifield et al. 1987).
Studies comparing total serum IgE concentrations in atopic and healthy dogs reveal
different results to those found in people. No significant differences were found
between the two groups when measured by radial immunodiffusion techniques or
ELISA (Vriesendorp et al. 1975; Schwartzman 1984; Nimmo Wilkie et al. 1990; Hill
et al. 1995; Jackson et al. 2002). Also, the severity of the clinical signs in atopic dogs
did not correlate with total serum IgE concentrations (Jackson et al. 2002). It has
been speculated that the discrepancy between the two species is due to a greater
exposure of the canine population to parasite infestation (Vriesendorp et al. 1975;
Hill et al. 1995), as elevated IgE levels are also seen in endoparasitic diseases
(Heiner & Rose 1970; Merrett et al. 1976). Furthermore, total serum IgE
concentrations in puppies has little value in predicting the onset of atopic dermatitis
(DeBoer & Hill 1999).
4.1.2 IgE response to environmental allergens
Various techniques have been used in the diagnosis and investigation of atopic
dermatitis in man and dogs to detect IgE-mediated immunological responses toward
environmental antigens, mainly in vivo skin tests (e.g. skin prick test (SPT) and
intradermal test (IDT)), in vitro antibody detection assays (e.g. ELISA and
radioallergosorbent test (RAST)), and antigen identification techniques, such as
Western immunoblotting .
The aim of skin testing is to detect allergen-specific IgE antibodies on the surface of
cutaneous mast cells, which cross-link in the presence of allergens triggering mast
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cell degranulation. The release of histamine as well as other mediators then causes
vasodilatation and increased vascular permeability leading to tissue oedema and the
development of a wheal (Frew 1997). In humans, skin testing is usually performed
by the skin prick method using diluted antigen extracts because the IDT involves
increased discomfort and risk of systemic reactions (Demoly et al. 1998). In contrast,
IDT is widely and almost exclusively used in dogs to define the allergens that
animals are hypersensitive to and a variety of environmental antigens are usually
included in the antigen panel (Hillier & DeBoer 2001). The antigens commonly used
in IDTs generally fall into the following categories: mite antigens; epithelial antigens;
pollens from grass, trees and weeds; mould antigens; and insect antigens (reviewed
in Hill & DeBoer 2001). By comparing the data published, the importance of
environmental antigens in canine atopic dermatitis seems to be associated with
geographical locations, with dust mite and epidermal antigens being important in
both the USA and Europe whereas pollen and mould antigens are more important in
the USA than that in Europe (Hill & DeBoer 2001).
In vitro tests measuring circulating antigen-specific IgE in sera are frequently used to
assist diagnosis in atopic human patients (Merrett 1997). For the diagnosis of canine
atopy, although varying correlations between IDT and in vitro tests have been
reported (Halliwell & Kunkle 1978; Codner & Lessard 1993; Bond et al. 1994b), in
vitro tests are generally considered to be less valuable than the IDT because they
only evaluate one aspect of the IgE/mast cell/microvasculature axis. There can also
be problems of reproducibility, sensitivity, specificity and false positive or negative
results with the assays (Codner & Lessard 1993; Bond et al. 1994b; Plant 1994;
DeBoer & Hillier 2001). As with the use of in vivo and in vitro tests in man, the
129
results of these tests in dogs should be interpreted in conjunction with the animals'
clinical history and signs (Kleinbeck 1994; Scott et al. 2001c).
The use of western immunoblotting techniques allows major allergens to be
determined from crude antigen extracts. These can then be further characterised by
biochemical and molecular techniques. A wide range of purified allergens have been
determined in man and many of them have now been identified (Chua et al. 1988;
Nilsen & Paulsen 1990; Thakur 1991; Lin et al. 1994; Asturias et al. 1997; Okada et
al. 1998; Suphioglu et al. 1999; Vrtala et al. 1999; Mills et al. 1999; Su et al. 1999).
Similar studies are limited in dogs and have predominantly focused on
Dermatophagoides mites (Noli et al. 1996; Masuda et al. 1999; McCall et al. 2001;
Nuttall et al. 2001).
4.1.3 Allergen-specific IgE responses to cutaneous microorganisms
Due to the increased susceptibility of the skin of patients with atopic dermatitis (man
and dogs) to colonisation with Staphylococcus and Malassezia species, many studies
looking at the IgE responses to these microorganisms have been undertaken in man.
In contrast, only a few investigations of this kind have been performed in dogs.
4.1.3.1 IgE responses to Staphylococcus bacteria
The results of numerous studies have suggested that specific IgE antibodies against
Staphylococcus aureus may play an important role in human atopic dermatitis. It has
been found that some human patients with atopic dermatitis and cutaneous
staphylococcal infections have detectable IgE to Staphylococcus aureus in their sera,
using an immunoradiometric method to detect specific IgE against whole organisms
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or purified cell wall (Friedman et al. 1985). Studies on IgE responses to a variety of
exotoxins secreted by Staphylococcus aureus showed that the majority of patients
suffering from atopic dermatitis had specific IgE antibodies to enterotoxins A and B
(Leung et al. 1993; Tada et al. 1996) and toxic shock syndrome toxin-1 (TSST-1)
(Leung et al. 1993) as measured by ELISA. The severity of atopic dermatitis has
been reported to correlate with the levels of IgE antibodies to enterotoxins A and/or
B (Bunikowski et al. 1999) or enterotoxin B alone (Nomura et al. 1999; Breuer et al.
2000). In one study, TTST-1 was demonstrated to augment allergen-specific IgE
production (Hofer et al. 1999). Stimulation of IgE synthesis by peripheral blood
mononuclear cells (PBMC) in vitro has also been shown with two surface proteins of
S. aureus, NP-tase and p70, in patients with atopic dermatitis (Jahreis et al. 2000).
The role of Staphylococcus intermedius and its exotoxins in the pathogenesis of
canine atopic dermatitis has not been fully defined. It has been demonstrated that
dogs with recurrent pyoderma, either idiopathic or associated with atopy, have higher
levels of anti-staphylococcal IgE in their sera than healthy dogs, as measured by
ELISA techniques (Halliwell 1987; Morales et al. 1994). However, the specific IgE
responses to staphylococcal exotoxins or other staphylococcal components have not
yet been studied in dogs.
4.1.3.2 IgE responses to Malassezia yeasts
The IgE responses to Malassezia species on human skin have been studied
extensively and various methods have been used to detect Malassezia-specific IgE,
including IDT, SPT, histamine release tests and in vitro serological tests such as
ELISA, RAST and immunoblotting. Although direct comparisons between the
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results of different studies are difficult due to the discrepancies in the methodologies
used by different investigators (such as the source of allergens and the definition of
positive reactions), similar findings have been documented using intradermal and
skin prick tests with Malassezia antigens. An increased sensitivity to these tests has
been reported in patients with generalised atopic dermatitis (Young et al. 1989;
Rokugo et al. 1990; Broberg et al. 1992) or those with lesions predominantly in the
head and neck (Waersted & Hjorth 1985; Kieffer et al. 1990; Nissen et al. 1998).
Using basophil histamine release test with whole blood samples, it has also been
found that most patients with atopic dermatitis had positive responses to Malassezia
extracts with a higher percentage seen in patients with head and neck dermatitis
(Kieffer et al. 1990; Nissen et al. 1998). Increased concentrations of Malassezia-
specific IgE were also found in the sera of patients with atopic dermatitis compared
to those with other atopic diseases or healthy controls, as measured by either ELISA
(Wessels et al. 1991) or RAST (Young et al. 1989; Nordvall et al. 1992; Savolainen
et al. 2001). Also, these antibodies were found to be present more frequently in the
first group (Nordvall & Johansson 1990; Broberg et al. 1992).
In contrast to the correlation between the concentration of specific IgE to certain
exotoxins derived from Staphylococcus aureus and the severity of atopic dermatitis
in human patients, a similar correlation has not been found with Malassezia-specific
IgE (Wessels et al. 1991; Back et al. 1995). However, by using western
immunoblotting to detect Malassezia-specific IgE, and the criteria that more than 50
% of the patients' sera reacting represents major allergens, a number of major IgE-
binding proteins in the range of 9-110 kDa have now been documented in man
(Johansson & Karlstrom 1991; Jensen-Jarolim et al. 1992; Zargari et al. 1994; Lintu
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et al. 1997; Nissen et al. 1998). Some antigens defined as major allergens in one
study have been cited as minor allergens by other investigators (listed in Ashbee &
Evans 2002). This is likely to be due to the disparity between methodologies and
antigen preparations used in different studies. Of the numerous antigens documented,
a limited number of antigens have been further characterised. Nine allergens of
Malassezia furfur (Mai f 1- Mai f 9) were recently sequenced and expressed as
recombinant proteins (Schmidt et al. 1997; Yasueda et al. 1998; Onishi et al. 1999;
Lindborg et al. 1999; Rasool et al. 2000). However, the strain used in some of these
studies has now been re-assigned to the species M. sympodialis (Scheynius et al.
2002), and the current nomenclature of purified Malassezia allergens is summarised
in Table 4.1.
Table 4.1 Three allergens of Malassezia furfur and six allergens of Malassezia sympodialis that






Mais 1 37 70 No homology to known proteins
Membrane or secreted cell wall protein
Mai f 2 21 72 Homology to peroxisomal membrane proteins of
Candida boidinii and Aspergillus fumigatus (Asp f 3)
Mai f 3 20 70 Homology to peroxisomal membrane proteins of
Candida boidinii and Aspergillus fumigatus (Asp f 3)
Mai f 4 35 83 Showing 57 % homology to mitochondria malate
dehydrogenase from Saccharomyces cerevisiae
Mais 5 18.2 48 No homology to known proteins
Mai s 6 17.2 48 Showing 82 % homology to cyclophilin from
Schizosaccharomyces pombe
Mais 7 16.2 40 No homology to known proteins
Mais 8 19.2 40 No homology to known proteins
Mai s 9 14 24 No homology to known proteins
AD: atopic dermatitis
It is important to note that many of the studies described above were performed using
the old classification of Malassezia species, and therefore might reflect the
characteristics of other more recently described Malassezia species. A study
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investigating IgE binding components in five of the seven species currently classified
under the Malassezia genus, including Malassezia furfur, M. globosa, M. restricta, M.
slooffiae, and M. sympodialis, showed that both species-specific and common
antigenic components were present between species, and the molecular weights of
bands most frequently recognised by the sera of AD patients were 67-72 (28 %), 45-
50 (80 %), 35-40 (39 %), 43-46 (20 %) and 19-22 kDa (43 %), respectively (Koyama
et al. 2001). It is likely that further studies comparing different species, and the use
ofmolecular techniques, will define more precisely the identity of major allergens of
Malassezia species.
In contrast to the large number of studies that have been carried out in humans during
the last two decades, it is only recently that IgE responses to Malassezia
pachydermatis in dogs have been investigated. Immediate hypersensitivity responses
to intradermal injections of M. pachydermatis extracts have been demonstrated in
atopic dogs with Malassezia overgrowth (Morris et al. 1998; Bond et al. 2002a),
suggesting that allergens from the organisms may be involved in the pathogenesis of
canine atopic dermatitis. Atopic dogs with and without Malassezia dermatitis and /or
otitis have also been shown to have significantly higher levels ofMalassezia-specific
IgE than either healthy dogs or non-atopic dogs with Malassezia dermatitis and /or
otitis as detected using ELISA (Nuttall & Halliwell 2001). However, the IgE binding
epitopes ofMalassezia pachydermatis have not yet been investigated.
4.1.4 Aims
The aim of this section was to complement the IgG data in chapter 3 by further
characterising the humoral immune response to Malassezia pachydermatis by
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comparing IgE responses to separated antigens of the yeast in atopic dogs with
Malassezia dermatitis and normal dogs. The initial objective of the experiments was
to develop and validate a Western blotting technique to detect specific IgE binding
proteins from M. pachydermatis. The first part of this chapter describes six protocols
that were investigated, and the second part describes the detection of IgE binding
allergens ofM. pachydermatis in the two groups of dogs.
135
VALIDATION AND OPTIMISATION OF METHODOLOGY TO DETECT
IgE BINDING PROTEINS IN M. PACHYDERMATIS
4.2 Summary of methodologies and reagents evaluated
Various methodologies and reagents were evaluated to detect IgE binding proteins in
M. pachydermatis (summarised in Table 4.2). Two methods were investigated to
allow immunoblot membranes to be probed with individual dog sera: cutting the
membrane into narrow strips or placing the whole membrane into a multi-channel
miniblotter (Immunetics Inc. Cambridge, USA). The blocking reagents that were
evaluated included skimmed milk (1-10 %), casein solution (Vector Laboratories,
Inc., Burlingame, CA, USA), Tween 20 (Fisher Scientific, UK), Tween 80 (Sigma,
UK), and an avidin/biotin blocking kit (Vector Laboratories, Inc., Burlingame, CA,
USA). The following IgE specific reagents were evaluated: a polyclonal epsilon
chain specific goat anti-dog IgE conjugated with horseradish peroxidase (HRP)
(Bethyl Laboratories, Montgomery TX, USA); two monoclonal mouse anti-dog IgE
antibodies (D9#3116, kindly donated by Dr. D.J. DeBoer, University of Wisconsin,
USA and E6-71A1, Custom Monoclonals International, W. Sacramento, USA); and a
biotinylated recombinant human IgE receptor alpha chain (kindly donated by Dr. C.
McCall, Heska Corporation, Fort Collins, USA). For visualization of binding, the
following conjugates labeled with either alkaline phosphatase (AP) or HRP were
used: a monoclonal mouse anti-goat IgG-AP (Sigma, UK); a monoclonal bovine
anti-mouse IgGl-HRP (Serotec, UK); two polyclonal goat anti-mouse IgG antibodies
labeled either with HRP (Sigma, UK) or AP (Southern Biotechnology Associates,
Inc., USA); and two avidin reagents (Vectastain® Elite ABC kit, Vector Laboratories,
Inc., Burlingame, CA, USA and Extravidin®-peroxidase, Sigma, UK). Two different
detection systems were evaluated: substrate colour change and chemiluminescence.
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For standard blots, DAB (3, 3'-diaminobenzidin, Vector Laboratories, Inc.,
Burlingame, CA, USA) and BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro
blue tetrazolium, Sigma, UK) were used to detect HRP and AP labeled reagents,
respectively. For chemiluminescent blots, ECL™ (Amersham pharmacia biotech, UK)
was used for HRP labeled reagents and CDP-Star™ (Tropix, Inc., Bedford, USA) for
AP labeled reagents (Table 4.2). Each protocol will be described in detail in the
following sections.
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4.3 Protocol 1-detection of IgE binding proteins with an epsilon chain
specific goat anti-canine IgE antibody conjugated with HRP
Aims
In chapter 3, IgG binding proteins from Malassezia pachydermatis were
demonstrated using an anti-dog IgG antibody and chromogenic detection. In this
section, the initial aim was to test the feasibility of using the same detection method
with an anti-dog IgE antibody to detect specific IgE binding allergens in M.
pachydermatis in atopic dogs with Malassezia dermatitis.
Methods
The SDS-PAGE and western blotting were performed as described in chapter 2.
Briefly, the Malassezia extract prepared with glass beads (123 pg, 150 pi of 1/20
dilution) was mixed with reducing sample buffer and a final volume of 300 pi was
added into a broad well running across the top of the gel. The electrophoresis was
run at 200 V for 60 minutes and the proteins were transferred to a membrane. The
membrane was then cut into narrow strips in order to be probed with individual sera
or different reagents. The strips were dipped in methanol for a few seconds and
rinsed with de-ionised water before placing into 8-channel trays.
Sixteen pre-wetted strips containing separated Malassezia proteins were placed into
two 8-channel incubation trays. They were blocked with 1 % skimmed milk in TBS
for 1 hour and washed with TBS containing 0.05 % Tween 20 (TTBS) for 15 minutes
(3x5 minute rinses). Due to the relatively low concentration of IgE in dog serum
compared to IgG, the strips were then incubated with dog sera for 1 hour rather than
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30 minutes as in the IgG study to increase the probability of binding and to enhance
the signal. Lower dilutions of dog sera and anti-IgE antibody were also used to
increase sensitivity. The first two strips in each tray were incubated with dilution
buffer (1 % skimmed milk in TTBS) alone to act as controls (Figure 4.1). The rest of
the strips were divided into two groups. Half of the strips were incubated with a
serum sample from an atopic dog with Malassezia dermatitis and the other half with
a serum sample from a normal dog, both of which were diluted 1/5, 1/10 or 1/50 in
dilution buffer. After further washing in TTBS for 15 minutes, the strips were
incubated for 1 hour with a HRP conjugated goat anti-dog IgE epsilon chain (Bethyl
Laboratories, Montgomery TX, USA) diluted 1/100 or 1/500. The strips were then
washed in TTBS for a further 15 minutes, and developed with DAB peroxidase
substrate.
Figure 4.1 Experimental design
Strips 1 2 3 4 5 6 7 8
Blocking 1 % skimmed milk in TBS
Serum Buffer Buffer AM 1/50 N 1/50 AM 1/10 N 1/10 AM 1/5 N 1/5
Anti-IgE Tray 1 1/500
Tray 2 1/100
AM: atopic dog with Malassezia dermatitis; N: normal dog.
Results
No visible bands were seen in any of the groups, regardless of the dilutions of dog
sera or anti-dog IgE (Figure 4.2). The strips incubated with anti-dog IgE diluted
1/500 generated light brown background, but, no bands were visible in any of the
strips. Similar results were seen in strips incubated with anti-dog IgE diluted 1/100.
In addition to the lack of bands, these strips also showed darker background
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compared to those in tray 1 due to the lower dilution of anti-dog IgE. Despite the low
dilutions of both dog sera and anti-dog IgE, no specific binding was generated using
this protocol (lanes 7 and 8 in tray 2), indicating that it was not sensitive enough to
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Figure 4.2 Examination of the feasibility of using a horseradish peroxidase
conjugated goat anti-dog IgE to detect IgE binding proteins from Malassezia
pachydermatis
The strips in lanes 1 and 2 were incubated with dilution buffer alone and the rest were
incubated with dog sera diluted 1/50, 1/10, or 1/5. A serum sample from an atopic dog
with Malassezia dermatitis and a normal dog were included in each dilution group.
Two different dilutions of anti-dog IgE conjugated with HRP were used: 1/500 (tray 1)
and 1/100 (tray 2).
All strips showed general background with the strips in tray 2 exhibiting darker staining
due to the low dilution of anti-dog IgE. Despite this, no visible bands were present in
any of the strips, suggesting an increase in sensitivity was required to obtain adequate
antigen signals.
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4.4 Protocol 2-introduction of an amplification step to protocol 1
Aims
Due to the lack of sensitivity seen in the previous experiments using a goat anti-dog
IgE and chromogenic substrate to detect Malassezia-specific IgE, a secondary
antibody was introduced in protocol 2 as an amplification step to increase the
sensitivity.
Methods
Four pre-wetted strips with separated Malassezia proteins were blocked with 1 %
skimmed milk in TBS for 1 hour and rinsed with TTBS for 15 minutes. They were
then incubated with serum samples either from an atopic dog with Malassezia
dermatitis or a normal dog diluted 1/100 in dilution buffer for 1 hour (Figure 4.3).
After rinsing with TTBS for 15 minutes, the strips were incubated with goat anti-dog
IgE diluted 1/1,000 for a further 1 hour and then washed in TTBS for 15 minutes.
Fligher dilutions of dog sera and anti-dog IgE were used in this experiment because
of the background seen in the previous experiments and because a secondary
antibody was being used in the following step. A monoclonal anti-goat IgG
conjugated with AP was used at dilutions of 1/5,000 or 1/10,000 and the incubation
lasted for 1 hour. The strips were washed again in TTBS and developed with alkaline
phosphatase substrate, BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue
tetrazolium).
Figure 4.3 Experimental design
Strips 1 2 3 4
Blocking 1 % skimmed milk in TBS
Serum AM 1/100 N 1/100 AM 1/100 N 1/100
Anti-IgE 1/1,000
2nd Ab 1/5,000 1/10,000
AM: atopic dog with Malassezia dermatitis; N: normal dog.
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Results
Although a secondary antibody was used in this experiment to amplify the binding
signal, there were still no visible bands present, neither in strips incubated with
serum from an atopic dog with Malassezia dermatitis nor a normal dog (Figure 4.4).
This could stem from high dilutions of the reagents and might be improved by
increasing their concentrations. However, the low sensitivity of the chromogenic
system and a rise in serum consumption indicated that a more sensitive,
chemiluminescent detection system should be considered. Protocols 1 and 2 were









Figure 4.4 Evaluation of using a secondary antibody as an amplification
step to enhance antigen signals
Immunoblots showing the effects of adding a secondary antibody, AP
conjugated monoclonal anti-goat IgG, on antigen signal amplification. Two
different concentrations of anti-goat IgG were evaluated: 1/5,000 (lanes 1 and 2)
and 1/10,000 (lanes 3 and 4). Each dilution group comprised a serum sample
chosen from an atopic dog with Malassezia dermatitis (lanes 1 and 3) and a
normal dog (lanes 2 and 4). All strips were incubated with serum diluted 1/100
and then anti-dog IgE diluted 1/1,000.
No improvement of signal enhancement was seen with the dilutions of reagents




4.5 Protocol 3-detection with a monoclonal mouse anti-canine IgE
antibody
4.5.1 Assessment of reagent specificity
Aims
The previous experiments demonstrated that chromogenic detection was not sensitive
enough to reveal visible bands on the strips. To increase the sensitivity, a
chemiluminescent protocol was investigated in this section. Furthermore, the
polyclonal goat anti-dog IgE was replaced with a monoclonal mouse anti-dog IgE to
ensure maximum specificity of the chemiluminescent method. A multi-channel
miniblotter was also introduced into the methodology because this potentially
provides several advantages over cutting a membrane into strips, such as the use of
minimal reagent volumes and maximal screening of multiple samples on a single
blot.
Methods
An intact membrane containing separated Malassezia proteins was pre-wetted with
methanol, rinsed with de-ionised water, and blocked with 1 % skimmed milk in TBS
for 1 hour. After washing in TTBS for 15 minutes (3x5 minute rinses), excess liquid
was removed using filter papers with care to avoid excessive drying of the membrane.
It was then placed into the miniblotter with the protein bearing side facing the
channels, covered with a foam cushion, and secured by tightening the screws around
the miniblotter as described in the manufacturer's instructions. A water vacuum
aspirator was used to remove excess liquid within the channels, and reagents were
loaded as soon as possible to prevent the membrane drying out. Approximately 60 pi
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of reagents was required to fill a channel. A serum sample from an atopic dog with
Malassezia dermatitis and a normal dog diluted 1/100 in dilution buffer were then
loaded into the channels and allowed to react for 1 hour. A pair of serum samples that
had been heat-treated at 56°C for 4 hours to denature IgE was also included for
comparison with non-heated samples (Figure 4.5). Any unused channel lying over
the membrane was filled with buffer to prevent side leakage and contamination. Dog
sera were then aspirated and each channel was flushed with TTBS twice using a
vacuum aspirator. The membrane was then incubated with monoclonal mouse anti-
dog IgE (D9#3116, kindly donated by Dr. D.J. DeBoer, University of Wisconsin,
USA) diluted 1/10,000 for 1 hour, washed with TTBS, and incubated with a HRP
conjugated goat anti-mouse IgG antibody diluted 1/1,000 for a further one hour
(dilutions determined from preliminary experiments, data not shown). After the
channels were flushed with TTBS once, the membrane was removed from the
miniblotter and further washed with TTBS for 15 minutes in a tray followed by 2
rinses with TBS. The chemiluminescent substrate for HRP, ECL™ western blotting
detection solution (Amersham pharmacia biotech, UK), was then added to cover the
whole membrane and allowed to react for 1 minute. Excess reagents were drained off
by holding the membrane vertically against a tissue. For visualisation of bands, the
membrane was wrapped in cling film, placed in a film cassette with the protein side
up and covered with a sheet of autoradiography film (Hyperfilm™ ECL™,
Amersham Life Science). The exposure lasted for 2 minutes.
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Figure 4.5 Experimental design
Channels 1 2 3 4 5 6 7 8 9 10
Blocking 1 % skimmedmilk in TBS
Serum AM N H-AM H-N Buffer Buffer AM N AM N
1/100 1/100 1/100 1/100 1/100 1/100 1/100 1/100
Anti-IgE 1/10,000 Buffer Buffer 1/10,000
2nd Ab 1/1,000 Buffer Buffer
H: heat-treated; AM: atopic dog with Malassezia dermatitis; N: normal dog.
Results
Strong signals were present in lanes 1, 3 and 7 where serum from an atopic dog with
Malassezia dermatitis was used, however, the bands were difficult to interpret due to
the diffuse images (Figure 4.6). In contrast, no binding was detected in lanes where
normal dog serum was applied (lanes 2, 4 and 8), suggesting that there were some
additional proteins in the atopic dog serum that were not present in the normal serum.
As compared to the lack of signal in lane 9 where the goat anti-mouse IgG was
replaced with buffer, the strong signal shown in lane 7 where anti-dog IgE was
omitted indicated that the binding seen in this experiment was mainly generated by
the anti-mouse IgG, and not the anti-dog IgE. Since no signal was detected if serum
was left out (lanes 5 and 6), the anti-mouse IgG must be binding to serum proteins
and not Malassezia extracts.
The weaker signal present in lane 3 where heated atopic serum was used compared to
non-heated serum (lane 1) suggested that some of the signal in lane 1 was due to
binding of anti-dog IgE. The IgE in dog serum would be denatured during the
heating process and not recognised by the anti-dog IgE, resulting in a decrease in
signal magnitude. However, a stronger binding density was seen in the lane where
anti-dog IgE was omitted (lane 7) compared to the other two lanes. One possible
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explanation for this phenomenon could be that the binding of anti-mouse IgG was
partially blocked by anti-dog IgE.
Taken together, the results of this experiment showed that the goat anti-mouse IgG
cross-reacted with serum proteins which were present in higher concentrations in
serum from atopic dogs with Malassezia dermatitis than from normal dog serum. It is
likely that the anti-mouse IgG bound to Malassezia-specific IgG in dog serum, as it
was demonstrated in chapter 3 that atopic dogs with Malassezia dermatitis had a









Figure 4.6 Assessment of reagent specificity on a chemiluminescent blot
X-ray film showing the result of reagent specificity evaluated using
chemiluminescent detection. A serum sample from an atopic dog with
Malassezia dermatitis was used in lanes 1, 3, 7 and 9, and a sample from a
normal dog was used in lanes 2, 4, 8 and 10. Samples in lanes 3 and 4 were
pre-heated at 56°C for 4 hours to denature IgE. In lanes 7 and 8, the anti-dog
IgE was replaced with dilution buffer, and in lanes 9 and 10, the conjugated
secondary Ab was replaced with dilution buffer.
A high signal was seen in lane 7 where the mouse anti-dog IgE was omitted,
indicating that the secondary Ab cross-reacted with other proteins, rather
than being specific for mouse IgG, resulting in non-specific signals on the
film.
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4.5.2 Cross-reactivity of the secondary antibody with canine IgG
Aims
The goat anti-mouse IgG used in the previous experiment was demonstrated to
generate non-specific binding on the blots probably due to cross-reactivity between
the anti-mouse IgG and canine IgG. The aim of these experiments was to test this
hypothesis by directly probing dog sera and purified canine IgG with the goat anti-
mouse IgG.
Methods
Since the anti-mouse IgG was specific for the whole mouse IgG molecule, the SDS-
PAGE was performed using both non-reducing and reducing conditions with the
latter acting as the control. Three different normal dog serum samples (including the
one used in the last experiment) and purified dog IgG (Sigma, UK) were diluted
1/100 and 1/20 respectively with PBS and mixed 1 : 1 with non-reducing or reducing
sample buffer for separation in a 12 % SDS-PAGE gel. After electrophoresis, one gel
was stained with Coomassie blue (section 2.11) and the other was used for
electrophoretic transfer and immunoblotting (sections 2.12 and 2.13).
The molecular weight standards transferred onto the membrane were cut off and
stained with Coomassie blue. The rest of the membrane was blocked for 1 hour with
1 % skimmed milk in TBS. After washing with TTBS for 15 minutes (3x5 minute
rinses), the membrane was incubated for 1 hour with the goat anti-mouse IgG diluted
1/1,000 in dilution buffer (1 % skimmed milk in TTBS). The membrane was washed




The protein profiles of normal dog serum and purified dog IgG obtained under non-
reducing and reducing conditions in an SDS-PAGE gel are shown in Figure 4.7 A-B.
Under non-reducing condition, purified dog IgG exhibited a strong single band at a
molecular weight of slightly over 200 kDa and this band was present in all three
serum samples, although there was a difference in strength between the samples.
(Figure 4.7 A). In contrast, two separated bands were shown in the gel when the
samples were mixed with reducing buffer (Figure 4.7 B), indicating that the IgG
molecule was cleaved into heavy and light chains.
Clear bands were shown in every sample on the non-reducing blot, which
corresponded to the high molecular weight band shown in the gel (Figure 4.7 C).
However, no binding was detected on the reducing blot (Figure 4.7 D). This
confirmed that the goat anti-mouse IgG was specific for the whole IgG molecule, but
did not detect the heavy or light chains specifically. Nevertheless, the binding on the
non-reducing blot verified that the anti-mouse IgG cross-reacted with canine IgG and
was able to bind to IgG in dog sera. Thus, protocol 3 was abandoned due to lack of
specificity.
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Figure 4.7 A-D Demonstration of non-specific binding between the HRP
conjugated goat anti-mouse IgG and purified canine IgG
A: Three different serum samples from normal dogs (lanes 1-3) and purified canine IgG
loaded in duplicate (lanes 4 and 5) were analysed using non-reducing sample buffer in
an SDS-PAGE gel. The whole IgG molecule exhibited a strong single band at the top of
the gel and this was present in each sample. B: An SDS-PAGE gel showing the same
samples analysed using reducing sample buffer. Two clear bands in lanes 4 and 5
represented heavy and light chains ofcanine IgG.
C: Cross-reactivity between the goat anti-mouse IgG and canine IgG demonstrated by
immunoblotting. Binding was shown in each lane, confirming that the anti-mouse IgG
cross-reacted with canine IgG and bound to IgG in dog sera. D: Immunoblot showing the
anti-mouse IgG did not react to either heavy or light chain of canine IgG.
153
4.6 Protocol 4-evaluation of a monoclonal bovine anti-mouse IgG as the
secondary antibody
4.6.1 Binding of bovine anti-mouse IgGl to mouse anti-canine IgE
Aims
Due to the cross-reactivity between the goat anti-mouse IgG and canine IgG as
demonstrated in the previous sections, a monoclonal bovine anti-mouse IgGl
antibody (Serotec, Oxford, UK) was evaluated as the secondary antibody for
immunoblotting. The aim of this experiment was to determine if the antibody could
bind to the primary antibody, monoclonal mouse anti-dog IgE, using dot blotting.
Methods
A piece of dry membrane was cut into a suitable size and the sites of application of
the antibody solutions were marked with a pencil. The use of a dry membrane
facilitated the confinement of antibody solutions to a small area and prevented
diffusion. A volume of 0.5 pi of monoclonal mouse anti-dog IgE (D9#3116, kindly
donated by Dr. D.J. DeBoer, University ofWisconsin, USA) diluted 1/1,000, 1/5,000
and 1/10,000 in dilution buffer was dropped at the marked areas and allowed to dry.
After the solutions had dried, another 0.5 pi of various dilutions of anti-dog IgE was
dropped at the same places and this was repeated 10 times. Mouse IgGlK (Sigma,
UK) at a dilution of 1/1,000 was used as the positive control, and dilution buffer for
the negative control. After the last drops were air-dried, the membrane was blocked
with 1 % skimmed milk in TBS for 1 hour and washed with TTBS for 15 minutes (3
x 5 minute rinses). It was then cut into four strips and incubated with HRP
conjugated bovine anti-mouse IgGl at dilutions of 1/1,000, 1/5,000 and 1/10,000
(Figure 4.8). After a 1-hour incubation, the strips were washed again in TTBS and
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then developed with a chemiluminescent substrate, ECL™, as described in section
4.5.1. The exposure lasted for 5 minutes.
Figure 4.8 Experimental design
Mouse anti-dog IgE Bovine anti-mouse IgGl
1/1,000 1/5,000 1/10,000 1/1,000




The binding ofbovine anti-mouse IgGl to mouse anti-dog IgE is shown in Figure 4.9.
A clear signal was seen at the location of the mouse IgGlK, but no binding was
detected at the site of the dilution buffer. This indicated that the binding exhibited in
this experiment was specific. Strong intensity of binding was present when anti-dog
IgE was used at a dilution of 1/1,000 regardless of the dilution of anti-mouse IgGl.
Higher dilutions of both antibodies resulted in a reduction of signal. The results of














Figure 4.9 Demonstration of binding between bovine anti-mouse IgGl and mouse
anti-dog IgE by dot blotting
Three different dilutions of bovine anti-mouse IgGl and mouse anti-dog IgE were used
to test their binding activity. Strong signals were present at the positions where mouse
IgG Ik and lower dilutions of both antibodies were used. In contrast, no binding was
shown at the site of the dilution buffer, indicating that the signals exhibited in this
experiment were specific. These results showed that bovine anti-mouse IgGl was able
to bind to mouse anti-dog IgE.
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4.6.2 Investigation into cross-reactivity of bovine anti-mouse IgGl with canine
IgG
Aims
The aim of this experiment was to examine the specificity of the bovine anti-mouse
IgGl antibody to further evaluate the feasibility of using this antibody in Malassezia
blots.
Methods
Mouse IgGlK (Sigma, UK), a normal dog serum sample, and purified dog IgG
(Sigma, UK) were diluted 1/10, 1/100, and 1/20 respectively with PBS and mixed 1 :
1 with non-reducing sample buffer. They were then separated in a 12 % SDS-PAGE
gel and blotted onto a membrane. The membrane was pre-wetted with methanol,
rinsed with de-ionised water and blocked with 1 % skimmed milk in TBS for 1 hour.
After washing with TTBS for 15 minutes (3x5 minute rinses), the membrane was
incubated with bovine anti-mouse IgGl diluted either 1/1,000 or 1/10,000 for 1 hour.
It was washed again in TTBS for a further 15 minutes, and then developed with DAB
peroxidase substrate or ECL™ chemiluminescent substrate.
Results
The anti-mouse IgGl was shown to bind to mouse IgG Ik, but not to either normal
dog serum or purified dog IgG on a DAB developed blot when used at a dilution of
1/1,000 (Figure 4.10 A). However, cross-reactivity with canine IgG was shown on a
chemiluminescent blot when the same dilution of anti-mouse IgGl was used (Figure
4.10 B). This confirmed that chemiluminescent reagents were more sensitive than
chromogenic reagents, and were able to detect weaker signals. Nevertheless, when
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used at the dilution of 1/10,000, the binding of anti-mouse IgGl to normal dog serum
and purified dog IgG was not present on the chemiluminescent blot under the same
exposure conditions (Figure 4.10 C). This suggested that the cross-reactivity might



















Figure 4.10 A-C Evaluation of the specificity of bovine anti-mouse IgGl using
chromogenic and chemiluminescent detection
A: Immunoblot incubated with bovine anti-mouse IgGl diluted 1/1,000 and
developed with DAB peroxidase substrate. Lanel: mouse IgGlK; lane 2: normal
dog serum; lane 3: purified dog IgG. The binding in lane 1 verified that the anti-
mouse IgGl was specific for mouse IgGl. No cross-reactivity with canine IgG was
seen in lanes 2 and 3 using chromogenic detection. B: Immunoblot incubated with
bovine anti-mouse IgGl diluted 1/1,000 and developed with chemiluminescent
substrate. Cross-reactivity of anti-mouse IgGl to canine IgG was seen in lanes 2
and 3 using the more sensitive detection method. C: Immunoblot incubated with
bovine anti-mouse IgGl diluted 1/10,000 and developed with chemiluminescent
substrate. The cross-reactivity was not detectable (lanes 2 and 3) on the
chemiluminescent blot when the anti-mouse IgGl was used at a higher dilution.
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4.6.3 Optimisation of anti-mouse IgGl dilution to overcome cross-reactivity
Aims
The previous experiments demonstrated that the bovine anti-mouse IgGl cross-
reacted with canine IgG when a lower dilution of the antibody was used with a
chemiluminescent substrate. However, the cross-reactivity was not detectable when
anti-mouse IgGl was used at a higher dilution. Hence, this experiment was designed
to evaluate the possibility of overcoming the cross-reactivity without loss of
sensitivity by optimising the dilution of anti-mouse IgGl for Malassezia
immunoblotting.
Methods
An intact membrane containing Malassezia extract was pre-wetted and blocked with
1 % skimmed milk for 1 hour. After washing in TTBS for 15 minutes (3x5 minute
rinses), the membrane was placed into the multi-channel miniblotter as described in
section 4.5.1. To conserve the supply of serum from atopic dogs with Malassezia
dermatitis, a serum sample from a normal dog that had shown a strong signal in a
preliminary experiment (data not shown) was used for this experiment. The serum
was diluted 1/5 in dilution buffer and loaded into channels. An aliquot of the same
sample that had been heated at 56°C for 4 hours was also included. Each incubation
step lasted for 1 hour. After flushing with TTBS, the majority of the channels were
filled with mouse anti-dog IgE diluted 1/10,000 and the others dilution buffer (Figure
4.11). The channels were further washed with TTBS and filled with bovine anti-
mouse IgGl diluted 1/1,000, 1/2,000, 1/4,000, 1/6,000, 1/8,000 and 1/10,000. At the
end of a 1-hour incubation, excess reagents were aspirated followed by another flush
with TTBS. The membrane was then removed from the miniblotter, and further
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washed in TTBS for 15 minutes. After rinsing with TBS, it was developed with
chemiluminescent substrate as described in section 4.5.1 and the exposure lasted for
5 minutes.
Figure 4.11 Experimental design
Channels 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Blocking 1 % skimmed milk in TBS
Serum 1/5 N H N N H N N H N N H N N H N N H N
Anti-IgE 1/10,000 B 1/10,000 B 1/10,000 B 1/10,000 B 1/10,000 B 1/10,000 B
2nd Ab 1/1,000 1/2,000 4^ OO0 1/6,000 oo ©o0 1/10,000
N: normal dog; H: heat-treated; B: dilution buffer.
Results
The effect of anti-mouse IgGl concentrations on its sensitivity and specificity in
Malassezia blots is shown in Figure 4.12. The intensity of signal decreased gradually
as the dilution of anti-mouse IgGl increased. However, although using more diluted
antibody solution helped to eliminate non-specific binding, it also reduced the total
signal level. There was no noticeable difference between channels where mouse anti-
dog IgE or dilution buffer was used at any dilution of conjugate. The intensity of the
signal shown by non-heated and heated serum samples was also very similar. These
results indicated that the binding shown on the blot was generated predominantly by
the non-specific binding of anti-mouse IgGl to canine IgG in dog serum. In
summary, this experiment did not demonstrate a dilution of anti-mouse IgGl that
could be used in a Malassezia blot to generate clear, but specific signals. This
protocol was therefore abandoned due to lack of specificity.
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Figure 4.12 The effect of bovine anti-mouse IgGl concentrations on its
sensitivity and specificity in Malassezia blots
X-ray film showing that the cross-reactivity of anti-mouse IgGl to dog serum
could not be eliminated by dilution. Lanes 2, 5, 8, 11, 14 and 17: heat-treated
normal dog serum. The others: non-heated serum. Lanes 3, 6, 9, 12, 15 and 18:
mouse anti-dog IgE was replaced with dilution buffer. Every dilution group of
bovine anti-mouse IgGl comprised three lanes, and the groups from left to right
were 1/1,000 (lanes 1-3), 1/2,000 (lanes 4-6), 1/4,000 (lanes 7-9), 1/6,000 (lanes
10-12), 1/8,000 (lanes 13-15)and 1/10,000 (lanes 16-18). No substantial difference
was seen between the three lanes in each dilution group, and they all showed
decreased signal when more diluted conjugate was used. No dilution tested in this
experiment generated specific binding.
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4.7 Protocol 5-evaluation of a biotinylated recombinant human IgE
receptor alpha chain as a detection reagent
4.7.1 Detection with avidin reagent 1- Vectastain® Elite ABC kit
4.7.1.1 Binding ofhuman IgE receptor to canine IgE
Aims '
In this section, a biotinylated recombinant human IgE receptor alpha chain was
evaluated for its suitability as a detection reagent. In theory, the IgE receptor should
allow total specificity for IgE, eliminating the problems of cross-reactivity with
canine IgG as seen in the previous experiments. Owing to the human origin of the
IgE receptor, it was important to demonstrate that this receptor was capable of
binding to canine IgE in the immunoblotting system used in this study.
Methods
Purified dog IgE (Bethyl Laboratories, Montgomery TX, USA) was diluted ten-fold
with PBS and mixed 1: 1 with non-reducing sample buffer. It was then separated in
an SDS-PAGE gel and transferred onto a membrane. The membrane was blocked
with 1 % skimmed milk in TBS for 1 hour, and washed in TTBS for 15 minutes (3 x
5 minute rinses). It was then probed with the human IgE receptor diluted 1/1,000 in
dilution buffer for 1 hour followed by another 15-minute wash. Bound receptor was
detected by incubating the membrane for 1 hour with Vectastain® Elite ABC reagents
(Vector Laboratories, Inc., Burlingame, CA, USA) containing Avidin DH and
biotinylated horseradish peroxidase H. After further washing with TTBS for 15
minutes, the membrane was rinsed with TBS and developed with ECL™
chemiluminescent substrate. The exposure lasted for 10 minutes.
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Results
Binding of the human IgE receptor to purified dog IgE is shown in two lanes where
dog IgE was used at the dilutions of 1/10 and 1/100 with the former exhibiting
stronger binding intensity (Figure 4.13). This indicated that the biotinylated human
IgE receptor was able to bind to dog IgE and that binding was detectable using the












Figure 4.13 Demonstration of binding between biotinylated recombinant
human IgE receptor alpha chain and purified canine IgE
Chemiluminescent blot showing the binding of human IgE receptor reagent to dog
IgE. Lanes 1-4: purified dog IgE diluted 1/10, 1/100, 1/1,000, and 1/10,000,
respectively. One high molecular weight band was present in lanes 1 and 2,
indicating that the IgE receptor reagent was able to bind to dog IgE.
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4.7.1.2 Assessment of reagent specificity in Malassezia blots
Aims
Having demonstrated the potential use of the human IgE receptor reagent in
immunoblotting, various combinations of reagents were tested in Malassezia blots to
assess their specificity. Also, in order to prevent the uncertainty of reagent side
leaking caused by using the miniblotter, and to ensure that every control was well
separated, the use of a miniblotter was abandoned and strips containing separated
Malassezia proteins were used in subsequent experiments.
Methods
Eight strips containing separated Malassezia proteins were pre-wetted and blocked
with 5 % skimmed milk in TBS for 1 hour. Due to the dark background shown on the
blots in preliminary experiments (data not shown), a higher concentration of
skimmed milk was used to block the strips. After washing with TTBS for 15 minutes,
two strips were incubated for 1 hour with a serum sample from an atopic dog with
Malassezia dermatitis diluted 1/10 in dilution buffer, and a serum sample from a
normal dog at the same dilution was used for another two strips. The others were
incubated with dilution buffer alone (Figure 4.14). The strips were washed again with
TTBS for 15 minutes. Half of them were probed with the IgE receptor reagent
diluted 1/500 for 1 hour followed by washing in TTBS for a further 15 minutes.
Vectastain® Elite ABC reagents were then applied to the majority of the strips and
allowed to react for 30 minutes. After another 15-minute wash, the strips were rinsed
with TBS and developed with ECL™ chemiluminescent substrate. The exposure
lasted for 1 minute.
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Figure 4.14 Experimental design
Strips 1 2 3 4 5 6 7 8
Blocking 5 % skimmed milk in TBS
Serum Buffer AM 1/10 N 1/10 Buffer Buffer AM 1/10 N 1/10 Buffer
FceRIa Buffer Buffer Buffer 1/500 Buffer
ABC Applied Buffer
AM: atopic dog with Malassezia dermatitis; N: normal dog.
Results
Strong binding in the high molecular weight range was shown in every strip except
the last strip which was incubated with buffer alone in all three blotting steps (Figure
4.15). The absence of binding in the last strip indicated that the chemiluminescent
substrate did not bind to proteins on the strips. However, the binding exhibited on the
strip incubated with ABC reagents only (lane 1) indicated that the ABC reagents
bound to components in the Malassezia extract non-specifically. As the binding
pattern was consistent in all strips, it was inferred that all the binding shown in this
experiment was generated mainly from the cross-reactivity of ABC reagents with
Malassezia proteins. However, more specific binding activity might have been
overshadowed by this strong cross-reaction. The most likely explanation was that the
Malassezia extract used in this study, produced by grinding whole organisms with
glass beads, could contain endogenous biotin, protein-bound biotin or other avidin
binding proteins that reacted with the ABC reagents. In order to overcome this cross-
reactivity, various reagents were used to block it in the following experiment.
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Figure 4.15 Assessment of the specificity of the IgE receptor and ABC
reagents in Malassezia blots
Chemiluminescent immunoblots showing the results of strips probed with various
combinations of reagents. Lanes 2 and 6: serum from an atopic dog with Malassezia
dermatitis. Lanes 3 and 7: serum from a normal dog. IgE receptor was used in lanes
4-7, and ABC reagents were applied to all strips except lane 8. No binding was
detected in lane 8, indicating that the chemiluminescent substrate did not bind to
proteins on the strips. The first strip was not probed with either dog serum or IgE
receptor, yet incubation with ABC reagents resulted in very strong binding signals,
suggesting cross-reactivity between the ABC reagents and certain components in
the Malassezia extract, possibly endogenous protein-bound biotin.
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4.7.1.3 Evaluation ofvarious blocking reagents
Aims
Cross-reactivity between the avidin reagent, Vectastain® Elite ABC, and the
Malassezia extract resulted in very strong signals on chemiluminescent blots as
shown in the previous experiment. A variety of blocking reagents were therefore
evaluated to try and block avidin binding sites in the Malassezia extract, and to
reduce the background on the strips. These included skimmed milk, Tween 20,
Tween 80, casein solution, and an avidin/biotin blocking kit.
Methods
Strips containing separated Malassezia proteins were pre-wetted and blocked with
various reagents for 1 hour (Figure 4.16). Both higher concentrations of skimmed
milk and Tween 20 were used in this experiment. The skimmed milk powder was
used at a concentration of 10 % and Tween 20, 0.1%. TBS containing Tween 20 or
Tween 80 (TTBS) was used to dissolve the milk powder as it has been reported that
TTBS generally produces a clean background (Gallagher et al. 1998). The blocking
solutions used were 10 % skimmed milk in TBS containing 0.1 % Tween 20 (TTBS
1), TTBS 1 alone, 10 % skimmed milk in TBS containing 0.5 % Tween 80 (TTBS 2),
TTBS 2 alone, and 0.5 % casein solution containing 0.1 % Tween 20 (Vector
Laboratories, Inc., Burlingame, CA, USA). The strips were washed for 15 minutes
with TTBS1 or TTBS 2 depending on which reagent was used for blocking, and one
strip from each blocking group was incubated with avidin D solution from the
avidin/biotin blocking kit (Vector Laboratories, USA) for 10 minutes to allow the
avidin to react with biotin on the strips. The others were incubated with buffer alone.
After washing with TTBS for another 15 minutes, the strips blocked with avidin D
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solution were incubated with biotin blocking solution from the same kit for a further
10 minutes to block the remaining biotin binding sites on the avidin. The strips were
washed again in TTBS for 15 minutes and incubated with ABC reagents for 30
minutes. A strip was incubated with buffer without ABC reagents to act as a control.
They were further washed in TTBS for 15 minutes, rinsed with TBS, and developed
with ECL™ chemiluminescent substrate. The exposure lasted for 1 minute.
Figure 4.16 Experimental design
Strips 1 2 3 4 5 6 7 8 9 10 11
Blocking 10 % skimmed
milk in TTBS1
TTBS1 TTBS1 10 % skimmed
milk in TTBS2
TTBS2 TTBS2 casein casein TTBS1
A/B kit Applied Buffer Applied Buffer Applied Buffer Applied Buffer Applied Buffer Buffer
ABC Applied Buffer
A/B kit: avidin/biotin blocking kit; TTBS1: TBS containing 0.1 % Tween 20; TTBS 2: TBS
containing 0.5 % Tween 80.
Results
The comparison of the various blocking reagents is shown in Figure 4.17. Strong
signals were present in all strips except the negative control that was not incubated
with ABC reagents. No substantial difference was shown between any of the strips,
indicating that none of the blocking reagents blocked the avidin binding sites in the
Malassezia extract effectively. There were two possible reasons for this. First, the
avidin binding sites in the extract might have outnumbered the avidin in the blocking
reagents. Secondly, the ABC reagents were claimed to be very sensitive which might
have magnified the cross-reactivity signals. Due to the difficulties in optimising the
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Figure 4.17 Evaluation of various blocking reagents to block the cross-
reactivity between ABC reagents and Malassezia extract
Lanes 1 and 2 were blocked with 10 % skimmed milk in TBS containing 0.1 %
Tween 20 (TTBS1). Lanes 3, 4, and 11: TTBS1 alone. Lanes 5 and 6: 10 %
skimmed milk in TBS containing 0.5 % Tween 80 (TTBS2). Lanes 7 and 8: TTBS2
alone. Lanes 9 and 10: casein solution. The strips in lanes 1, 3, 5, 7, 9 were further
blocked with avidin/biotin blocking reagents. The ABC reagents were applied to
lanes 1-10. None of the blocking reagents tested in this experiment successfully
blocked the cross-reactivity ofABC reagents with the Malassezia extract.
171
4.7.2 Detection with avidin reagent 2- Extravidin®
4.7.2.1 Assessment of reagent specificity
Aims
Given the failure of various blocking reagents to block cross-reactivity of ABC
reagents with the Malassezia extract as demonstrated in the previous experiment, and
the limited possibility to adjust the ABC reagent concentrations, the feasibility of
using another avidin reagent, Extravidin® (Sigma, UK), in Malassezia blots was
evaluated. Extravidin® is a modified form of affinity purified avidin and it combines
the advantages of high specific activity of avidin with the low background staining of
streptavidin. The aim of this experiment was to determine if Extravidin® cross-
reacted with Malassezia proteins.
Methods
Five pre-wetted strips with separated Malassezia proteins were blocked with 5 %
skimmed milk in TBS containing 0.1 % Tween 20 (TTBS) for 1 hour and washed in
TTBS for 15 minutes. Three of the strips were incubated with a serum sample from
an atopic dog with Malassezia dermatitis diluted 1/10 in dilution buffer (1 %
skimmed milk in TTBS) and the other two strips with buffer alone for 1 hour (Figure
4.18). After a further wash in TTBS for 15 minutes, the IgE receptor diluted 1/500
was applied to three strips, and allowed to react for 1 hour. The others were
incubated in buffer. The strips were washed again in TTBS for 15 minutes, and the
majority were then incubated with Extravidin® diluted 1/1,000 for a further hour,
followed by another 15-minute wash. The strip incubated in buffer without
Extravidin® was used as the negative control. The chemiluminescent detection was
performed as described in section 4.5.1, and the exposure lasted for 2 minutes.
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Figure 4.18 Experimental design
Strips 1 2 3 4 5
Blocking 5 % skimmed milk in TTBS (0.1 % Tween 20)
Serum AM 1/10 AM 1/10 AM 1/10 Buffer Buffer
FceRIa 1/500 1/500 Buffer 1/500 Buffer
Extravidin® 1/1,000 Buffer 1/1,000 1/1,000 1/1,000
AM: atopic dog with Malassezia dermatitis.
Results
All the strips incubated with Extravidin® exhibited very strong and consistent
binding to high molecular weight bands with a few bands in the lower molecular
weight range between 31 and 66 kX)a (Figure 4.19). In contrast to the absence of
binding on the strip incubated in buffer without Extravidin®, the binding shown on
the strip incubated with only Extravidin® indicated that this reagent also cross-
reacted with components in the Malassezia extract. The very similar results
generated by two different reagents suggested that the sources of cross-reactivity
could be the same, and it further increased the possibility that it was endogenous
protein bound biotin in the extract. Despite the cross-reactivity of Extravidin® with
the Malassezia extract, it was possible that the problem could be overcome by






1 2 3 4 5
Figure 4.19 Assessment of the specificity of the IgE receptor and Extravidin®
in Malassezia blots
Immunoblots showing the results of strips probed with various combinations of
reagents. The strips in lanes 1-3 were incubated with serum from an atopic dog with
Malassezia dermatitis. The strips in lanes 1, 2, and 4 were then incubated with IgE
receptor. Extravidin® was applied to all strips except lane 2. The strips that were not
probed with working reagents were incubated with buffer alone. The binding on the
strip incubated without serum and IgE receptor, but with Extravidin® (lane 5)
indicated that Extravidin® cross-reacted with the Malassezia extract.
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4.7.2.2 Evaluation of optimising various factors to overcome cross-reactivity of
Extravidin®with theMalassezia extract
Aims
The signal intensity of cross-reactivity between Extravidin® and Malassezia proteins
depends on the concentration ofMalassezia extract, the effectiveness of blocking, the
working concentration of Extravidin®, and the length of exposure. In order to
overcome the cross-reactivity, various adjustments were to be made to these factors
to determine the optimal conditions.
Methods
Due to the strong non-specific binding shown by both ABC reagents and Extravidin
(sections 4.7.1.2. and 4.7.2.1), and the failure of an avidin/biotin blocking kit to
block it (see section 4.7.1.3), the protein concentration of the Malassezia extract used
in an SDS-PAGE gel was reduced by half. Briefly, Malassezia extract prepared with
glass beads (60 pg, 150 pi of 1/40 dilution) was mixed with reducing sample buffer
and a final volume of 300 pi was added into a broad well running across the top of
the gel.
Four strips containing separated Malassezia proteins were pre-wetted and blocked
with 5 % skimmed milk in TBS containing 0.1 % Tween 20 (TTBS) for 1 hour,
followed by washing with TTBS for 15 minutes. All the strips were further blocked
with reagents in the avidin/biotin blocking kit, consisting of 10-minute incubations of
avidin D solution followed by biotin solution for another 10 minutes with a 15
minute wash in TTBS after each incubation step. Unlike the blocking reagents used
in section 4.7.1.3, in which both avidin D and biotin solutions were prepared by
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adding one drop of the stock solution into 5 ml of TTBS as suggested in the
manufacturer's instructions, 10 drops of each solution was used in the same volume
of TTBS in this experiment. This was intended to block all the avidin binding sites in
the Malassezia extract by providing an excess of avidin in the blocking solution.
Each strip was then incubated for 1 hour with a different dilution of Extravidin® in
dilution buffer (1 % skimmed milk in TTBS), including 1/1,000, 1/2,000, 1/5,000,
and 1/10,000. After further washes with TTBS for 15 minutes, the strips were rinsed
with TBS and developed with ECL™ chemiluminescent substrate. The exposure
lasted for 2 minutes.
Figure 4.20 Experimental design
Strips 1 2 3 4
Blocking 5 % skimmed milk in TTBS (0.1 % Tween 20)
A/B kit Applied (10 drops each in 5 ml TTBS)
Extravidin® 1/1,000 1/2,000 1/5,000 1/10,000
A/B kit: avidin/biotin blocking kit.
Results
By reducing the amount ofMalassezia extract in the gel, increasing the concentration
of blocking reagents, and increasing the dilution of Extravidin®, a successful
blocking of cross-reactivity between Extravidin® and the Malassezia extract was
achieved in three of the strips (Figure 4.21). No binding was detected on strips
incubated with Extravidin® diluted 1/2,000-1/10,000. Although at the dilution of
1/1,000 there was still strong binding present in the high molecular weight range, the
strip showed clear background and the bands with lower molecular weights seen in
the previous experiments were not present. These results confirmed that the
component in the Malassezia extract to which the two avidin reagents reacted was
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endogenous biotin. A Malassezia blot prepared using 60 pg of extract, 0.1 % Tween
20, 10 x avidin/biotin blocking solutions, and an Extravidin® dilution of 1/2,000 was











Figure 4.21 Optimisation of Extravidin® dilution to block its cross-reactivity
with the Malassezia extract
The strips in lanes 1-4 were incubated with Extravidin® diluted 1/1,000, 1/2,000,
1/5,000, and 1/10,000, respectively. A strong signal was present in the high
molecular weight range in lane 1. However, no binding was detected in lanes 2-4,
indicating that the cross-reactivity between Extravidin® and Malassezia extract
could be blocked by using the avidin reagent at higher dilutions.
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4.7.2.3 Using the FcsRIa reagent and Extravidin ® in Malassezia immunoblots
Aims
It had been demonstrated in the previous experiment that the cross-reactivity between
Extravidin® and Malassezia extract could be overcome by optimising various
reagents. The aim of this experiment was to further examine whether cross-reactivity
would be a problem in Malassezia blots using dog sera and detection reagents.
Methods
A membrane comprising separated Malassezia proteins was prepared using 60 pg of
the extract in an SDS-PAGE gel and blotted onto the membrane. The membrane was
cut into strips and each strip was blocked for 1 hour with 5 % skimmed milk in TBS
containing 0.1 % Tween 20 (TTBS), followed by washing in TTBS for 15 minutes.
They were further blocked with lOx avidin/biotin blocking reagents for 10 minutes
each with a 15 minute wash after each blocking step. Three of the strips were
incubated with a serum sample from an atopic dog with Malassezia dermatitis
diluted 1/10 in dilution buffer (1 % skimmed milk in TTBS) and the other two strips
with buffer alone for 1 hour (Figure 4.22). The strips were washed again in TTBS for
15 minutes, and three of the strips were incubated with the IgE receptor diluted 1/50
for 1 hour. The others were incubated in buffer. A lower dilution of IgE receptor
reagent was used in this experiment in order to increase the sensitivity after excessive
blocking. After a further wash in TTBS for 15 minutes, the majority of the strips
were then incubated with Extravidin® diluted 1/2,000 for a further hour, followed by
another 15-minute wash. The strip incubated in buffer without Extravidin® was used
as the negative control. All strips were then rinsed with TBS and developed with
ECL™ chemiluminescent substrate. The exposure lasted for 2 minutes.
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Figure 4.22 Experimental design
Strips 1 2 3 4 5
Blocking 5 % skimmed milk in TTBS (0.1 % Tween 20)^
A/B kit Applied (10 drops each in 5 ml TTBS)
Serum AM 1/10 AM 1/10 AM 1/10 Buffer Buffer
FceRIa 1/50 1/50 Buffer 1/50 Buffer
Extravidin® 1/2,000 Buffer 1/2,000 1/2,000 1/2,000
AM: atopic dog with Malassezia dermatitis.
Results
Binding signals were detected in all strips incubated with Extravidin® (Figure 4.23).
The strips incubated with serum exhibited very strong non-specific binding and no
distinct bands were visible (lanes 1 and 3). The binding shown by the strip incubated
only with serum and Extravidin® (lane 3) indicated that Extravidin® also reacted with
certain components in dog serum that might have bound to the blocking reagents
non-specifically as this was not seen prior to excessive blocking (Figure 4.19). No
improvement was achieved by optimising the dilutions of serum and Extravidin® in a
later experiment, and the strips incubated with sera generated similar results (data not
shown). General background was seen on the strip incubated only with the IgE
receptor and Extravidin® (lane 4) as well as the strip with Extravidin® alone (lane 5).
This could stem from insufficient washing during the blotting procedure. Despite this,
no bands were detected on these strips, indicating that the blocking had successfully
eliminated the cross-reactivity between Extravidin® and the Malassezia extract.
Nevertheless, the strong non-specific binding shown by the strips incubated with dog
serum revealed that this protocol was of no value to detect specific IgE binding
proteins in Malassezia blots.
In summary, two avidin reagents were tested in protocol 5 and both of them cross-
180
reacted with Malassezia extracts. Although the cross-reactivity of the second reagent,
Extravidin®, was overcome by optimising various reagents as demonstrated in
section 4.7.2.2, those conditions did not generate specific binding when used with
serum as shown here. This protocol was therefore abandoned due to lack of
specificity.
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Figure 4.23 Assessment of reagent specificity in Malassezia blots using dog
sera and detection reagents
Immunoblots showing the results of strips probed with various combinations of
reagents after blocking with 5 % skimmed milk in TTBS and lOx avidin/biotin
blocking reagents. The strips in lanes 1-3 were incubated with serum from an
atopic dog with Malassezia dermatitis. The strips in lanes 1, 2, and 4 were then
incubated with IgE receptor. Extravidin® was applied to all strips except lane 2.
The strips that were not probed with working reagents were incubated with buffer
alone. Despite the general background which might result from inadequate
washing, the lack of bands on the strips incubated without serum, but with
Extravidin® (lanes 4 and 5) indicated that the cross-reactivity of Extravidin® with
the Malassezia extract had been overcome by the blocking steps. However, the
strong non-specific binding shown by the strip incubated with serum and
Extravidin®, but without the IgE receptor (lane 3) suggested a non-specific
binding reactivity among the blocking reagents, dog serum, and Extravidin®.
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4.8 Protocol 6-evaluation of a monoclonal antibody/conjugate
combination previously used in an ELISA
4.8.1 Cross-reactivity of secondary antibody with canine IgG
Aims
Due to the difficulty in preventing cross-reactivity of the avidin reagents with
Malassezia proteins in protocol 5, a combination of reagents that had previously been
used successfully to detect IgE binding in ELISA assays was assessed to detect IgE
binding proteins in the Malassezia extract, including a monoclonal anti-dog IgE and
an alkaline phosphatase conjugated goat anti-mouse IgGl antibody that had been
passed though a canine IgG column three times. In this protocol, a new detection
method was also assessed. A digital image station and compatible software was used
to visualise the bands on the blot, rather than overlaying the blot with an X-ray film,
as the former provided the advantage ofmultiple setting options to optimise images.
The aim of this experiment was to examine the specificity of the newly purchased
AP conjugated goat anti-mouse IgGl antibody prior to affinity purification.
Methods
Purified mouse IgGlK, a normal dog serum sample, and dog IgG were diluted 1/10,
1/100, and 1/20 respectively with PBS and mixed 1:1 with non-reducing buffer
before being subjected to electrophoresis. They were then separated in an SDS-
PAGE gel and blotted onto a membrane. The membrane was blocked for 1 hour with
5 % skimmed milk in TBS containing 0.1 % Tween 20 (TTBS). After washing with
TTBS for 15 minutes (3x5 minute rinses), the membrane was incubated for 1 hour
with an AP conjugated goat anti-mouse IgGl antibody (Southern Biotechnology
Associates, Inc., Birmingham, AL, USA) diluted 1/1,000 in dilution buffer (1 %
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skimmed milk in TTBS). The membrane was washed again in TTBS for a further 15
minutes, and then rinsed with detection buffer comprising 0.1 M Tris-HCl, 0.1 M
NaCl, and 5 mM MgCl2 (BDH, UK), pH 9.5. As the conjugate was labeled with AP,
a chemiluminescent substrate for AP labeled reagents, CDP-Star™ (Tropix, Inc.,
Bedford, USA), was prepared following the manufacturer's instruction and slowly
loaded onto the membrane until it was completely covered. After a 5-minute
incubation, excess reagents were drained off by holding the membrane vertically
against a tissue and the membrane was wrapped in cling film. For visualisation of
bands, the membrane was placed on a Kodak Digital Science™ Image Station 440CF
with the protein side down along with Coomassie blue stained molecular weight
markers. The membrane was exposed for 5 minutes, and the blot was visualised on
the computer screen.
Results
The unpurified AP conjugated goat anti-mouse IgGl reacted not only with mouse
IgGlK, but also normal dog serum and purified dog IgG (Figure 4.24). The conjugate
showed binding to the whole molecule ofmouse IgGl as well as its heavy and light
chains. Also, the intensity of binding to the whole mouse IgGl molecule was much
stronger than that to the heavy and light chains. The reason for this might be that a
minority of the molecules were cleaved during the heating process after mixing with
non-reducing sample buffer. However, the binding of the conjugate to normal dog






Figure 4.24 Demonstration of the cross-reactivity of the AP conjugated goat
anti-mouse IgGl with canine IgG
Lanel: Mouse IgGlic; Lane 2: Normal dog serum and Lane 3: Purified canine IgG.
More than one band was detected in lane 1, likely due to denaturation of the IgG
molecule into heavy and light chains. The single band detected in lanes 2 and 3
indicated that the AP conjugated goat anti-mouse IgGl cross-reacted with purified
canine IgG and IgG in dog serum.
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4.8.2 Affinity purification of secondary antibody conjugate
Aims
The AP conjugated goat anti-mouse IgGl was demonstrated to cross-react with
canine IgG in the previous experiment. A canine IgG column was therefore used to
remove the cross-reactivity of the conjugate by immunoabsorption.
Methods
To eliminate the cross reactivity of the AP conjugated goat anti-mouse IgGl, affinity
chromatography was used to further purify the conjugate. Purified dog IgG (10 mg)
dissolved in 0.15 M NaCl (Sigma, UK) was exchanged with sodium hydrogen
carbonate buffer (0.2 M NaHC03 and 0.5 M NaCl, pH 8.5) using HiTrap Desalting
(Amersham pharmacia biotech, UK) and coupled to cyanogen bromide (CNBr)-
activated Sepharose™ 4B (Amersham pharmacia biotech, UK). The remaining active
sites in the Sepharose were blocked with 1M ethanolamine (Sigma, UK), and the gel
was then packed into a column. The column was equilibrated using an FPLC® system
(Amersham Pharmacia Biotech, UK) with three washing cycles consisting of PBS
and citric acid (0.1 M citric acid and 0.5 M NaCl, pH 2.5) for 10 and 3 minutes each
at a flow rate of 1 ml per minute, which also helped to flush out unbound residuals.
The AP labeled goat anti-mouse IgGl (Southern Biotechnology Associates, Inc.,
USA) was then passed through the canine IgG column on three occasions.
Antibodies that did not bind to canine IgG were collected. The specificity of the
solution passed through the column was checked after each run using the method
described in section 4.8.1, and the dilution was carried out by multiplying 1/1,000 by
the estimated volume ratio of fluid collected after purification to that loaded into the
column on the first run. After the third passage, the purified antibody conjugate was
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concentrated using Centriplus™ concentrators (Amicon, Inc., Beverly, USA). The
protein concentration of concentrated solution was measured with a
spectrophotometer, and diluted 1:1 in glycerol (BDH, UK) to a final concentration of
0.29 mg/ml.
Results
The blots demonstrating the conjugate specificity after each passage through the
canine IgG column are shown in Figure 4.25 A-C. After the first passage, the binding
of the conjugate to both normal dog serum and purified dog IgG was much weaker
compared to Figure 4.24 (Figure 2.25 A), indicating that the majority of the cross-
reactivity had been removed. Following passage through the column twice, the
conjugate showed even weaker binding to normal dog serum and dog IgG, although
it was still detectable using the chemiluminescent detection system (Figure 2.25 B).
Elimination of cross-reactivity was seen after the third passage using the
concentrated conjugate that had been mixed with glycerol at a dilution of 1/2,000


















Figure 4.25 A-C Examination of conjugate specificity after purification with
affinity chromatography
A: Immunoblot showing the specificity of AP conjugated goat anti-mouse IgGl
that had been passed through the canine IgG column once. The signal in mouse
IgGlK (lane 1) was very strong, suggesting that the specificity of the conjugate for
mouse IgGl was not affected by purification procedures. However, weak binding
to normal dog serum (lane 2) and purified dog IgG (lane 3) indicated that the
cross-reactivity was not completely eliminated. B: Immunoblot showing the result
after the second passage. The bands in lanes 2 and 3 were slightly weaker than
those in A. C: Immunoblot showing the result after the third passage. No bands
were detected in lanes 2 and 3 using the concentrated conjugate diluted 1/2,000.
This purified conjugate was therefore used in subsequent experiments.
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4.8.3 Specificity of the anti-canine IgE antibody and purified conjugate
Aims
The cross-reactivity of the AP conjugated goat anti-mouse IgGl had been removed
by passing the conjugate through the canine IgG column three times as demonstrated
in the previous section. However, it was unknown at this stage whether the
combination of a monoclonal mouse anti-dog IgE and the conjugate selected in this
protocol was specific for canine IgE. The aim of this experiment was to further
examine the specificity of these reagents.
Methods
Purified dog IgE and IgG were diluted with PBS, mixed 1:1 with non-reducing
sample buffer, and used at a concentration of 0.2 pg per lane. They were then run in
an SDS-PAGE gel and transferred to a membrane. The membrane containing
separated dog IgE or IgG was blocked for 1 hour with 5 % skimmed milk in TBS
containing 0.1 % Tween 20 (TTBS) followed by washing in TTBS for 15 minutes. A
monoclonal mouse anti-dog IgE (E6-71A1, Custom Monoclonals International, W.
Sacramento, USA) was diluted 1/500 in dilution buffer (1 % skimmed milk in TTBS)
and allowed to react with the membrane for 1 hour. For the control groups, the anti-
dog IgE antibody was replaced with dilution buffer. After a 15-minute wash, the
membrane was incubated for 1 hour with the purified conjugate diluted 1/2,000. It
was washed again with TTBS for a further 15 minutes, rinsed with detection buffer,




Binding was only detected on the membrane containing dog IgE with the presence of
both monoclonal mouse anti-dog IgE and AP conjugated goat anti-mouse IgG 1
(Figure 4.26). The conjugate did not bind to either dog IgE without the presence of
anti-dog IgE, or dog IgG with or without the presence of anti-dog IgE antibody.
These results verified that the combination of the monoclonal mouse anti-dog IgE
and purified AP conjugated secondary antibody was specific for canine IgE, and













Figure 4.26 Specificity of a monoclonal mouse anti-dog IgE and purified AP
conjugated anti-mouse IgG for canine IgE
Purified dog IgE (lanes 1 and 2) and IgG (lanes 3 and 4) were run in an SDS-PAGE
gel using non-reducing sample buffer and transferred to a membrane. The
membranes were then sequentially incubated with monoclonal mouse anti-dog IgE,
goat anti-mouse IgG which had been passed through a canine IgG column three
times, and the chemiluminescent substrate (lanes 1 and 3). For the control groups
(lanes 2 and 4), the anti-dog IgE antibody was replaced with the dilution buffer.
The secondary antibody did not bind to either dog IgE without the presence of anti-
dog IgE, or dog IgG with or without the presence ofanti-dog IgE antibody.
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4.8.4 Optimisation of purified antibody conjugate dilution
Aims
The aim of this experiment was to determine the optimal dilution of AP labeled goat
anti-mouse IgG that had been passed through a canine IgG column three times to
detect IgE binding components in Malassezia blots.
Methods
In chapter 3, IgG binding antigens in Malassezia pachydermatis were demonstrated
using membranes containing Malassezia extract separated in 12 % SDS-PAGE gels.
However, 10 % SDS-PAGE gels were deemed to be more suitable for detecting IgE
binding proteins in Malassezia pachydermatis, as 10 % gels provided better protein
separation and more distinct bands on the blot than 12 % gels (data not shown).
Therefore, 10 % SDS-PAGE gels were used to separate the Malassezia extract in
subsequent experiments.
Four strips with separated Malassezia proteins were pre-wetted and blocked with 5
% skimmed milk in TTBS for 1 hour. They were washed with TTBS for 15 minutes
and then incubated for 1 hour with a serum sample from an atopic dog with
Malassezia dermatitis diluted 1/5 in dilution buffer (1 % skimmed milk in TTBS).
Due to the limited serum supply, only one serum dilution was evaluated in this
experiment. Similar serum dilutions to 1/5 had been used to detect IgE binding
components from Malassezia furfur in man (Johansson & Karlstrom 1991; Jensen-
Jarolim et al. 1992). The control strip was incubated with dilution buffer alone
(Figure 4.27). After further washing in TTBS for 15 minutes, bound IgE was
detected by incubating the strips for 1 hour with anti-dog IgE (E6-71A1, Custom
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Monoclonals International, W. Sacramento, USA) diluted 1/500 as suggested on the
product datasheet. The strips were then washed again in TTBS for a further 15
minutes and incubated with AP conjugated goat anti-mouse IgG diluted 1/2,000,
1/5,000 or 1/10,000 for 1 hour. After another 15-minute wash, the strips were rinsed
with detection buffer and incubated with CDP-Star™ chemiluminescent substrate for
5 minutes. Excess reagents were drained off and the strips were wrapped in cling
film and exposed for 15 minutes on the Kodak Digital Science™ Image Station.
Blots were then visualised on the computer screen.
Figure 4.27 Experimental design
Strips 1 2 3 4
Blocking 5 % skimmed milk in TTBS (0.1 % Tween 20 )
Serum AM 1/5 Buffer
Anti-IgE 1/500
2nd Ab 1/2,000 1/5,000 1/10,000 1/5,000
AM: atopic dog with Malassezia dermatitis.
Results
Gradually decreasing binding activity was seen on the strips as the dilution of
secondary antibody conjugate was increased (Figure 4.28). Although less
background was generated when the conjugate was used at dilutions of 1/5,000 and
1/10,000, the bands on the strips were not as clear as those on the strip incubated
with the conjugate diluted 1/2,000. A serum dilution of 1/5, an anti-dog IgE dilution
of 1/500, and a conjugate dilution of 1/2,000 were deemed to provide the best results.




Figure 4.28 Optimisation of goat anti-mouse IgG dilutions
Three different dilutions of AP conjugated goat anti-mouse IgG (1/2,000-1/10,000)
were evaluated. The strips were blocked with 5 % skimmed milk in TTBS and
incubated with a serum sample from an atopic dog with Malassezia dermatitis
(lanes 1-3) diluted 1/5. The strip incubated with dilution buffer was used as a
control (lane 4). Bound IgE was detected by incubating the strips with anti-dog IgE
antibody diluted 1/500 and then anti-mouse IgG diluted 1/2,000 (lane 1), 1/5,000
(lanes 2 and 4) or 1/10,000 (lane 3). Comparing the results from three strips, anti-
mouse IgG diluted 1/2,000 was deemed to provide the best outcome and therefore
used to analyse all subsequent serum samples.
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IgE RESPONSE TO MALASSEZIA PACHYDERMATIS ALLERGENS IN DOGS
4.9 Detection of IgE binding proteins from Malassezia pachydermatis in
atopic dogs with Malassezia dermatitis and normal dogs
4.9.1 IgE binding to proteins ofMalassezia pachydermatis in individual dogs
Aims
In this section, the optimal conditions for immunoblotting to detect Malassezia
pachydermatis specific IgE were used to analyse individual dog serum samples from
atopic dogs with Malassezia dermatitis and normal dogs.
Methods
The strips containing separated Malassezia proteins were pre-wetted with methanol
and blocked for 1 hour with 5 % skimmed milk in TBS containing 0.1 % Tween 20
(TTBS). After washing with TTBS for 15 minutes (3x5 minute rinses), each strip
was incubated with individual dog serum diluted 1/5 in dilution buffer (1 % skimmed
milk in TTBS) for 1 hour. The strips were then washed again in TTBS for a further
15 minutes. Bound IgE was detected by incubating the strips for 1 hour with
monoclonal mouse anti-dog IgE E6-71A1 (diluted 1/500). After further washing with
TTBS for 15 minutes, the strips were incubated with affinity purified AP-labeled
goat anti-mouse IgGl (diluted 1/2000) for 1 hour. The strips were washed again with
TTBS for 15 minutes, and then rinsed with detection buffer. The development was
carried out by incubating the strips with CDP-Star™ chemiluminescent substrate for
5 minutes. After draining off excess liquid, the strips were wrapped in cling film and
placed on a Kodak Digital Science™ Image Station 440CF along with Coomassie
blue stained molecular weight markers. The membrane was exposed for 15 minutes,
and blots were visualised on the computer screen. Kodak Digital Science™ ID
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Image Analysis Software was used to detect the bands on the blots and to determine
the molecular weight of bands by analysing their positions relative to molecular
weight markers.
Results
The IgE immunoblots of individual dog sera from the two groups are shown in
Figure 4.29 A-B. The intensity of binding seen in normal dogs (Figure 4.29 A) was
much weaker than that seen in the atopic dogs with Malassezia dermatitis (Figure
4.29 B).
The intensity of binding in atopic dogs with Malassezia dermatitis was strongest
between 45 and 63 kDa. IgE binding proteins with molecular weights of 45 (61 % of
dogs), 52 (50 %), 56 (61 %), and 63 (68%) kDa were recognised by more than 50 %
of the dogs (Figure 4.30). Strong bands were also detected at 26 (29 %), 48 (39 %),
and 60 (18 %) kDa.
Approximately one third of the normal dogs showed faint binding to proteins
between 45 and 63 kDa, but clearer bands at 45 (in 18 % of dogs), 52 (36 %), 56 (32
%) and 63 kDa (36 %) were detected by the image analysis software (Figure 4.30).
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Figure 4.29 IgE-binding proteins in extracts ofM. pachydermatis detected by
immunoblotting with dog sera from two different groups
A: Normal dogs; B: Atopic dogs with Malassezia dermatitis. The images of blots
were captured by a digital imaging station and printed out directly from the
computer. The numbers along the bottom signify the strips probed with individual
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Figure 4.30 Percentage of dogs from the two groups showing IgE binding to
individual proteins in extracts ofM. pachydermatis
The bands on the blots shown in Figure 4.29 were detected using Kodak Digital
Science™ ID Image Analysis Software and the molecular weight of bands
generated by the software was used to calculate the percentage of dogs reacting to
individual bands. Black columns, atopic dogs with Malassezia dermatitis; Open
columns, normal dogs. X axis: molecular weights of the bands detected on the
strips; Y axis: percentage of dogs reacting to those bands.
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4.9.2 Verification of IgE binding
Aims
In order to confirm that the major bands detected on the blots in the previous
experiment represented IgE-binding proteins, a pooled serum sample was prepared
from the atopic dogs with Malassezia dermatitis and from the normal dogs. The
pooled serum samples were heat treated at 56°C for 2, 4 and 8 hours to detect the
heat lability ofbinding reactions.
Methods
Two pooled serum samples were generated: one from all the atopic dogs with
Malassezia dermatitis and one from all the normal dogs. An aliquot of each pooled
sample was then heat treated at 56°C for 2, 4 and 8 hours. The immunoblotting was
performed on nine pre-wetted strips containing separated Malassezia proteins as
described in section 4.9.1. After blocking, the strips were incubated with unheated
serum pools or pooled serum samples that had been heat treated (Figure 4.31). The
strip incubated with dilution buffer (1 % skimmed milk in TBS containing 0.1 %
Tween 20) was used as a control. All strips were then analysed with anti-dog IgE and
purified secondary antibodies followed by chemiluminescent detection using the
same conditions described in section 4.9.1.
Figure 4.31 Experimental design
Strips 12 3 4 5 6 7 8 9
Blocking 5 % skimmed milk in TTBS (0.1 % Tween 20)
Serum 1/5 AM 0 AM 2 AM 4 AM 8 NO N 2 N 4 N8 Buffer
Anti-IgE 1/500
2nd Ab 1/2,000
AM: atopic dog with Malassezia dermatitis; N: normal dog; 0: non-heated serum pool; 2, 4, and 8:
after heating for 2, 4, and 8 hours, respectively.
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Results
The binding patterns seen in the two serum pools (Figure 4.32) were very similar to
those seen in the corresponding individual serum samples shown in Figure 4.29. As
with the individual blots, the binding intensity seen in the atopic dog serum pool was
much stronger than that in the normal dogs. Between 45 and 63 kDa, the binding
intensity declined dramatically over the period when serum pools were heated.
Gradually decreasing binding activity was also seen on one single band at 26 kDa.
Accordingly, bands of 26 kDa and any binding detected between 45 and 63 kDa on
the strips from the individual dogs were regarded as IgE specific.
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AM N C
Figure 4.32 Heat-lability of binding detected in two serum pools: one from
atopic dogs with Malassezia dermatitis and one from normal dogs
AM: atopic dogs with Malassezia dermatitis; N: normal dogs; C: control (dilution
buffer: 1 % skimmed milk in TTBS). The numbers represent the length of heat
treatment. 0: non-heated serum pool; 2, 4, and 8: after heating for 2, 4, and 8 hours,




4.10.1 Validation and optimisation ofmethodology
In the first part of this chapter, six protocols were evaluated to detect IgE binding
proteins in Malassezia pachydermatis. Whilst optimising the methodology, various
problems of lack of sensitivity and specificity were encountered (summarised in
Table 4.2). Detection of IgE responses is generally considered to be much more
difficult than IgG responses due to the low concentrations of IgE antibodies in sera.
The fact that levels of allergen-specific IgG may be several thousandfold higher than
levels of IgE in normal and atopic animals (Wassom & Grieve 1998) means that even
when there is a small degree of cross-reactivity, the IgG signal may be apparent and
interfere with the result. Furthermore, non-specific binding was found between the
mixed and complex antigens in the Malassezia extract and the secondary-developing
reagents. Therefore, various combinations of reagents were evaluated in protocols 1-
6 to examine their suitability for use in Malassezia immunoblots.
In protocols 1 and 2, a polyclonal anti-dog IgE was used as the primary antibody.
Despite the fact that polyclonal antibodies usually provide greater sensitivity than
monoclonal antibodies, these two protocols were rejected because there were no
visible bands on the blots, even with the amplification step introduced in protocol 2.
To increase the sensitivity of the technique, various chemiluminescent protocols were
investigated (protocols 3-6). Luminescent detection methods provide several
advantages over traditional chromogenic procedures, such as generally increasing the
sensitivity of both HRP and AP systems, rapid detection, and long lasting signals
permitting multiple exposures (Gallagher et al. 1998). To increase the specificity of
the chemiluminescent methods, monoclonal antibodies and an IgE receptor reagent
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were investigated. Also, the multi-channel miniblotter provided several potential
advantages over cutting membranes into strips, and its use in Malassezia blots was
evaluated (section 4.5.1). In protocols 3 and 4, the secondary antibodies cross-reacted
with canine IgG and they were abandoned due to lack of specificity. This problem is
confounded by the fact that levels of Malassezia-specific IgG are much higher than
levels of IgE as shown by the results obtained in chapter 3 using a less sensitive
substrate (DAB) to detect Malassezia-specific IgG. The high levels of Malassezia-
specific IgG in dog sera could enhance the IgG signals and eclipse the IgE reaction.
The high-affinity receptor for IgE, FcsRI, is a requisite for the IgE-mediated
immediate hypersensitivity reaction and the interaction between IgE and FcsRI is
highly specific (Turner 2001). FcsRI has been used in ELISAs to measure canine IgE
because of its high affinity for canine IgE and lack of reactivity with canine IgG
(Wassom & Grieve 1998; Stedman et al. 2001). In view of its likely ability to
eliminate the problems of cross-reactivity with canine IgG as seen in protocols 3 and
4, the suitability of the receptor for use in Malassezia blots was investigated in
protocol 5. In spite of offering absolute specificity for IgE, the detection with FcsRI
receptor reagent was not successful because the secondary avidin reagents bound to
Malassezia proteins. As the Malassezia extract used in this study contained a crude
mixture of both cytoplasmic and cell wall components, the non-specific binding
between avidin reagents and Malassezia proteins was likely to stem from
endogenous protein-bound biotin in the extract. This was further confirmed by
optimising various reagents to abolish the cross-reactivity including avidin/biotin
blocking solutions (section 4.7.2.2).
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In protocol 6, a combination of reagents that had previously been used successfully
to detect IgE binding in ELISA assays (unpublished observations) was assessed. In
this protocol, the cross reactivity of the secondary antibody was removed by
immunoabsorption through a canine IgG column. Although protocol 6 proved to be
successful, it is likely that the use of the cross-absorbed secondary reagent with other
primary antibodies would also be suitable. With this protocol, a digital imager was
used to resolve the bands, rather than assessment of X-ray films. It was found that x-
ray films produced previously reported problems such as weak bands being
overshadowed by adjacent strong signals, broad diffuse images resulting from
overexposure and film saturation. The image station and image analysis software
provided better resolution of the bands and enabled more accurate determination of
their molecular weights than traditional chemiluminescent methods. It is important to
note that chemiluminescent blots are not visible to the naked eye and can only be
visualised on X-ray film or on a computer screen (when using digital imaging).
Furthermore, the bands on chemiluminescent blots are often not as clear and distinct
as those seen on normal chromogenic blots. However, the use of imaging software
allows the bands to be resolved without investigator bias.
Despite the various problems associated with lack of specificity, there are three lines
of evidence that confirm Malassezia-specific IgE has been detected in the present
study. First, it was demonstrated that the reagents used in protocol 6 did not cross-
react with canine IgG (see Figure 4.26). Secondly, the IgE binding to the major
allergens was shown to be heat labile (Figure 4.32). Thirdly, the antigens detected in
this chapter were different from those detected in chapter 3 using reagents to detect
IgG.
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4.10.2 IgE response to Malassezia pachydermatis allergens in dogs
In the second part of this chapter, specific IgE binding proteins in extracts of
Malassezia pachydermatis were demonstrated using sera from atopic dogs with
Malassezia dermatitis and normal dogs. The results of the immunoblotting with
individual dog sera indicate that the majority of the atopic dogs with Malassezia
dermatitis had a greater IgE response to allergens ofM. pachydermatis than normal
dogs suggesting that Malassezia dermatitis in atopic dogs is associated with an IgE
response to the organism. This also confirms the findings of previous studies that
have demonstrated elevated concentrations ofMalassezia-specific IgE in atopic dogs
with Malassezia overgrowth by ELISA (Nuttall & Halliwell 2001) and positive
responses following intradermal injection ofMalassezia extracts (Morris et al. 1998;
Bond et al. 2002a). Furthermore, the immunoblots showed that the IgE response was
predominantly targeted against proteins with molecular weights of 45, 52, 56, and 63
kDa. As these proteins were recognised in over 50 % of the atopic dogs with
Malassezia dermatitis, but only recognised by a minority of normal dog sera, they
can be classified as major allergens. Strong bands were also detected with molecular
weights of 26, 48, and 60 kDa but as these were recognised in less than half of the
atopic dogs, they can be regarded as minor allergens. Weak IgE binding was also
seen in some normal dogs between 45 and 63 kDa. The cause of this weak IgE
binding in normal dogs is unknown. It has been shown that extracts of M.
pachydermatis at high concentrations are capable of inducing wheal and flare
responses in normal dogs (Morris et al. 1998). This could be an irritant reaction or an
IgE response present to commensal populations of the yeast. The latter is certainly
the case with IgG responses as shown in previous studies (Chen et al. 2002; Nuttall
& Halliwell 2001). It has also been proposed that the positive IDTs to environmental
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allergens and the presence of allergen-specific IgE in normal dogs might be
explained by the existence of heterogeneity of IgE or variations in the propensity for
mediator release between atopic and normal dogs (Halliwell et al. 1998; Halliwell &
DeBoer 2001). This is speculated from the evidence that human IgE may be
functionally heterogeneous in terms of its ability to mediate histamine release
(MacDonald et al. 1995), the finding of physico-chemical heterogeneity in canine
IgE (Peng et al. 1997) and the tendency of leukocytes from atopic dogs to release
more histamine than those from normal dogs (Jackson et al. 1996).
Of all the allergens detected, those with molecular weights of 45 and 48 kDa seemed
to be the most relevant because they were recognised by most atopic dogs with
Malassezia overgrowth but only a few normal dogs (Figure 4.30). Further studies are
required to determine the identity of these proteins using protein purification and N-
terminal sequencing. They may represent two different proteins or a single protein
with variable glycosylation.
In contrast to the low molecular weight allergens of Malassezia furfur (Mai s 1, Mai
f 2-Mal f 4, Mai s 5-Mal s 9) recognised by humans, dogs recognised higher
molecular weight allergens in this study. Similar findings have been documented
with Dermatophagoides allergens. Most human atopic sera have high IgE titers to
group 1 and group 2 allergens ofDermatophagoides (Le Mao et al. 1998; Thomas et
al. 1998) which are low molecular weight proteins, whereas in dogs, the most
important Dermatophagoides allergens are high molecular weight proteins greater
than 90 kDa (Noli et al. 1996; McCall et al. 2001; Nuttall et al. 2001). Although a
few Malassezia proteins in the molecular weight range between 46 and 58 kDa were
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recognised by more than 50 % of the human atopic patients in one study (Huang et al.
1995), similar to the results obtained in the present study, their characteristics have
not been further defined.
In human studies, it is considered that both protein and carbohydrate antigens of
Malassezia spp. are important, although the importance of carbohydrate antigens is
emphasised less, probably due to their appearance as diffuse bands or even absence
in SDS-PAGE gels (Ashbee & Evans 2002). In addition to the proteins with various
molecular weights identified by immunoblotting, one study reported positive RAST
results with Malassezia mannan in 77 % of the patients with atopic dermatitis
indicating that mannan was also an important allergen of Malassezia organisms
colonised on human skin (Lintu et al. 1997). It has been shown that the cross-
reacting IgE antibodies between Malassezia spp. and Candida albicans were likely
to be directed at mannans or mannoproteins (Savolainen & Broberg 1992; Doekes et
al. 1993; Doekes & Ieperen-van Dijk 1993). Although a correlation between M.
pachydermatis extracts and mold mix allergens was not found in dogs (Morris et al.
1998), the importance of carbohydrate antigens in dogs is uncertain and awaits
further investigation.
In summary, the experiments in this chapter have developed and validated a Western
blotting technique to detect specific IgE binding proteins from M. pachydermatis.
Using this technique, proteins of 45, 52, 56, and 63 kDa were demonstrated to be
recognised by over 50 % of the atopic dogs with Malassezia dermatitis and appeared
to be clinically relevant in these dogs. However, further characterisation of these
allergens with protein purification and sequencing techniques is required before they
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could be used for diagnosis and treatment purposes. The purified allergens could
potentially be used in intradermal testing and in vitro IgE assays to provide




THE EFFECT OF EXTRACTS FROM
MALASSEZIA PACHYDERMATIS ON THE
PROLIFERATION OF CANINE KERATINOCYTES
5.1 Introduction
Malassezia dermatitis, like a number of other chronic inflammatory dermatoses, is
often associated with marked epidermal hyperplasia (Scott & Miller 1989; Yager
1994; Mauldin et al. 1997; Muse 2000; Scott et al. 2001a). Epidermal hyperplasia is
a protective mechanism mounted by the skin in response to environmental insults
and is caused by an increase in the proliferation of keratinocytes resulting in
increased number of epidermal cells (Scott et al. 200Id). The regulation of
keratinocyte proliferation is an extremely complex process and the molecular
mechanisms involved are of great clinical importance in terms of understanding the
pathogenesis and treatment of skin diseases. The essential mechanism by which cells
divide is a cycle of duplication and division, also known as the cell cycle, which
comprises four phases including M, Gl, S, and G2 phases (Alberts et al. 2002a). In
keratinocytes, the cell cycle is mainly regulated in the Gl phase and the progression
through the cycle is determined by the stage of cell differentiation, cell adhesion, and
the balance between stimulatory and inhibitory growth factors (Gniadecki 1998). The
cells that have proliferative capacity in the epidermis are located in the basal layer,
whereas terminally differentiated suprabasal keratinocytes are unable to proliferate
(Suter et al. 1997; Gniadecki 1998; Hashimoto 2000). Adhesion to a substratum,
such as tissue culture plastic or purified extracellular matrix proteins, is known to be
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required for keratinocyte growth, and loss of attachment can cause a rapid growth
arrest (Gniadecki 1998). It has also been shown that cell attachment is important for
expression of cyclins and complex formation between cyclin and cyclin-dependent
kinases (cdks) in the G1 phase, both of which play pivotal roles in controlling the
cell proliferation cycle (reviewed in Assoian 1997).
5.1.1 Stimulatory factors for keratinocyte proliferation
5.1.1.1 Epidermal growth factor family
Growth factors are typically secreted proteins that are released from cells, act upon
their target, and regulate cell proliferation (Heath 2001). Among the factors that
stimulate keratinocyte growth, the epidermal growth factor (EGF) family is of central
importance (Suter et al. 1997; Hashimoto 2000). The EGF family comprises EGF
itself, transforming growth factor (TGF)-a, heparin-binding EGF-like growth factor
(HB-EGF), amphiregulin (AR), epiregulin, betacellulin (BTC), and neuregulins.
TGFa, HB-EGF, AR and epiregulin are produced and secreted by human
keratinocytes (Hashimoto 2000; Heath 2001). Stimulation of keratinocytes with EGF
and TGFa results in an increased rate of proliferation and migration (Barrandon &
Green 1987; Gibbs et al. 2000). HB-EGF and AR, which have binding affinity for
heparinoids, in addition to TGFa and epiregulin, act as autocrine growth factors and
form a regulatory network during keratinocyte growth (Piepkorn et al. 1994;
Hashimoto et al. 1994; Shirakata et al. 2000).
EGF receptors include four forms (ErbBl-4, also referred to as Her1-4), of which
EGF, HB-EGF, TGFa, AR, BTC and epiregulin bind to ErbBl, whereas neuregulins
bind to ErbB3 and 4 (Hashimoto 2000). The binding of a ligand to the receptor
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causes the receptor to dimerize and activate intracellular protein tyrosine kinases,
which then bind to adaptor proteins such as She, Grb2, and Sos, leading to the
activation of Ras protein (Tomic-Canic et al. 1998; Freedberg et al. 2001). Activated
Ras, in turn, activates a cascade of three protein kinases, Rafl, mitogen-activated
protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) (MEK), and
ERK, the last of which translocates to the nucleus, phosphorylates, and activates
transcription factors, such as ATF2, SAP1, c-Jun, and Elkl. These transcription
factors then regulate gene expression and cell division (Freedberg et al. 2001).
5.1.1.2 Fibroblast growth factorfamily
As with the EGF family, the fibroblast growth factor family comprises several
structurally related mediators which currently include 16 members (Werner 1998).
The initially discovered acidic fibroblast growth factor (aFGF) and basic FGF (bFGF)
can both be synthesized by keratinocytes (Feliciani et al. 1996) and are now called
FGF 1 and 2. The latter is more potent at stimulating the growth of keratinocytes
(Rothe & Falanga 1989; Suter et al. 1997). Another member of the FGF family,
keratinocyte growth factor (KGF, FGF-7), is produced by fibroblasts and has a role
in wound repair in which it influences proliferation and/or differentiation of
keratinocytes (Werner 1998; Werner & Smola 2001). The actions of FGFs on cells
are mediated via binding of three different molecules: heparan sulfate proteoglycan, a
low-affinity transmembrane FGF-binding protein, and a high affinity transmembrane
FGF receptor of the tyrosine kinase family (Werner 1998; Alberts et al. 2002b). Four
FGF receptors (FGFR 1-4) have been described and the different members of the
FGF family bind with differing affinity, although KGF only binds to a splice variant
of FGFR-2 (Williams & Kupper 1996; Werner 1998). Binding of FGF leads to
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dimerization of FGF receptors, activation of receptor tyrosine kinases, and
subsequent autophosphorylation of the cytoplasmic domains (Klint & Claesson-
Welsh 1999). The autophosphorylation sites serve as binding sites for enzymes, such
as phospholipase C-y and Src, as well as adaptor proteins, She, Grb2, and Sos. The
binding signals then trigger activation of the Ras signaling pathway leading to up-
regulation of ERKs and cell proliferation as described above for the EGF family
(Boilly et al. 2000).
5.1.1.3 Insulin-like growth factors
Insulin-like growth factor 1 (IGF-1), one of two members currently known in this
family, has been identified as a keratinocyte mitogen (Neely et al. 1991; Barreca et al.
1992). IGF-1 is produced by keratinocytes of the stratum granulosum and by dermal
fibroblasts (Rudman et al. 1997; Suter et al. 1997). The stimulatory effects of IGF-1
on keratinocytes are associated with its interaction with receptors for EGF and
induction of TGFa and amphiregulin (Krane et al. 1991; Vardy et al. 1995). IGF-1
receptors are localised to the basal proliferative cells in the normal epidermis (Krane
et al. 1991). Three survival (anti-apoptosis) signaling pathways have been
demonstrated for IGF-1 receptors (Navarro & Baserga 2001). However, the pathways
that signal cells to proliferate have not been fully elucidated. The most well-known
mitogenic/survival pathway is via the activation of phosphatidylinositol-3 kinase
(PI3K). The cytoplasmic tyrosine kinase domains of IGF-1 receptors undergo
autophosphorylation upon IGF-1 stimulation, which then phosphorylate a substrate
of the IGF-1 receptor, insulin receptor substrate-1 (IRS-1), thus activating PI3K.
PI3K, in turn, activates protein kinase B which inactivates BAD, a protein that
normally encourages cells to undergo apoptosis, thereby promoting cell survival
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(Alberts et al. 2002b).
5.1.1.4 Interleukin 1 (IL-1)
IL-1 is an initiator of keratinocyte activation and its characteristics and functions
have been extensively reviewed (Sauder 1989; Freedberg et al. 2001; Grone 2002).
Two major forms of IL-1, a and (3, are present in an unprocessed form in the
cytoplasm of keratinocytes (Freedberg et al. 2001). In response to injury,
keratinocytes process and release IL-1, which serves as an autocrine signal, resulting
in activation and proliferation (Kupper 1990). Keratinocytes express three different
receptors for IL-1: type I receptor (functional), type II receptor (decoy), and IL-1
receptor antagonist (Eller et al. 1995; Feliciani et al. 1996). After IL-1 binds to type I
receptors on the cell surface, the intracellular domain of the receptor recruits protein
kinases leading to activation of at least three transcription factor systems in the
nucleus, resulting in modulation of gene expression (Freedberg et al. 2001).
5.1.1.5 Interleukin 6 (IL-6)
IL-6 is produced in small quantities by normal keratinocytes, but production
increases after stimulation with cytokines such as IL-1 and TNFa, and physical
insults such as ultraviolet light exposure (Feliciani et al. 1996; Suter et al. 1997;
Grone 2002). The induction of keratinocyte proliferation by IL-6 has been
demonstrated in vivo (Sawamura et al. 1998; Sato et al. 1999). Binding of IL-6 to its
receptor at the cell surface causes the activation of cytoplasmic tyrosine kinases,
Jakl/Jak2/Tyk2, which then phosphorylate a gene regulatory protein, signal
transducers and activators of transcription-3 (STAT3). When phosphorylated, STAT3
conveys the signal directly from the plasma membrane into the nucleus without
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second messengers or cytoplasmic kinase cascade intermediates. It then dimerises
and translocates to the nucleus where it activates gene transcription (Tomic-Canic et
al. 1998).
5.1.1.6 Granulocyte macrophage-colony stimulatingfactor (GM-CSF)
Keratinocytes produce large quantities of GM-CSF following injury or stimulation
with tumor promoters (Feliciani et al. 1996; Mann et al. 2001). GM-CSF was
recently shown to induce both keratinocyte proliferation and apoptosis in vivo
(Breuhahn et al. 2000). As a result, transgenic mice with constitutive overexpression
ofGM-CSF by keratinocytes in unwounded skin showed normal epidermal thickness
and differentiation indicating that GM-CSF alone did not evoke epidermal
hyperplasia (Breuhahn et al. 2000). Based on the same model, a further study
proposed that the accelerated process ofwound healing seen in these transgenic mice
was due to not only the direct action of GM-CSF, but also the indirect effect of its
induction of other cytokines (Mann et al. 2001). The kinase associated with the GM-
CSF signaling is Jak2, which then activates STAT5 (Alberts et al. 2002b).
In addition to the growth factors and cytokines listed above, other factors that have
been associated with induction of keratinocyte proliferation include human leukocyte
elastase (Rogalski et al. 2002), nerve growth factor (Pincelli & Marconi 2000),
histamine and serotonin released by mast cells (Maurer et al. 1997), and urokinase-
type plasminogen activator (uPA) (Jensen & Lavker 1999).
5.1.2 The effects ofmicroorganisms on keratinocytes
Following infection with microorganisms, there is some evidence that suggests
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keratinocytes play an active role in host defense mechanisms and the pathogenesis of
dermatitis. One study investigated the production of proinflammatory molecules
produced by keratinocytes co-cultured with Streptococcus pyogenes. Infection of
keratinocytes with adherent, but not nonadherent, streptococci resulted in increased
expression ofmRNA for IL-la, IL-1 (3, and IL-8 (Wang et al. 1997). Both adherent
and nonadherent streptococci induced expression of IL-6 and promoted release of
prostaglandin E2, but adherent streptococci were much more potent (Wang et al.
1997). Stimulation of TNFa production by keratinocytes has also been reported
following incubation with Staphylococcal enterotoxin B (Tokura et al. 1994). Similar
studies have also been performed with Malassezia organisms. In contrast to
streptococci, Malassezia furfur down-regulated mRNA expression for IL-la,
inhibited the expression of IL-6 and TNFa, and up-regulated the immunosuppressive
cytokines IL-10 and TGF-pi. These findings may explain the minimal inflammation
seen in the human dermatosis associated with M. furfur (Baroni et al. 2001a). The
release of IL-la by normal human keratinocytes in response to extracts from M.
furfur serovar B (M globosa) was reported to be donor-dependent (Walters et al.
1995). The release of IL-1 p, IL-6, IL-8 and TNFa from normal human keratinocytes
co-cultured with M. furfur, irrespective of whether the whole organisms or culture
supernatants were used, was low or undetectable (Watanabe et al. 2001). However,
infection of human keratinocytes with whole organisms of M. pachydermatis, M.
slooffiae and M. sympodialis, but not culture supematants, was shown to induce
secretion of IL-ip, IL-6, IL-8 and TNFa, with the highest levels seen with M.
pachydermatis (Watanabe et al. 2001).
Epidermal proliferation has been implicated as an important mechanism in the
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defense against superficial fungal infections. Increased proliferative activity and
thickness of the epidermis has been demonstrated in mice/guinea pigs with
experimental dermatophytosis and candidiasis (Sohnle & Kirkpatrick 1978; Tagami
1985; Sohnle & Hahn 1989). In contrast to the epidermal responses to fungi, one
study showed no direct effect ofM proteins, receptor proteins of S. pyogenes, on the
proliferative activity of human keratinocytes (Wollina et al. 1998). To the author's
knowledge, no similar study has been reported in human keratinocytes co-cultured
with Malassezia organisms, but a preliminary report demonstrated a significant
increase in a cellular proliferation marker in cultured canine keratinocytes infected
with M. pachydermatis compared to non-infected cells (von Tscharner et al. 1999).
However, the mechanisms by which M. pachydermatis might induce keratinocyte
proliferation are not understood.
5.1.3 Aims
One hypothesis for the epidermal hyperplasia seen in Malassezia dermatitis is that a
product within, or secreted from, the organism may have a direct stimulatory effect
on keratinocyte proliferation. The aim of this study, therefore, was to test this
hypothesis by evaluating the direct effects of extracts and culture supernatants from
Malassezia pachydermatis on the proliferation rate of cultured canine keratinocytes.
The initial purpose of the experiments was to evaluate the use of a colourimetric cell
proliferation assay to detect the number of viable canine keratinocytes. The assay
was then used to quantify the number of keratinocytes cultured with extracts and
culture supernatants from M. pachydermatis.
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VALIDATION AND OPTIMISATION OF A CELL PROLIFERATION ASSAY
TO DETECT KERATINOCYTE PROLIFERATION
5.2 Correlation between cell numbers and absorbance in the assay
Aims
In order to use a colourimetric cell proliferation assay to quantify the number of
canine keratinocytes, it was essential to demonstrate that the absorbance was
proportional to the number of living keratinocytes in culture. The aim of the initial
experiment was to validate the feasibility of using the cell proliferation assay with
canine keratinocytes and to determine the optimal assay conditions.
Methods
Keratinocytes grown in tissue culture flasks were harvested by trypsinisation (section
2.19). After the cells were washed and counted in a haemocytometer (section 2.17),
100 pi of cell suspension (containing two fold dilutions from 2 x 105 to 3125 viable
cells per well) was added in triplicate to a 96-well plate. Wells with 100 pi of
medium only were included as background controls. Twenty microliters of Celltiter
96® AQueous One Solution reagent (Promega, Southampton, UK) was then added to
all wells and the plate was incubated at 37°C in a humidified atmosphere with 5 %
C02 in air for up to 4 hours (an incubation time of 1-4 hours was suggested by the
manufacturer). In order to determine the optimal incubation time for canine
keratinocytes, the absorbance of the reaction was evaluated after incubation for 2, 3
and 4 hours using an ELISA reader (Dynatech MR5000, Dynatech Laboratories Ltd,
Billingshurst, UK) at a wavelength of 490 nm and a reference wavelength of 630 nm
(section 2.25). The plate was returned to the incubator for further colour
development between each reading.
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Results
The absorbance obtained after incubation for 2, 3, and 4 hours was plotted against
the number of viable cells per well. A linear correlation was found between the
absorbance and cell number when both parameters were transformed to logarithms
(Figure 5.1 A-C). This assay was therefore judged to be a valid method for
measuring canine keratinocyte proliferation in vitro.
The absorbance obtained after a 2-hour incubation (Figure 5.1 A) was the lowest
among three sets of results. Higher absorbance was seen after a 3-hour incubation
(Figure 5.1 B), and there was only a small increase of absorbance when the plate was
incubated for a further 1 hour (Figure 5.1 C). These results indicated that a 3-hour
















































103 104 105 106
Cells/well
C ellsAv ell Absorbance Average
3125 0204 0.199 0.191 0.198
6250 0290 0290 0279 0286
12500 0.454 0.478 0.404 0.445
25000 0.726 0.750 0.693 0.723
50000 1.102 1.185 1.137 1.141
100000 1.716 1.767 1.706 1.730
200000 2293 1.981 1.890 2.055
CellsAwell Absorbance Average
3125 0.188 0.184 0.191 0.188
6250 0282 0276 0280 0279
12500 0.454 0.469 0397 0.440
25000 0.675 0.691 0.619 0.662
50000 0.965 1.088 1.049 1.034
100000 1.670 1547 1.662 1.626
200000 1.896 2.074 2.130 2.033
C ellsAv ell Absorbance Average
3125 0.163 0.141 0.151 0.152
6250 0.261 0.217 0220 0233
12500 0.402 0.441 0.355 0399
25000 0.596 0.629 0.533 0586
50000 0.870 0.876 0.795 0847
100000 1.130 1.166 1.129 1.142
200000 1295 1.436 1273 1335
Figure 5.1 A-C Correlation between cell numbers and absorbance in the
Celltiter 96 colourimetric assay
A: Results obtained after incubation for 2 hours. B: After 3 hours. C: After 4 hours.
The absorbance is proportional to cell number between 2 x 105 and 3125 when
both X and Y axes are transformed to logarithmical scales. Higher absorbance was
seen when the incubation time was increased. However, little difference was
observed between the results obtained after 3 and 4 hours. Data shown are the
mean of triplicates, but the error bars are so small they cannot be displayed on the
figure. X axis: cell number per well, Y axis: absorbance at 490 nm with a
reference wavelength of 630 nm.
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5.3 Effects of growth factors on keratinocyte proliferation
Aims
To verify that the culture conditions used to grow keratinocytes (section 2.16) were
optimal and to further confirm that the colourimetric cell proliferation assay was
suitable to evaluate keratinocyte growth.
Methods
Cells harvested from tissue culture flasks were washed, resuspended in William's
Medium E (WME) and counted in a haemocytometer. Various combinations of
supplements including foetal calf serum (FCS), cholera toxin (CT), and murine
epidermal growth factor (mEGF) were added to the concentrations of 10 %, 0.1 nM,
and 10 ng/ml, respectively. Cells were then plated into a 96-well plate in
quadruplicate (100 pl/well, 2 x 104 cells/cm2), and cultured in WME alone; with
WME and FCS; with WME, FCS and CT; with WME, FCS and mEGF; and with
WME, FCS, CT, and mEGF (complete medium). The density of cell plating was
determined in preliminary experiments (data not shown). Three identical plates were
prepared for performing the assay on three different days and the plates were
cultured at 37°C with 5 % C02 in air for up to 7 days. Cells from the same passage
were also plated in flasks to be used for generating a standard curve in the cell
proliferation assay.
The proliferation assay was carried out on days 3,5, and 7. Medium in the remaining
plates was changed accordingly on the same days. On the day of the assay, cells
grown in the flasks were trypsinised, washed and counted in a haemocytometer to
generate a standard curve. A volume of 100 pi of cell suspension (containing two
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fold dilutions from 2 x 105 to 3125 cells per well) was added in triplicate to empty
wells. Wells used for background controls were filled with 100 pi of medium alone.
Twenty microliters of Celltiter 96® AQueous One Solution reagent was then added to
all the wells and the plate was incubated for a further 3 hours before evaluating the
absorbance of the reaction using an ELISA reader. The absorbance of wells
containing keratinocytes and WME with or without various combinations of
supplements was compared with the standard curve and the results were calculated as
cells per well, all of which were generated automatically by the ELISA reader. This
experiment was repeated on three different occasions.
Results
The results obtained from three repeated experiments were very similar and a
representative set of results obtained from three assays is shown in Figure 5.2. Cells
grown in the complete medium (containing FCS, CT, and mEGF) had the highest
proliferation rate, with more cells detected than in the other groups in all three assays
performed during the seven-day incubation. This contrasted with the cells cultured in
WME alone, showing minimal increase in number on days 3 and 5, and a
discontinuation of growth on day 7. Although higher growth rates were seen in the
groups with addition of FCS, FCS plus CT, and FCS plus mEGF, they fell between
those of the previous two groups. Hence, canine keratinocyte cultures were routinely
grown in complete medium since it provided the best growth rates. Also, the results




WME WME+FCS WME+FCS+CT WME+FCS+mEGF WME+FCS+CT+mEGF
Medium type
Figure 5.2 Comparison of the proliferation rate of keratinocytes cultured
in William's Medium E with and without supplementation
The data set shown is a representative example of three repeated experiments
giving similar results. Keratinocytes grown in medium with FCS, CT and
mEGF (complete medium) showed the highest growth rate compared to the
other groups and this was detected in all three assays carried out on days 3, 5
and 7. In contrast, unsupplemented WME failed to support keratinocyte
growth. Therefore, keratinocytes were routinely cultured in complete medium.
Each bar represents the mean and standard error of the mean of quadruplicates.
Shaded bars: day 3, White bars: day 5, Black bars: day 7. WME: William's
medium E; FCS: foetal calf serum; CT: cholera toxin; mEGF: murine
epidermal growth factor.
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EFFECTS OF EXTRACTS FROM MALASSEZIA PACHYDERMATIS ON
THE PROLIFERATION OF CANINE KERATINOCYTES
5.4 Culture of keratinocytes with extracts from Malassezia pachydermatis
5.4.1 Establishment of assay conditions for culture of keratinocytes with
Malassezia extracts
Aims
The aim of this experiment was to determine the concentration range of Malassezia
extracts used for co-culture with keratinocytes and the optimal time for performing
the proliferation assay.
Methods
Cultured keratinocytes were washed, resuspended in complete medium and counted
in a haemocytometer. Some cells were plated into flasks to be used for generating a
standard curve in the assay and the others were plated into two 96-well plates at a
density of 2 x 104 cells/cm2 (100 pl/well). The plates were incubated at 37°C for 24
hours to allow cells to attach to the plastic, and the medium was changed the next
day to remove non-adherent cells. Sterile Malassezia extracts (see section 2.7)
prepared with protease inhibitors (10 mg/ml) were diluted 10-fold with PBS and 100
pi of each dilution was added in quadruplicate into wells containing keratinocytes
and 100 pi of fresh medium, resulting in final concentrations of 5, 5x10"', 5x10~2,
5xl0"3, 5xl0"4and 5x10"5 mg/ml. Wells containing medium alone and PBS served as
controls. After a further 3 day incubation, one plate was used for the assay, whilst the
medium in the other was changed and the Malassezia extracts were re-applied
accordingly. Before performing the assay, wells were washed and filled with 100 pi
of fresh medium. The number of viable cells in each well was then detected using the
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proliferation assay as described in section 5.3. On day 8, the assay was carried out
again with the second plate in the same manner.
Results
Higher numbers of cells were detected in most of the wells after a 7 day incubation
(with or without Malassezia extracts), indicating that keratinocytes cultured with
Malassezia extracts were capable of proliferating (Figure 5.3 A-B). However, far
fewer cells were detected when Malassezia extracts were used at a concentration of 5
mg/ml compared to the others on day 4 (Figure 5.3 A), and only a few viable cells
were detected on day 8 (Figure 5.3 B), indicating that Malassezia extracts at the
concentration of 5 mg/ml inhibited cell growth and led to cell death. This
concentration was therefore abandoned in the subsequent experiments due to its
cytotoxic effect on canine keratinocytes. Although the difference in number between
cells grown without and with Malassezia extracts at concentrations of 5 x 10"'- 5 x
10"5 was not dramatic in this experiment, repetition of similar experiments was
required in order to obtain replicates for statistical analyses.
The results obtained on day 4 generally fell in the middle of the standard curve
(containing two fold dilutions from 2 x 105 to 3125 cells per well), whereas those on
day 8 were approaching the upper limit. Furthermore, the majority of the wells were
confluent on day 8 when observed microscopically. Since a cessation of cell growth
can be expected with confluent cultures, and detecting cells in their proliferation
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Figure 5.3 A-B Evaluation of different concentrations of Malassezia
extracts and culture periods for culture with canine keratinocytes
A: Results obtained on day 4. B: Results obtained on day 8. Each bar
represents the mean and standard error of the mean of quadruplicates. Far
fewer cells were detected in the group cultured with Malassezia extracts at a
concentration of 5 mg/ml on both days, indicating that high concentrations
may have cytotoxic effects on keratinocytes. Although more cells were seen
on day 8 than day 4, indicating that the cells were able to proliferate,
confluent cultures were observed on day 8 indicating a decrease in activity.
Day 4 was therefore deemed to be the optimal time to perform the cell
proliferation assay.
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5.4.2 Effects ofMalassezia extracts on keratinocyte proliferation
Aims
In this section, the protocol and extract concentrations determined in section 5.4.1
were used to further investigate the effects of Malassezia extracts on keratinocyte
proliferation. In order to examine the role ofproteases in keratinocyte proliferation as
well as other proteins in the Malassezia extracts, an extraction buffer made with and
without protease inhibitors was used in this experiment.
Methods
Keratinocytes harvested from tissue culture flasks were washed, counted in a
haemocytometer and seeded into 96-well plates at 2 x 104 cells/cm2 in complete
medium as well as into flasks to be used for generation of a standard curve in the cell
proliferation assay. After 24 hours, the medium was changed in order to remove non¬
adherent cells. Fresh medium and Malassezia extracts made with and without
protease inhibitors were added into wells at a final concentration of 5 x 10'1- 5 x 10"5
mg/ml (see sections 2.5.2 and 2.7 for Malassezia extract preparation and
sterilisation). Wells containing medium alone and PBS were used as controls. All
wells were plated in at least quadruplicate for each experiment, and the plates were
incubated for 3 days. Wells were washed and filled with 100 p.1 of fresh medium on
the day of the assay and the number of viable cells in each well was measured using
the colourimetric cell proliferation assay described earlier (section 5.3). The
experiment was repeated five times and the results were combined to give more
replicates for each group in the statistical analyses. One-way ANOVA (Prism®,
Graphpad Inc., San Diego, USA) was used to compare the number of keratinocytes
cultured with or without various concentrations of Malassezia extracts, and
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significance was set at P < 0.05.
Results
The results obtained from 5 separate experiments are shown in Figure 5.4 A-B. There
was no significant difference in cell numbers between any group of keratinocytes
cultured with 5 x 10"1- 5 x 10"5 mg/ml of extracts, either with or without protease
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Figure 5.4 A-B Dose response of canine keratinocytes to Malassezia extracts
A: Extracts produced using buffer containing protease inhibitors. B: Extracts
without protease inhibitors. Data shown are the mean of five separate experiments
and error bars show the standard error of the mean. The differences between
groups were analysed using one-way ANOVA and no significant difference was
found between groups.
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5.5 Culture of keratinocytes with culture supernatants from M.
pachydermatis
5.5.1 Establishment of assay conditions for culture of keratinocytes with
culture supernatants fromM. pachydermatis
Aims
Having determined the optimal conditions to perform the proliferation assay on
keratinocytes cultured with Malassezia extracts, the same conditions were evaluated
for their use on cells grown with culture supernatants from M. pachydermatis. Also,
different dilutions of the supernatants were assessed for their cytotoxic effects on
canine keratinocytes.
Methods
Keratinocytes cultured in flasks were harvested, counted in a haemocytometer and
plated into a 96-well plate at the density of 2 x 104 cells/cm2 (100 pl/well). Some
cells were also seeded into flasks to be used for generating a standard curve in the
cell proliferation assay. Non-adherent cells were removed the next day and the wells
were filled with 100 pi of fresh medium. An aliquot of the concentrated Malassezia
culture supernatants that had been sterilized (see sections 2.6 and 2.7 for preparation
and sterilisation) was diluted 10-fold with PBS and dilutions of 1/10-1/1,000 as well
as undiluted supernatants were added into wells in quadruplicate. Due to the high
protein content in the Sabouraud liquid medium, it was not possible to quantify the
amount of specific Malassezia proteins in the supernatants. Their concentrations
were therefore expressed as dilution ratios. A volume of 100 pi of undiluted sterile
Sabouraud liquid medium or PBS was used in control wells. The plate was incubated




After culturing keratinocytes with Malassezia culture supernatants for 3 days, the
number of viable cells detected in most of the groups was within the range of the
standard curve generated from two-fold dilutions from 2 x 105 to 3125 cells per well
(Figure 5.5), validating the use of the protocol described above. Nevertheless,
undiluted Malassezia culture supernatants and sterile Sabouraud liquid medium
suppressed the growth of keratinocytes and caused cell death. In contrast, this
cytotoxic effect was not seen in the groups cultured with Malassezia culture





Figure 5.5 Evaluation of various dilutions of culture supernatants from M.
pachydermatis for culture with canine keratinocytes
Undiluted Malassezia culture supernatants and three dilutions were evaluated. After
a 3 day incubation, the groups cultured with undiluted Malassezia culture
supernatants and sterile Sabouraud liquid medium showed very few viable cells,
indicating that this concentration had cytotoxic effect on keratinocytes, and was
therefore not suitable for use in co-culture. Each bar represents the mean and
standard error of the mean of quadruplicates. S: sterile Sabouraud liquid medium;
M: culture supernatants from M. pachydermatis.
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5.5.2 Effects of culture supernatants from M. pachydermatis on keratinocyte
proliferation
Aims
The aim of this experiment was to investigate the effects of culture supernatants from
M. pachydermatis on the proliferation of canine keratinocytes by measuring the
number of viable cells after culturing keratinocytes with various dilutions of
Malassezia culture supernatants using the protocol and dilutions assessed in section
5.5.1.
Methods
Keratinocytes were plated into 96-well plates at 2 x 104 cells/cm2 in complete
medium. For generating a standard curve in the cell proliferation assay, some cells
were also seeded into flasks. The medium was changed the next day to remove non¬
adherent cells. Concentrated Malassezia culture supernatants and sterile Sabouraud
liquid medium were diluted 10-fold with PBS and dilutions of 1/10 - 1/10,000 were
added into wells in at least quadruplicate for each experiment. The plates were
incubated at 37°C with 5 % C02 in air for 3 days and the wells were washed on the
day of the assay before adding 100 pi of fresh medium. The cell proliferation assay
was performed as described earlier and the experiment was repeated on four different
occasions to obtain more replicates for statistical analyses. Results obtained from
repeated experiments were combined and T-tests (Prism®, Graphpad Inc., San Diego,
USA) were used to compare the cell numbers of keratinocytes incubated with culture
supernatants of M. pachydermatis and sterile medium for each dilution ratio.
Significance was set at P < 0.05.
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Results
Figure 5.6 shows the combined results of four repeated experiments. No significant
difference was found between each group of cells incubated with culture
supernatants from M. pachydermatis at the four dilutions compared to the individual
negative controls (P > 0.05).
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Figure 5.6 Dose response of canine keratinocytes to culture supernatants
from Malassezia pachydermatis
Data shown are the mean of four experiments and error bars show the standard
error of the mean. The differences between cells cultured with supernatants and
sterile medium were analysed using t-tests. There was no significant difference
between the two groups at any dilution. White bars: sterile medium, Black bars:
culture supernatants from Malassezia.
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5.6 Discussion
5.6.1 Validation and optimization of the cell proliferation assay
The initial aim of the experiments in this chapter was to validate the use of a
colourimetric proliferation assay with canine keratinocytes. Proliferation assays
provide several advantages over traditional manual counting and have been widely
used in proliferation and cytotoxicity studies. The tetrazolium assay, first described
by Mosmann (1983) and generally known as the MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide) assay, is a colourimetric assay based on the
bioreduction of a tetrazolium salt to a coloured substance, formazan. The procedure
involves a solubilisation step to dissolve the formazan product of MTT, which is a
crystalline precipitate, prior to reading absorbance. This can be troublesome and the
difficulty associated with incomplete solubilisation of the crystals is the main
drawback of this assay. The second generation assays use tetrazolium salts that form
soluble formazans, such as MTS (3-[4,5-dimethylthiazol-2-yl]-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) and XTT (sodium (2,3-
bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide), and an
electron coupling reagent, phenazine methosulfate (PMS). However, the MTS/PMS
mixture has been demonstrated to be much more stable than XTT/PMS (Goodwin et
al. 1995), and the MTS assay has been shown to be equivalent to the 3H-thymidine
incorporation assay using human epidermal keratinocytes (Kaplan et al. 1995). The
reagent used in this study is an improvement over the original MTS assay and
contains stable pre-combined MTS/PMS. Using this reagent, a linear correlation
between the absorbance and cell number per well was demonstrated with
logarithmical scales in section 5.2, indicating its potential value for application in
canine keratinocyte research requiring rapid and quantitative measurement.
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In order to further validate the use of this proliferation assay on canine keratinocytes
and to verify that the culture conditions for keratinocytes were optimal, the assay was
used to compare the proliferative activity of canine keratinocytes cultured with
various combinations of growth factors (section 5.3). The results showed that canine
keratinocytes had a higher proliferation rate in medium containing both cholera toxin
(CT) and EGF, as was shown by Wilkinson et al. (1987) using manual counting with
a haemocytometer. Both CT and EGF act directly to increase the growth and life
span of cultured keratinocytes (Wilkinson et al. 1987). CT is an 84 kDa protein
composed of two subunits, A and B (Okada et al. 1982), and it stimulates the growth
of keratinocytes via increasing intracellualr cyclic adenosine 5'-monophosphate
(cAMP) (Green 1978; Okada et al. 1982). The effect of CT on keratinocyte
proliferation was shown to be biphasic, with a stimulatory effect at low cell densities
and inhibitory effects after the culture reached confluence (Okada et al. 1982). In
contrast, EGF increased keratinocyte proliferation especially at high cell densities,
and it also facilitated successful cell cultivation as well as colony formation
(Rheinwald & Green 1977). It has been proposed that EGFs induce keratinocyte
proliferation primarily by enhancing cell migration to enlarge colonies (Barrandon &
Green 1987). By adding CT and EGF to culture medium, they enhance colony
formation and cell growth at both low and high cell densities.
5.6.2 Effects of extracts from M. pachydermatis on keratinocyte proliferation
The main purpose of this study was to determine if extracts and culture supernatants
from Malassezia pachydermatis could directly induce proliferation of canine
keratinocytes. This was suggested by a preliminary study using live organisms (von
Tscharner et al. 1999). The proteins and proteases extracted from M. pachydermatis
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or secreted by the organisms might have a direct influence on the proliferation of
keratinocytes via their binding to receptors on the surface of keratinocytes triggering
a cascade of proliferative signals. They might also promote the production of
stimulatory factors for keratinocyte proliferation such as EGF, FGF, IGF-1, IL-1, IL-
6 and GM-CSF, which could form an autocrine and paracrine regulatory network
resulting in activation of the secretory keratinocyte and its neighboring cells. The
findings of this study, however, showed that Malassezia extracts did not affect
keratinocyte proliferation, either with extracts produced with or without protease
inhibitors. These results suggest that products from M. pachydermatis do not directly
lead to the epidermal hyperplasia seen in Malassezia dermatitis.
Similarly, the proliferation of keratinocytes was not affected by co-culturing
keratinocytes with culture supernatants from Malassezia pachydermatis. The protein
profile shown in Figure 2.6 indicates that proteins with molecular weights between
66 and 45 kDa were generated in the liquid medium or released from Malassezia
organisms during culture. It is unclear what these products are without further
purification and analysis. However, protease activity has been demonstrated in yeast-
free supernatants when M. pachydermatis was cultured in liquid medium (Mathieson
et al. 1998). It is likely, therefore, that the culture supernatants used in this study
contained proteases as well. Enzyme secretion is one of the virulence factors
possessed by many microorganisms. Protease is an important virulence factor of
candidiasis in humans (Macdonald & Odds 1983; Cassone et al. 1987), and a
keratinolytic protease of Candida albicans has been shown to digest human stratum
corneum in vitro (Negi et al. 1984). Enzymes produced by Malassezia organisms are
generally considered to be potential pathogenic factors. Coutinho and Paula (2000)
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demonstrated that all the strains of Malassezia pachydermatis isolated from dogs
with otitis and dermatitis showed protease activity. Protease released by M.
pachydermatis was proposed to be the mediator of itch at free nerve endings in the
skin and contribute to the prominent pruritus seen in affected dogs (Mason & Evans
1991). However, little work has been done looking at the role of proteases in the
pathogenesis of histopathological changes associated with Malassezia dermatitis.
They might promote mitosis of keratinocytes as with the stimulation of keratinocytes
by neutrophil proteases (Rogalski et al. 2002). However, in this study, there was no
difference in the growth rate of keratinocytes cultured with Malassezia extracts
produced either with or without protease inhibitors, or keratinocytes cultured with
supernatants from M. pachydermatis compared to sterile medium. These results
indicate that proteases or other proteins secreted by the organism do not cause
changes in keratinocyte proliferation in vitro. Taken together, the results of this
chapter suggest that neither of the mechanisms mentioned above happened in vitro.
However, further studies are required to determine if extracts and culture
supernatants from M. pachydermatis could alter cytokine expression in cultured
canine keratinocytes. If M. pachydermatis can induce keratinocyte proliferation
directly, it is likely that cell to cell interaction is required between the whole
organism and the keratinocyte. This hypothesis is tested in the next chapter.
This study was performed using healthy dog skin. It is important to consider the
possibility that there may a difference in proliferation rate in response to M.
pachydermatis between normal and Malassezia-infected skin. Higher thymidine
incorporation has been demonstrated in basal cells of Candida-infected skin
compared to normal skin of guinea pigs (Sohnle & Kirkpatrick 1978). Whether this
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is the case in dogs with Malassezia dermatitis remains to be investigated. It is also
possible that skin from dogs with atopic dermatitis might exhibit different
proliferative responses to those of normal dogs, although this awaits further study.
In summary, the results of this chapter have shown that Malassezia extracts, either
with or without protease inhibitors, do not cause proliferation of normal canine
keratinocytes in vitro. Likewise, culture supernatants from Malassezia pachydermatis
had no effect on the growth rate of keratinocytes. It seems likely, therefore, that the








The studies described in chapter 5 indicated that extracts or culture supernatants from
Malassezia pachydermatis had no stimulatory effect on the proliferation of canine
keratinocytes, regardless of whether or not they were prepared with protease
inhibitors. In this chapter, the influence of the interaction between viable Malassezia
organisms and canine keratinocytes was investigated.
It is possible that direct contact between an organism and keratinocytes could be
required to stimulate a proliferative response. This response would initially depend
on adherence of the organism to the cell surface, followed by activation of signal
transduction mechanisms and culminating in modulation of the cell cycle or up-
regulation of growth factor secretion. Adherence is generally considered to play an
important role in the colonisation and infection ofmany microorganisms. The initial
stage in skin infections likely involves interaction between the organism and
keratinocytes, and the adhesion molecules that mediate this process have been widely
investigated in pathogenic bacteria and fungi. Multiple surface proteins of
Staphylococcus aureus have been reported to play a role in adhesion to human
keratinocytes in vitro, including staphylococcal protein A, clumping factor, coagulase,
and fibronectin-binding proteins A and B (Mempel et al. 1998). A specific surface-
exposed protein, M protein, has been found to be an adhesin of Streptococcus
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pyogenes that allows adherence to keratinocytes (Okada et al. 1994). A surface
protein of keratinocytes, membrane cofactor protein (MCP or CD46), has been
demonstrated to bind to a region ofM protein, known as the C repeat domain, and
thus serve as the receptor for adherence of S. pyogenes (Okada et al. 1995; Perez-
Casal et al. 1995). Wang et al. (1997) studied the response of keratinocytes to
adherent and non-adherent S. pyogenes and revealed distinct patterns of keratinocyte
reaction induced by the two different strains. These included cytokine gene
expression, prostaglandin production and membrane damage, suggesting that adhesin
expression of S. pyogenes and its interaction with keratinocytes modulated
keratinocyte responses during skin infection. In dogs, the adhesion molecules that
mediate the adherence of Staphylococcus intermedins to canine keratinocytes and
their interactions have not been documented (McEwan 2000; Saijonmaa-Koulumies
& Lloyd 2002; Forsythe et al. 2002).
The interaction between adhesins of Candida albicans and host cell ligands has been
the subject of numerous studies due to the importance of this yeast as a pathogen in
humans. The adhesins and ligands involved in the adherence of C. albicans to
epithelial cells include lectin-like mannoprotein, mannan factor 6 and chitin
possessed by the yeast, and glucoside ligands with terminal fucosyl or N-
acetylglucosamine residues present on the host cell surface (reviewed by Kennedy
1988; Calderone et al. 1994; Fukazawa & Kagaya 1997). In contrast, the adherence
of Malassezia spp. has not been studied extensively. It was found that Malasezia
furfur adhered to human stratum corneum cells in vitro in a dose, time and
temperature-dependent manner, and the adherence to cells from different anatomical
sites did not differ significantly (Faergemann et al. 1983). One study looking at the
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effect ofMalasezia furfur on an adhesion molecule of human keratinocytes reported
that there was no difference in the expression of mRNA for intercellular adhesion
molecule 1 (ICAM 1) between control and Malasezia furfur-treated keratinocyte cell
lines, thus suggesting that Malasezia furfur did not modulate ICAM 1 expression
(Baroni et al. 2001a). In accordance with the study on Malasezia furfur, Malassezia
pachydermatis was found to adhere to canine corneocytes in vitro in a dose and time-
dependent manner (Bond & Lloyd 1996b). Furthermore, trypsin-sensitive proteins or
glycoproteins on the yeast cell wall and on the corneocyte surface were shown to be
important in the adherence of M. pachydermatis in vitro (Bond & Lloyd 1996b).
Carbohydrate adhesins and/or ligands were also involved in adherence of M.
pachydermatis in vitro, however, apparent variability has been shown between strains
(Bond & Lloyd 1998). More recently, the adherence of M. pachydermatis to
cornified epithelial cells from canine ear canals was suggested to be mediated by
lipid (Masuda et al. 2001). It seems likely, therefore, that the candidate adhesins and
ligands for M. pachydermatis include proteins, carbohydrates and lipids. However,
the precise identities of these molecules are not yet known. The interaction between
adhesins ofM. pachydermatis and ligands on the keratinocyte surface could trigger
intracellular signal transduction and thus modulate the functions of keratinocytes,
such as proliferation. Very little research in this respect has been reported.
The main aim in this chapter was to further investigate the role of Malassezia
pachydermatis in canine keratinocyte proliferation by evaluating the growth of
keratinocytes co-cultured with live Malassezia organisms by cell counting and
immunohistochemistry using antibodies against proliferation markers. The effect of
Malassezia organisms on the viability of canine keratinocytes was also investigated
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using reagents to detect apoptotic cells in keratinocyte monolayers co-cultured with
M. pachydermatis. The first part of this chapter describes the validation of cell
counting methods and keratinocyte quantification. The immunohistochemistry
staining is reported in the second part.
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EFFECTS OF MALASSEZIA PACHYDERMATIS ON THE PROLIFERATION
OF CANINE KERATINOCYTES
6.2 Evaluation of the Celltiter 96® colourimetric assay to enumerate
canine keratinocytes co-cultured with M. pachydermatis organisms
6.2.1 Assessment of reactivity between assay reagent and Malassezia organisms
Aims
In chapter 5, the Celltiter 96® colourimetric cell proliferation assay was used to
determine keratinocyte numbers when cultured with extracts and culture supernatants
from Malassezia pachydermatis. The initial aim of this part of the study was to test
the feasibility of using this assay to count keratinocytes co-cultured with live
Malassezia organisms, and to test whether or not the yeast cells reacted with the
assay reagent and generated a signal.
Methods
Keratinocytes grown in tissue culture flasks were harvested by trypsinisation (section
2.19), washed, and counted in a haemocytometer (section 2.17). They were then
plated into a 96-well plate (100 pl/well, 2 x 104 cells/cm2) and cultured in complete
medium at 37°C in a humidified atmosphere with 5 % C02 in air. Some cells were
also plated in flasks to be used for generating a standard curve in the cell
proliferation assay. After 24 hours, the medium in the plate was replaced with
complete WME without Penicillin, Streptomycin, and Fungizone (PSF). On day 3,
the medium was changed again to remove any trace of PSF and the plate was
incubated at 37°C while preparing the Malassezia suspension.
A strain of Malassezia pachydermatis originating from the ear canal of a dog with
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Malassezia otitis was cultured on Sabouraud Dextrose agar for 48 hours at 37°C
before harvesting (section 2.4). Malassezia colonies were carefully harvested and
suspended in PBS for a washing procedure that consisted of three cycles of
centrifugation at 500 g for 5 minutes followed by removal of the supernatant and
resuspension in PBS. After the last washing cycle, the cells were resuspended in
complete WME without PSF, counted in a haemocytometer, and adjusted to a
concentration of 107 yeast cells/ml. The suspension was then serially diluted ten-fold
(107-103) and 100 pi of each dilution was added in quadruplicate into both empty
wells and wells containing 100 pi of medium and growing canine keratinocytes,
resulting in a density of 106-102 yeast cells per well. Another 100 pi of complete
WME without PSF was added into wells with yeast cells alone, so that all wells
contained 200 pi of medium. Wells with keratinocytes alone or 200 pi of medium
served as controls. The plate was incubated at 37°C with 5 % C02 in air for a further
24 hours, and the cell proliferation assay was performed in the same manner as
described in the previous chapter. Briefly, keratinocytes grown in flasks were
trypsinised, washed and counted in a haemocytometer for generating a standard
curve. A volume of 200 pi of cell suspension (containing two fold dilutions from 1 x
105 to 3125 cells per well) was added in triplicate to empty wells. Wells used for
background controls were filled with 200 pi of medium alone. Forty microliters of
Celltiter 96® AQueous One Solution reagent (Promega, UK) was then added to all
used wells and the plate was incubated for a further 3 hours. The absorbance of the
reaction was evaluated using an ELISA reader at a wavelength of 490 nm and a
reference wavelength of 630 nm (section 2.25). The absorbance of wells containing
keratinocytes and various numbers of Malassezia organisms as well as yeast cells
alone was compared with the standard curve and the results were calculated as cells
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per well, all ofwhich were generated automatically by the ELISA reader. The signal
generated by Malassezia cells alone was expressed as the equivalent number of
keratinocytes that generated the same amount of colour change.
Results
The results of the different groups (keratinocytes alone, Malassezia organisms alone,
keratinocytes plus Malassezia organisms) are shown in Figure 6.1 A. Malassezia
organisms were shown to react with the assay reagent and generate detectable signals
in a dose response manner. Stronger signals were seen in the wells containing higher
numbers of yeast cells. This indicated that the signals detected in wells containing
both keratinocytes and Malassezia organisms were generated not only from the
keratinocytes but also the yeast cells, and this was especially so in keratinocytes
cultured with the highest density ofMalassezia. Therefore, the signals detected from
wells containing yeast cells alone were treated as background controls, and
subtracted from those obtained in wells containing both keratinocytes and
Malassezia organisms (Figure 6.1 B). After subtraction, the results showed that more
keratinocytes were present in the groups co-cultured with higher numbers of
Malassezia cells, suggesting that Malassezia organisms stimulated keratinocyte
proliferation. However, this was not in agreement with microscopic observation of
the monolayers. Fewer keratinocytes were observed at the bottom ofwells containing
higher numbers of Malassezia cells compared to control wells where keratinocytes
were cultured alone, and this was particularly apparent in those with 106 yeast cells
(Figure 6.2 A-B). A possible explanation for this discrepancy might be that there
were detached keratinocytes floating in the medium, the number of which was
difficult to determine by microscopic observation. These cells could be viable or
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dead, but could still possibly be detected by the assay reagent. In order to test
whether the reagent could detect dead cells, the proliferation assay was performed
with dead keratinocytes in the following experiment.
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Figure 6.1 A-B Use of the Celltiter 96® assay to quantify keratinocyte numbers
in co-culture experiments
A: Comparison of the results obtained from keratinocytes co-cultured with various
densities of Malassezia organisms (Black bars) to those from yeast cells alone
(White bars). Each bar represents the mean and standard error of the mean of
quadruplicates. The signals generated by Malassezia organisms were expressed as
the equivalent number of keratinocytes that generated the same amount of colour
change, and the results showed a dose response trend, indicating that M.
pachydermatis reacted with the assay reagent. Therefore, the yeast cells also
contributed to the colour changes detected in wells containing both keratinocytes
and Malassezia organisms.
B: Results obtained after subtracting the numbers generated by Malassezia
organisms alone from those by keratinocytes and yeast cells. More keratinocytes
were shown to be present in the groups with higher numbers of Malassezia
organisms. However, this was not in agreement with microscopic observation of the
monolayers (see text for details).
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Figure 6.2 A-B Comparison of the morphology of canine keratinocyte cultures
co-cultured with orwithout Malassezia pachydermatis organisms (xlOO)
A: Keratinocytes co-cultured with 106 Malassezia organisms. B: Keratinocytes
cultured alone. Apparent difference in the degree of confluence was observed
between the two cultures.
Scale bars = 100 pm.
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6.2.2 Confirmation of reagent specificity for viable cells
Aims
Discrepancies were found between the results obtained using the cell proliferation
assay and those observed by microscopic examination as mentioned in the previous
section. The aim of this experiment was to test the hypothesis that the assay reagent
detected dead keratinocytes in the medium which caused the inconsistency. In order
to assess whether or not the reagent reacted with dead cells, the assay was carried out
using keratinocytes that had been killed by subjecting them to a freeze/thaw cycle.
Methods
Keratinocytes cultured in flasks were harvested, counted in a haemocytometer and
plated into a 96-well plate at a density of 2 x 104 cells/cm2 (100 pl/well) in complete
medium. Non-adherent cells were removed the next day and the wells were filled
with 100 pi of complete WME without PSF. After a further one day incubation, the
medium was changed again and the plate was frozen at -80°C for an hour followed
by thawing at 37°C. The Malassezia suspension was prepared as described in the
previous section and 106-102 yeast cells per well were added in quadruplicate to
empty wells and wells containing keratinocytes. Control wells contained
keratinocytes alone or 200 pi of medium. The plate was incubated at 37°C with 5 %
C02 in air for a further 24 hours and the cell proliferation assay was performed as
described earlier.
Results
The results obtained from the groups with or without keratinocytes are shown in
Figure 6.3 A. There was a clear difference in cell numbers in the groups containing
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keratinocytes and Malassezia organisms when compared to those in Figure 6.1 A. In
this experiment, the cell numbers detected in wells with or without keratinocytes
were very similar at every density of Malassezia organisms used, and after the
numbers obtained from Malassezia cells alone were subtracted from those generated
in wells with both keratinocytes and yeast cells, the figures were close to zero
(Figure 6.3 B). These results suggested that the signals detected in wells containing
keratinocytes and Malassezia organisms were generated predominantly from the
yeast cells, but not from the keratinocytes that had been killed by a cycle of freezing
and thawing, indicating that the assay reagent did not react with dead cells. This
could not, therefore, be used to explain the discordant results in section 6.2.1.
Although it was likely that there were some viable cells in the medium which were
detected by the reagent, the number of these cells was unlikely to be high enough to
generate signals of the magnitude that were detected in Figure 6.1, since unattached
keratinocytes are unable to proliferate (Gniadecki 1998). Due to the difficulties in
explaining the discrepancy between the results obtained using the cell proliferation
assay and the observations of cell numbers by microscopy, this assay method was
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Figure 6.3 A-B Assessment of the reactivity of Celltiter 96® assay reagent with
keratinocytes subjected to a cycle of freezing and thawing
A: Comparison of the results obtained from dead keratinocytes cultured with
various densities ofMalassezia organisms to those from yeast cells alone. Each bar
represents the mean and standard error of the mean of quadruplicates. The numbers
shown by dead keratinocytes were very similar to those by Malassezia organisms
alone, regardless of the density of yeast cells they were co-cultured with, suggesting
that the assay reagent did not react with dead keratinocytes and the colour changes
were predominantly generated by Malassezia organisms. Black bars: keratinocytes
cultured with Malassezia organisms, Open bars: Malassezia organisms alone.
B: Subtraction of the numbers generated by Malassezia organisms alone from those
by dead keratinocytes and yeast cells. The results further confirmed the similarity
of cell numbers detected in the two groups at any density ofM. pachydermatis.
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6.3 Investigation into the effect of Malassezia pachydermatis on cultured
canine keratinocytes using manual counting
Aims
Due to suspected technical problems when using the Celltiter 96® proliferation assay
to quantify keratinocytes in co-culture experiments, an alternative method of
quantification was evaluated. This involved direct manual cell counting using a
haemocytometer. Although this technique would be more laborious, it would allow
counting of the keratinocyte population in both the monolayer and the medium. It
would also allow easy discrimination between keratinocytes and yeast cells.
Methods
Keratinocytes harvested from tissue culture flasks were washed, resuspended in
complete WME and counted in a haemocytometer. In order to obtain greater numbers
of cells to facilitate manual counting, 12-well tissue culture plates (in which the area
of each well was much larger than that of a 96-well plate) were used in this
experiment. Cells were plated into three 12-well plates at a density of 1.5 x 104
cells/cm2 (1 ml/well) and incubated at 37°C with 5 % C02 in air. After 24 hours, the
medium was replaced with complete WME without PSF. On day 3, the medium was
changed again to ensure no PSF remained and the keratinocytes were co-cultured
with Malassezia organisms suspended in complete WME without PSF at similar
densities to the experiments performed in 96-well plates. Due to the limited number
of wells in a 12-well plate, four densities of Malassezia organisms were used: 107,
105, 103, and 102per well (1 ml/well), each ofwhich were added in duplicate in every
plate. Keratinocytes cultured in 2 ml of complete WME without PSF and yeast cells
acted as controls. Over the following three days, the morphology of the culture was
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observed and photographed, and manual counting with a haemocytometer was
performed with one plate on each day. Before trypsinising the cells attached to the
plate, the medium in each well was collected and the cells in the medium were also
counted. The cell viability was assessed by trypan blue exclusion (section 2.17). This
experiment was repeated three times to confirm the reproducibility of results. The
cells used in three repeated experiments were obtained from two different dogs and
were at their second, third and fourth passage when the experiments were conducted.
In order to investigate the significance of the relationships between the number of
keratinocytes per well and both the density ofMalassezia organisms and the duration
ofMalassezia-keratinocyte co-cultures, standard generalised linear models were used
on the data obtained from the monolayers and the media. The numbers of
keratinocytes were log transformed to normalise the data, and the software Splus
2000 (Insightful Corporation, Seattle, USA) was used to performed the analyses. The
potential effect of three repeated experiments was also taken into account by putting
replicates in the model as a factor at the beginning of the analyses. Two factors,
logarithm of Malassezia densities and day of co-culture, were then added into the
model sequentially. The suitability of the model was checked by considering the
error structures which were found to be normal. In all cases, a P value < 0.05 was
taken to indicate significance.
Results
The results obtained from three experiments were very similar and are shown in
Figures 6.4.1-6.4.3. Figures 6.4.1 A, 6.4.2 A and 6.4.3 A show the number of viable
keratinocytes in the monolayer after co-culture with or without 102, 103, 105, and 107
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Malassezia organisms for one, two and three days respectively. There was a
significant difference in log cells/well between the three repeated experiments (F2
87=191.13, PO.OOOl), which might be due to the different sources and passages of
the cells used. Despite this, there was a significant decrease in log cells/well as the
density of Malassezia organisms increased (F, 86=74.32, P <0.0001). The tendency
for fewer keratinocytes to be present in the monolayers co-cultured with higher
numbers of Malassezia organisms was in accordance with the microscopic
observations in the experiment using the cell proliferation assay (section 6.2.1).
Furthermore, as the co-culture was lengthened, there was a significant increase in the
total of log cells/well in the monolayer (Ft 85=38.62, P <0.0001). However, the
increase in cell numbers was mainly contributed by control keratinocytes and those
co-cultured with low numbers of Malassezia organisms. The cell counts obtained
from the keratinocyte monolayers in three experiments during the three-day co-
culture are summarised in Figure 6.4.4. Rapid increases in keratinocyte numbers
were seen on the last day of co-culture in control keratinocytes and those co-cultured
with low numbers ofMalassezia organisms (Black bars). By contrast, cells cultured
with 10s or 107 Malassezia organisms showed minimal growth, and the latter
exhibited the lowest cell counts during the three-day co-culture. In contrast to the
trend towards confluence and dense cell populations shown by control keratinocytes,
no apparent increase in cell density was observed microscopically in keratinocytes
co-cultured with 101 Malassezia cells (Figure 6.5 A-F). These cells also showed
abnormal morphology on the last day of co-culture (Figure 6.5 E).
Figures 6.4.1 B, 6.4.2 B and 6.4.3 B show the number of dead (red lines) and viable
keratinocytes (blue lines) in the medium after co-culture with or without 102, 103, 10s,
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and 107 Malassezia organisms for one, two and three days respectively. There were
also significant differences in the data of dead cells (F2 87=5.32, P = 0.0066) and
viable cells (F2 87=9.77, P = 0.0002) in the medium between three repeated
experiments, which might be due to the same reason described above. In contrast to
the results shown by adherent keratinocytes, the cell counts in the medium revealed
an opposite effect of co-culture with Malassezia organisms. There was a significant
increase in log cells/well of dead cells in the medium with increasing number of
Malassezia organisms (F, 86=145.29, P <0.0001). However, there was no significant
change in viable cells in the medium as the number of Malassezia organisms was
increased (F, 86=2.72, P = 0.1031). Nevertheless, the number of both dead and viable
cells in the medium increased significantly the longer the co-cultures were
maintained (F, 85=60.51, P <0.0001; Fj 85=5.66, P = 0.0196).
In summary, keratinocytes cultured with higher numbers of Malassezia organisms
exhibited a significantly lower proliferation rate. In contrast, the number of dead
cells in the medium rose significantly as the density of Malassezia organisms
increased. Taken together, these results indicated that Malassezia organisms did not
stimulate proliferation of keratinocytes. However, they induced these cells to detach
from the monolayer and undergo cell death.
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Figure 6.4.1 A-B Cell counts of keratinocytes co-cultured with Malassezia
pachydermatis organisms for one day
A: The results obtained from three repeated experiments (1-3) showing the number of
viable keratinocytes in the monolayer after co-culture with or without 102, 103, 105, and
107 Malassezia organisms for one day. A prominent decrease in cell number was
detected when the keratinocyte monolayer was co-cultured with 107 Malassezia
organisms. B: The results obtained from three repeated experiments showing the
number of cells in the medium after co-culture with or without 102, 103, 105, and 107
Malassezia organisms for one day. In contrast to the monolayers, higher numbers of
dead cells tended to be present in the medium when keratinocytes were co-cultured
with higher numbers of Malassezia organisms (Red lines), whereas the number of
viable cells in the medium was not dramatically affected by co-culture (Blue lines).
Each data point represents the mean and standard error of the mean of duplicates.
5000-
2500-




















10' 102 103 10" 105 106 107 10e
Malassezia organ isms/well
•K.
101 102 103 104 105 106 107 10s
Malassezia organisms/well
10' 102 103 104 105 106 107 10s
Malassezia organisms/well
B 30000














10' 102 103 104 105 106 107 108
Malassezia organisms/well
Figure 6.4.2 A-B Cell counts of keratinocytes co-cultured with Malassezia
pachydermatis organisms for two days
A: The results obtained from three repeated experiments (1-3) showing the number of
viable keratinocytes in the monolayer after co-culture with or without 102, 103, 105, and
107 Malassezia organisms for two days. Keratinocytes cultured with higher numbers of
Malassezia organisms tended to have lower numbers of cells in the monolayer. B: The
results obtained from three repeated experiments showing the number of cells in the
medium after co-culture with or without 102, 103, 105, and 107 Malassezia organisms
for two days. The number of dead cells in the medium rose as the number of
Malassezia organisms increased (Red lines). Also, the number of viable cells in the
medium remained relatively consistent (Blue lines), compared to that of dead cells.
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Figure 6.4.3 A-B Cell counts of keratinocytes co-cultured with Malassezia
pachydermatis organisms for three days
A: The results obtained from three repeated experiments (1-3) showing the number of
viable keratinocytes in the monolayer after co-culture with or without 102, 103, 105,
and 107 Malassezia organisms for three days. A decrease in cell numbers was detected
in the groups co-cultured with higher numbers ofMalassezia organisms compared to
the control. B: The results obtained from three repeated experiments showing the
number of cells in the medium after co-culture with or without 102, 103, 105, and 107
Malassezia organisms for three days. As in Figures 6.4.1 B and 6.4.2 B, higher
numbers of dead cells were present in the medium as the number of Malassezia
organisms increased, whilst the number of viable cells was relatively unaffected,
irrespective of the density of yeast cells. Each data point represents the mean and








Figure 6.4.4 Comparison of the proliferation rate of keratinocytes co-cultured
with Malassezia pachydermatis
Combined data from three repeated experiments shown in Figure 6.4.1 A, 6.4.2 A,
and 6.4.3 A. Rapid growth was seen in keratinocytes cultured without Malassezia
organisms and those co-cultured with low numbers of yeast cells on the last day of
co-culture. In contrast, keratinocytes co-cultured with high numbers ofMalassezia
organisms only exhibited limited growth during three-day co-culture. Each bar
represents the mean and standard error of the mean of six replicates. Shaded bars:
day 1 of co-culture, Open bars: day 2, Black bars: day 3.
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Figure 6.5 A-F Morphology of canine keratinocyte cultures co-cultured with or without
Malassezia pachydermatis organisms (xlOO)
A, C, and E: Keratinocytes co-cultured with 107 Malassezia organisms for one, two and three
days, respectively. No apparent increase in cell density was observed during three-day co-
culture. The keratinocyte culture showed abnormal morphology in E.
B, D, and F: Keratinocytes cultured without Malassezia organisms served as controls for A, C,
and E, respectively. Nearly confluent culture is shown in D, and the culture in F exhibited
even denser cell populations with some cells being smaller than others.
Scale bars =100 pm.
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IMMUNOHISTOCHEMISTRY STAINING OF CANINE KERATINOCYTES
CO-CULTUREDWITH MALASSEZIA PACHYDERMATIS
6.4 Detection of proliferation markers in canine keratinocyte cultures co-
cultured with Malassezia pachydermatis
Aims
No stimulatory effect of Malassezia organisms on the proliferation of canine
keratinocytes was demonstrated in the previous section within three days of co-
culture. The aim of the experiments in this section was to assess the proliferation rate
of keratinocytes co-cultured with Malassezia organisms within 24 hours of co-
culture, using immunohistochemistry techniques with antibodies against two
proliferation markers, PCNA and Ki-67.
Methods
Keratinocytes were washed, resuspended in complete WME and counted in a
haemocytometer. They were then plated into 8-well chamber slides at 2 x 104 viable
cells/cm2 (1.4 x 104 cells/well), and incubated at 37°C with 5 % C02 in air. After 24
hours, the medium was replaced with complete WME without PSF and the slides
were incubated for a further three days to allow monolayer formation. On day 5, the
medium was changed again and the monolayers were co-cultured with Malassezia
organisms at similar densities to the experiments in the former sections. A volume of
100 pi of Malassezia suspension prepared as described in section 6.2.1 and
containing ten fold dilutions from 2x 106 to 2 x 102 yeast cells per well was added to
wells containing growing keratinocytes and 300 pi of medium. Keratinocytes
cultured in 400 pi of medium without Malassezia organisms served as the controls.
At 4, 12, 16 and 24 hours post-co-culture, the cells were fixed with 4 %
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paraformaldehyde as described in section 2.21 and the slides were stored at 4°C in 70
% alcohol until used. The immunohistochemistry staining of PCNA and Ki-67 was
carried out following the procedures described in section 2.28.1 and 2.28.2,
respectively. The proliferation rate was determined by counting the number of
positively stained cells out of 100 in each chamber (section 2.29) and the positive
cells were subjectively graded into two groups depending on the strength of staining.
6.4.1 Proliferating cell nuclear antigen detection
Results
Figure 6.6 A shows an example of PCNA labeled canine keratinocytes after the
monolayer was co-cultured with 2 x 103 Malassezia organisms for 16 hours.
Positively stained cells showed brown staining nuclei whereas negative cells
appeared blue, the colour of the counterstain. All cells stained blue in the negative
control slide (Figure 6.6 B). Between 80-90 % of the keratinocytes counted stained
positively for PCNA, regardless of the density of Malassezia organisms used and at
all time points (Figure 6.7 A-D). Furthermore, the number of strongly and weakly
labeled positive cells did not differ between groups. The results indicated that
Malassezia organisms did not affect PCNA expression in canine keratinocytes within
24 hours of co-culture.
6.4.2 Ki-67 antigen detection
Results
The Ki-67 staining of canine keratinocytes is shown in Figure 6.8. Positively labeled
cells stained brown in comparison to unstained cells exhibiting blue staining (Figure
6.8 A) and cells in the negative control slide (Figure 6.8 B). Keratinocytes stained
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with anti-Ki-67 Ab revealed similar results to those of PCNA staining. Of the 100
keratinocytes counted, approximately 80-90 % of the cells were positively stained in
the monolayers co-cultured with or without various densities of Malassezia
organisms at 4, 12, 16 and 24 hours post-co-culture (Figure 6.9 A-D). However,
keratinocytes cultured with 2x 106 Malassezia organisms showed a slightly lower
proliferation rate after 12 hours. Also, fewer strongly labeled cells tended to be
present in these keratinocytes compared to the other groups, which might explain the
low numbers of keratinocytes detected in the monolayers co-cultured with the
highest density of Malassezia organisms in section 6.3. These results indicated that
Malassezia organisms did not affect Ki-67 expression in canine keratinocytes within
24 hours of co-culture, and further confirmed that Malassezia organisms did not
stimulate proliferation of canine keratinocytes.
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Figure 6.6 A-B PCNA staining in canine keratinocytes co-cultured with
Malassezia pachydermatis organisms (x400)
A: PCNA staining in a keratinocyte monolayer co-cultured with 2 x 103 Malassezia
organisms for 16 hours. Keratinocytes reacting positively with anti-PCNA Ab
showed brown staining. Negatively stained cells appeared blue, the colour of the
counterstain. B: Keratinocytes stained with Ab negative control. All cells were
negatively stained.
Scale bars =10 pm.
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Figure 6.7 A-D PCNA-positive canine keratinocytes co-cultured with
Malasseziapachydermatis organisms
A: PCNA-positive keratinocytes detected at 4 hours post-co-culture. B: 12 hours;
C: 16 hours; D: 24 hours. Approximately 80-90 % of the cells counted were
positively stained with PCNA in keratinocyte monolayers co-cultured with or
without Malassezia organisms, irrespective of the density of yeast cells used. The
number of strongly and weakly labeled cells was similar, indicating that
Malassezia pachydermatis had no effect on PCNA expression in canine






















Figure 6.8 A-B Ki-67 staining in canine keratinocytes co-cultured with
Malassezia pachydermatis organisms (x400)
A: Ki-67 staining in a keratinocyte monolayer co-cultured with 2 x 103 Malassezia
organisms for 16 hours. Keratinocytes reacting positively with anti-Ki-67 Ab
showed brown staining. B: Keratinocytes stained with Ab negative control. All cells
appeared unstained.
Scale bars = 10 pm.
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Figure 6.9 A-D Ki-67 positive canine keratinocytes co-cultured with
Malasseziapachydermatis organisms
A: Ki-67 positive keratinocytes detected at 4 hours post-co-culture. B: 12 hours; C:
16 hours; D: 24 hours. Approximately 80-90 % of the cells counted were
positively stained with Ki-67 in keratinocyte monolayers co-cultured with or
without Malassezia organisms, irrespective of the density of yeast cells used. The
results indicated that Malassezia pachydermatis did not affect Ki-67 expression in
canine keratinocytes within 24 hours of co-culture. The keratinocyte monolayers
co-cultured with 2 x 106 Malassezia organisms tended to have fewer strongly
labeled cells. Black bars: strongly labeled cells; Open bars: weakly labeled cells.
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6.5 Detection of cell death in canine keratinocytes co-cultured with
Malassezia pachydermatis
Aims
In section 6.3, keratinocyte monolayers co-cultured with high numbers ofMalassezia
organisms were shown to have high numbers of dead cells in the medium. In order to
investigate the possibility that Malassezia organisms caused cell death, an apoptosis
detection kit was used to label keratinocytes co-cultured with Malassezia organisms
in this experiment.
Methods
Cultivation of keratinocytes on chamber slides and Malassezia co-culture were
carried out as described in section 6.4. Six chamber slides containing keratinocyte
cultures were prepared and the keratinocyte monolayers were co-cultured with five
different densities ofMalassezia organisms (2x 106 to 2 x 102 yeast cells per well).
Keratinocytes cultured without Malassezia organisms acted as controls. At 4, 12, 16,
24, 48 and 72 hours post-co-culture, the slides were fixed with 4 %
paraformaldehyde, and stored at 4°C in 70 % alcohol until used. The apoptosis
detection was performed using DermaTacs™, an in situ apoptosis detection kit for
skin cells and tissues (R&D Systems Europe, Oxon, UK), and the manufacturer's
instructions were followed (see section 2.28.3 for details). The whole area of a well
on the chamber slide was scanned for apoptotic cells following the criteria described
in section 2.29.
Results
Figure 6.10 A-C shows a representative apoptotic cell identified using the apoptosis
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detection kit as well as the positive and negative controls. The positively stained cell
in Figure 6.10 A shows blue staining in the nucleus, indicating that it contained
fragmented nuclear chromatin characteristic of apoptosis, detected by the labelling
process mediated by TdT enzyme. The positive control slide was treated with
nuclease and all cells showed blue nuclear staining (Figure 6.10 B). No blue stained
cells were present in the negative control slide which was generated by omitting TdT
enzyme in the staining procedure (Figure 6.10 C).
The results obtained at 4, 12, 16, 24, 48 and 72 hours post-co-culture are shown in
Figure 6.11 A-F. More apoptotic cells were present in keratinocyte monolayers co-
cultured with 2x 105 or 2 x 106 Malassezia organisms as compared with the control
or cells co-cultured with lower densities ofMalassezia within 24 hours of co-culture.
The number of apoptotic cells in monolayers co-cultured with 2x 102 to 2 x 104
Malassezia organisms also gradually increased during this period of time. At 48
hours post-co-culture, the monolayer co-cultured with 2 x 103 Malassezia organisms
had the highest number of apoptotic cells, and the number of these cells continued to
increase between 48 and 72 hours post-co-culture. In contrast, lower numbers of
apoptotic cells were detected in keratinocytes co-cultured with 2x 105 or 2 x 106
Malassezia organisms at 48 and 72 hours post-co-culture. However, far fewer cells
were observed to be attached to the slides in these two groups, which might explain
the low numbers of apoptotic cells detected. The results of this experiment suggested
that Malassezia organisms appeared to induce canine keratinocytes to undergo cell
death.
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Figure 6.10 A-C Apoptosis detection in canine keratinocytes co-cultured with
Malassezia pachydermatis organisms
A: An apoptotic cell (x400). The cell showed blue nuclear staining and pink
cytoplasm. B: Positive control (x250). All cells exhibited blue stain in their nuclei
due to the use of nuclease. C: Negative control (x250). No blue staining was present
and all cells stained pink, the colour of the counterstain.
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Figure 6.11 A-F Induction of cell death in canine keratinocytes by Malassezia
pachydermatis
A: The number of apoptotic cells detected at 4 hours post-co-culture. B: 12 hours; C:
16 hours; D: 24 hours; E: 48 hours; F: 72 hours. More apoptotic cells were present in
the keratinocyte monolayers co-cultured with 2 x 105 or 2 x 106 Malassezia organisms
within 24 hours of co-culture. At 48 and 72 hours post-co-culture, the highest number
was detected in the groups co-cultured with 2 x 103 Malassezia organisms, whereas the
monolayers co-cultured with 2 x 105 or 2 x 106 yeast cells exhibited lower numbers of
apoptotic cells, which might be due to the considerably fewer keratinocytes attached to
the slides compared to the other groups. The increasing numbers of apoptotic cells
detected in keratinocyte monolayers during three-day co-culture with Malassezia
organisms indicated that M. pachydermatis appeared to induce death of canine
keratinocytes.
6.6 Discussion
6.6.1 Assessment of a cell proliferation assay for use with canine keratinocytes
co-cultured with Malassezia pachydermatis
The initial aim of this part of the study was to assess the feasibility of using a
colourimetric cell proliferation assay, described in the previous chapter, to evaluate
the proliferation of cultured canine keratinocytes co-cultured with Malassezia
pachydermatis organisms. The results shown in section 6.2.1 demonstrated that
Malassezia organisms reacted with the assay reagent and generated detectable signals,
especially with high numbers of yeast cells. Although the signals generated by
Malassezia organisms alone were treated as background and subtracted from the
wells containing growing keratinocytes and Malassezia organisms, the results were
not in accordance with microscopic observation. It appeared that the assay
overestimated the number of keratinocytes that were actually present in the wells and
this was particularly apparent in the groups co-cultured with high numbers of
Malassezia organisms. The specific reason for this discrepancy was not known. One
explanation could be that Malassezia organisms provoke changes in cell components
that are not reflected by changes in cell number. As was mentioned in section 5.7.1,
this colourimetric assay is based on the bioreduction of a tetrazolium salt to a
coloured formazan. The process is mediated by a variety of intracellular
dehydrogenases and mitochondrial dehydrogenases such as succinic dehydrogenase
that is tightly bound to the mitochondrial inner membrane (reviewed in Marshall et al.
1995). Increased formazan production by cells has been observed in studies
investigating the effects of interferons and cytotoxicity of anti-tumour drugs, even
when the overall cell numbers decrease. The investigators concluded that this was
attributed to enhanced mitochondrial activity in surviving cells (Jabbar et al. 1989;
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Pagliacci et al. 1993). A similar reaction might happen in canine keratinocytes co-
cultured with high numbers of Malassezia pachydermatis organisms, possibly
indicating increased activity ofmitochondria in keratinocytes, but not an increase in
cell numbers. A second explanation is that changes in the pH of the medium might
be responsible for the discrepancy. The enzyme kinetics, redox potentials of
tetrazolium salts and absorption spectra of formazans within the assay process can all
be sensitive to pH changes and as a result, pH shifts could distort dose-response
curves observed in tetrazolium assays (Marshall et al. 1995). It is possible that the
pH value of the medium containing growing keratinocytes and Malassezia organisms
was different from that containing Malassezia organisms alone. Thus, the activities
of keratinocytes used to generate the standard curve might not represent those of the
cells co-cultured with Malassezia organisms, and the activities of Malassezia
organisms alone could not reflect those co-cultured with keratinocytes. Due to these
pitfalls of the assay system, this method was deemed to be unsuitable for use in the in
vitro Malassezia pachydermatis-canme keratinocyte co-culture system and was
therefore abandoned.
In order to eliminate the above problems, a direct cell counting technique was
developed. The advantages of this method include easy discrimination between
keratinocytes and yeast cells, individual quantification of keratinocytes in the
monolayer or the medium, and minimal interference with biochemical or
environmental factors due to its direct measurement of cell numbers. However, the
manual counting procedure is laborious and more likely to suffer from investigator
bias. Also, it is almost inevitable that some cells are lost during the trypsinisation
step required for attached cell cultures. This renders the direct cell counting
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technique prone to more technical errors than biochemical assays, such as the
colourimetric cell proliferation assay tested in section 6.2 which does not require a
trypsinisation step. Furthermore, the direct counting technique is less suitable for
processing large numbers of samples. It is possible that other microculture assays
might be suitable for the in vitro yeast-keratinocyte system. One example is a
colourimetric assay that is less sensitive to environmental fluctuations and based
upon a stoichiometric association between a protein binding dye, sulforhodamine B
(SRB), and the protein content of the cell, in contrast to the enzymatically driven
tetrazolium assays (Rubinstein et al. 1990; Skehan et al. 1990). In a SRB assay,
cultures are fixed with trichloroacetic acid (TCA) before staining with SRB dissolved
in 1 % acetic acid. The SRB then binds electrostatically to basic amino acid residues
of proteins in fixed cells under mildly acidic conditions. After unbound dye is
removed by washing with 1 % acetic acid, the protein-bound dye is extracted from
cells and solubilised for optical density measurement by a weak base such as 10 mM
Tris. The SRB assay offers several advantages over tetrazolium assays. By adding
TCA at elevated concentrations into a single cell suspension in which cells have been
allowed to settle down, it promotes cell attachment to the plastic substratum, which
can be useful for adherent cultures that shed floating cells or small aggregates into
the medium. The assay procedure is less sensitive to environmental fluctuations such
as pH change, and is independent of intermediary metabolism. Additionally, it
generates a stable colourimetric end point that does not have to be measured within
any fixed period of time (Skehan et al. 1990). However, careful validation would be
required before it could be applied to co-cultures of canine keratinocytes and
Malassezia organisms.
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6.6.2 The effect ofMalasseziapachydermatis on cultured canine keratinocytes
The experiments performed using viable Malassezia pachydermatis organisms in this
chapter followed on from those in the previous chapter using extracts and culture
supernatants. Similar to the findings presented in the previous chapter, the results in
section 6.3 showed that Malassezia organisms did not cause canine keratinocyte
proliferation. These results have two implications. They could indicate that M.
pachydermatis has no direct effect on keratinocyte proliferation either in vitro or in
vivo. If this is the case, the epidermal hyperplasia is likely to be due to the
inflammatory reaction stimulated by the organism itself or the underlying diseases.
Alternatively, M. pachydermatis has no direct effect in this in vitro system, but could
have a direct effect in a living epidermis with a blood supply and a functional
immune system. This possibility can be supported by the studies on Candida
albicans which have demonstrated increased epidermal proliferative responses to this
fungus in vivo using experimental animals (Sohnle & Kirkpatrick 1978; Sohnle &
Hahn 1989). Furthermore, the epidermal proliferation appeared to be enhanced by
the host's immunological reactions to experimental cutaneous candidiasis (Sohnle &
Kirkpatrick 1978; Wilson & Sohnle 1986).
The dose-dependent increase in dead keratinocytes in the culture medium indicated
that Malassezia pachydermatis had a cytotoxic effect on canine keratinocytes in vitro.
Various mechanisms might explain why keratinocytes detached from the culture
plates and shed into the medium. Malassezia organisms might affect the function of
transmembrane adhesion proteins of keratinocytes. The counting of cells in the
monolayers treated with high numbers ofMalassezia organisms (105 or 107) revealed
that the increase in cell numbers was minimal during a three day co-culture. Since
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adhesion to the substratum is required for keratinocyte growth and loss of attachment
would cause a rapid growth arrest (Gniadecki 1998), the increasing number of dead
cells in the medium could be explained by the scenario that the cells in the
monolayers treated with 105or 101Malassezia organisms were proliferating, but the
adherence of Malassezia organisms and their interactions with keratinocytes
damaged the ability of keratinocytes to adhere to the culture plate. However, the
identity of such an adhesion molecule is not known and awaits further study.
Secondly, the keratinocytes in the growing monolayers could simply undergo
necrosis and then shed into the medium. A necrotic effect of Malassezia furfur at
high ratios of yeast cells to human keratinocytes has been reported in a study
investigating the effect of Malassezia furfur on a human keratinocyte cell line
(Baroni et al. 2001a). Finally, Malassezia pachydermatis could be internalised by
canine keratinocytes and induce keratinocyte apoptosis leading to cell detachment.
Engulfment of Malassezia furfur has been shown with human keratinocytes (Baroni
et al. 2001a). Invasion of human keratinocytes by Staphylococcus aureus has also
been demonstrated to cause necrosis and apoptosis (Nuzzo et al. 2000; Mempel et al.
2002). Although keratinocyte apoptosis was not investigated in the study by Baroni
et al. (2001a), it is possible that invasion of canine keratinocytes by Malassezia
pachydermatis could cause keratinocytes to undergo apoptosis. In order to confirm
this possibility, further studies using May-Grumwald Giemsa stain or electron
microscopy (Baroni et al. 2001a; Baroni et al. 2001b) to demonstrate the
internalisation ofM. pachydermatis by canine keratinocytes are required.
The immunohistochemistry staining studies described in sections 6.4 and 6.5 were
designed as preliminary studies due to time constraints. The results of the staining for
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cellular proliferation markers, PCNA and Ki-67, showed that there was no prominent
difference in expression of PCNA and Ki-67 between canine keratinocytes co-
cultured with Malassezia pachydermatis and those cultured without, regardless of the
number of Malassezia organisms used. This was not in agreement with the only
previous report which demonstrated a significant increase in expression of Ki-67 in
canine keratinocytes co-cultured with M. pachydermatis in vitro compared to
keratinocytes cultured alone in vitro (von Tschamer et al. 1999), despite using the
same antibody. As the details of this study have not been reported in a peer-reviewed
publication, it is currently difficult to provide possible explanations for the
discrepancy.
In section 6.5, more apoptotic cells were observed in the keratinocyte monolayers co-
cultured with high numbers of Malassezia organisms compared to those cultured
without, and the number increased after prolonged incubation. Despite the decreased
number of positively stained keratinocytes observed in the groups co-cultured with
2x 105 or 2 x 106 Malassezia organisms at 48 and 72 hours post-co-culture, which
might be explained by the decline in the number of attached cells, the results
suggested that Malassezia pachydermatis could induce canine keratinocytes to
undergo cell death in vitro. The biological significance of this effect remains open to
question, since apoptosis is not a characteristic feature in histopathological sections
from the skin of dogs with Malassezia dermatitis. Nevertheless, these results
provided further evidence in support of the findings in section 6.3 that Malassezia
pachydermatis could cause death of keratinocytes. Another explanation for the
increase in the number of apoptotic cells in keratinocyte monolayers co-cultured with
Malassezia organisms during a 3 day co-culture could be that the nutrients in the
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medium were gradually depleted leading to cell deletion in the proliferating
populations. In order to assess this speculation, other non-pathogenic
microorganisms might be introduced into the in vitro system as controls.
In summary, the experiments in this chapter have demonstrated that Malassezia
pachydermatis does not accelerate the proliferation of canine keratinocytes in vitro.
However, the organisms appear to induce keratinocytes to detach from the monolayer
and to undergo cell death. Future studies would involve further investigation of the
role of M. pachydermatis in epidermal hyperplasia associated with Malassezia
dermatitis using living epidermis (skin explants) and an air-medium interface culture
system. Also, application of Malassezia organisms to the skin of experimental dogs,
both normal and atopic, and investigation of the effect of M. pachydermatis on
cytokine production and expression of adhesion molecules by canine keratinocytes
would provide further insight into the role of M. pachydermatis as a pathogenic




Malassezia dermatitis, an inflammatory dermatosis associated with elevated
cutaneous populations of Malassezia pachydermatis, has been recognised with
increasing frequency in recent years, and dogs with atopic dermatitis are especially
predisposed to the condition (reviewed in section 1.3.3). Atopic dogs have been
found to have elevated levels of Malassezia-specific IgG and IgE in their sera
(Nuttall & Halliwell 2001). Significantly greater intradermal test (IDT) reactivity to
M. pachydermatis extracts has been observed in atopic dogs with cytological
evidence ofMalassezia overgrowth than in atopic dogs without excessive numbers of
the organism (Morris et al. 1998). Significantly higher frequencies of positive IDT
reactivity to M. pachydermatis extract has also been found in atopic dogs compared
to healthy dogs (Bond et al. 2002a). Furthermore, anti-Malassezia IgE antibodies
have been demonstrated to be functional in Type I hypersensitivity reactions using
passive cutaneous anaphylaxis tests (Morris & DeBoer 2002). The data from these
studies provide evidence that some atopic dogs can become sensitised to M.
pachydermatis-derived allergens, and the possible immunological pathways for this
sensitisation are reviewed in section 1.4.1.2. However, there remained a lack of
information on IgG and IgE binding proteins from M. pachydermatis in atopic dogs.
In this study, the protein antigens that might trigger M. pachydermatis-specific IgG
and IgE responses in atopic dogs with Malassezia dermatitis were detected using
SDS-PAGE and Western blotting techniques. The experiments described in chapter 3
demonstrated a greater IgG response to M. pachydermatis in atopic dogs with
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Malassezia dermatitis and identified a 25 kDa antigen that was recognised in the
majority of these dogs. This 25 kDa antigen was only recognised by less than 25 %
of the atopic dogs without Malassezia dermatitis and none of normal dogs,
suggesting a degree of specificity for the IgG response to this antigen in atopic dogs
with Malassezia dermatitis. The IgE immunoblots with sera from atopic dogs with
Malassezia dermatitis and normal dogs revealed that the majority of the dogs in the
former group had a greater IgE response to M. pachydermatis than normal dogs
(chapter 4). Proteins with molecular weights of 45, 52, 56, and 63 kDa were
recognised by over 50 % of the atopic dogs with Malassezia dermatitis, but only
recognised by a minority of normal dog sera. Therefore, they can be classified as
major allergens. These results suggest that Malassezia dermatitis in atopic dogs is
associated with an IgG and IgE response to M. pachydermatis, which provides
further evidence to support the hypothetical mechanisms stated in section 1.4.1.2.
However, the identities of the proteins described above are not known and await
further investigation.
In human medicine, some of the recombinant allergens (rMal s 1 and rMal s 5-9)
have been tested for use in skin prick testing, atopy patch testing, and in vitro IgE
assays (Zargari et al. 2001; Johansson et al. 2002). In order to improve the specificity
of IDT with M. pachydermatis extracts in atopic dogs, which is currently performed
only for research purposes (Morris et al. 1998; Bond et al. 2002a), future studies are
planned to determine the identities of the 45, 52, 56, and 63 kDa allergens. The crude
Malassezia extracts used in this study could be purified using high-performance
liquid chromatography (HPLC) and separated by electrophoresis. The 45, 52, 56, and
63 kDa allergens recognised by the sera of atopic dogs with Malassezia dermatitis
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could then be identified by N-terminal sequencing and further expressed as
recombinant proteins by cloning techniques (Schmidt et al. 1997; Yasueda et al.
1998; Onishi et al. 1999; Lindborg et al. 1999; Rasool et al. 2000). The recombinant
proteins could be tested for use in IDT and might improve the diagnosis of M.
pachydermatis-associated Type I hypersensitivity in dogs with atopic dermatitis and
Malassezia overgrowth. Furthermore, the treatment of Malassezia dermatitis is
currently based on anti-fungal therapy (reviewed in section 1.3.3.3.3). The use of
recombinant proteins could provide an alternative therapeutic approach to
Malassezia dermatitis in atopic dogs: allergen-specific immunotherapy. Further
studies on the efficacy of immunotherapy with Malassezia allergens would yield data
with therapeutic implications.
The role of the IgG response to the 25 kDa antigen in atopic dogs with Malassezia
dermatitis was not investigated in this study. The 25 kDa antigen could also be
further characterised using protein purification and sequencing techniques. The
purified antigen could be used to investigate cell-mediated immune responses to M.
pachydermatis such as cytokine production as T-cell mediated immune responses
have been suggested to be important in host immunity against superficial mycoses
(Hay 1992). Additionally, it could be used to study the capability of M.
pachydermatis to activate complement by the classical and alternative pathways,
allowing comparison with Pityrosporum orbiculare and P. ovale (Belew et al. 1980;
Sohnle & Collins-Lech 1983). Such studies in the future would improve our
understanding of the interaction between M. pachydermatis and the immune system
of its canine host.
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In addition to activation of the skin immune system, the skin also protects itself from
environmental insults by thickening the epidermis. Epidermal hyperplasia is one of
the characteristic features seen in histopathology of Malassezia dermatitis (section
1.3.3.3.2). Little is known about the direct interaction between Malassezia organisms
and canine keratinocytes but a preliminary report had demonstrated a significant
increase in a cellular proliferation marker in canine keratinocytes co-cultured with M.
pachydermatis compared to control cells in vitro (von Tscharner et al. 1999). In order
to further investigate the potentially pathogenic role of M. pachydermatis in
epidermal hyperplasia associated with Malassezia dermatitis, studies were designed
to evaluate the proliferation of canine keratinocytes co-cultured with extracts and
culture supernatants from M. pachydermatis (chapter 5) and live Malassezia
organisms (chapter 6). The experiments in chapter 5 showed that Malassezia extracts,
either with or without protease inhibitors, and culture supernatants from the yeast,
did not affect the proliferation of normal canine keratinocytes in vitro. Likewise,
Malassezia organisms did not cause canine keratinocyte proliferation in vitro
(chapter 6). However, they induced keratinocytes to detach from the substratum and
to undergo cell death. Although the biological significance of these effects is not yet
clear, these results indicate that M. pachydermatis has no direct effect on
proliferation of canine keratinocytes in vitro.
Nevertheless, it is possible that M. pachydermatis organisms might have a direct
effect on the living epidermis with a blood supply and a functional immune system.
Also, the comparison of the proliferative responses of keratinocytes from atopic dogs
or dogs with Malassezia dermatitis to that of normal dogs was not addressed in this
study. Skin from these dogs might react differently to M. pachydermatis. These
283
questions could be addressed by repeating the keratinocyte proliferation studies using
cells obtained from affected dogs but it is unlikely that sufficient keratinocytes could
be acquired for such experiments. The use of skin explants or in vitro epidermal
culture systems based on an air-medium interface might allow further refinement of
the experimental methodology. In vivo experiments involving application of live
Malassezia organisms and extracts to the skin of dogs would also provide further
information on the pathological processes involved.
Alternatively, M. pachydermatis might have no direct effect on keratinocyte
proliferation, either in vitro or in vivo. If this is the case, the epidermal hyperplasia is
likely to be due to the inflammatory reaction stimulated either by the organism itself,
or the underlying diseases. Future studies involving investigation of the effect ofM.
pachydermatis on cytokine production and expression of adhesion molecules by
canine keratinocytes would provide further information concerning the regulation of
epidermal hyperplasia induced by overgrowth ofMalassezia organisms.
A single strain ofM. pachydermatis was used throughout the studies described in this
thesis. This was deemed appropriate due to the homogeneity of M. pachydermatis
that has been demonstrated by different investigators. Senczek et al. (1999)
compared the electrophoretic karyotypes of M. pachydermatis isolated from 198
dogs using pulse-field gel electrophoresis. All isolates of M. pachydermatis
examined revealed similar electrophoretic karyotypes with the majority showing six
bands of chromosomal DNA ranging between 840 and 1850 kBp, regardless of the
origin of the isolates (ear/skin/vagina). Coutinho et al. (1997) compared the protein
profiles of cell wall extracts from M. pachydermatis isolated from 15 dogs with otitis
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to 15 dogs with dermatitis using SDS-PAGE. The results revealed protein bands
ranging from 15 to 146 kDa, however, no statistical differences were found in the
protein patterns obtained from the two groups, either with the molecular weights or
the number of bands. In a similar study, Bond and Lloyd (2002) obtained Malassezia
extracts by mechanically disrupting the yeast cells and compared the protein patterns
of extracts from 6 different strains ofM. pachydermatis isolated from dogs with skin
diseases or otitis externa using SDS-PAGE. A high level of uniformity was observed
between the six strains with each strain showing protein bands with molecular
weights of 23-220 kDa, and only minor differences were observed between strains.
The protein profiles of culture supernatants from M. pachydermatis have also been
investigated using the same technique. Although considerable variability was
revealed between strains, the protein patterns of concentrated broth culture
supernatants from M. pachydermatis obtained from healthy dogs did not differ from
that of dogs with dermatitis. No clear association between the origin of the strain and
the expression of particular proteins was identified (Bond 2002). Furthermore, when
used in intradermal testing, the reactivity to two extracts prepared from different
strains ofM. pachydermatis in 8 dogs was shown to be closely correlated, especially
at higher concentrations (Bond et al. 2002a). Taken together, the results of these
studies indicate that antigens ofM. pachydermatis are likely to be ubiquitous within
strains and different strains may have similar antigenicity. Additionally, using a
single strain allows more experiments to be performed with limited volumes of
serum samples. Due to the low dilution ratio required in the IgE blots (chapter 4),
examination ofmultiple strains would have reduced the number of experiments that
could have been performed. Based on all these factors, it was decided to use a single
strain ofM. pachydermatis throughout these studies. However, consideration should
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be given to the use of different strains in future studies investigating the interaction
between M. pachydermatis and canine skin.
In conclusion, this study has contributed to our understanding of the host response to
M. pachydermatis, and suggested possible mechanisms by which overgrowth of
Malassezia organisms induces immunological responses and histopathological
changes in affected dogs. It is hoped that these findings can be extended in future
studies to further define the properties of the 25, 45, 52, 56, and 63 kDa proteins, and
to further explore the factors involved in triggering histopathological changes
associated with Malassezia dermatitis. Studies of protein identification might lead to
the development of standardised M. pachydermatis allergens for use in intradermal
testing, in vitro assays and allergen-specific immunotherapy. Also, the recognition of
important factors which mediate the formation of epidermal hyperplasia seen in
Malassezia dermatitis such as cytokines and adhesion molecules might lead to novel
approaches to prevent or better control Malassezia dermatitis in dogs.
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Summary
Overgrowth of Malassezia pachydermatis is a common
occurrence on the skin of dogs wilfi atopic dermatitis,
but the interaction between the organism and the host's
immune system has not been extensively investigated.
The aim of this study was to characterise one arm of the
humoral immune response to M. pachydermatis by
comparing immunoglobulin G (IgG) responses to antigens
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis in 18 atopic dogs with Malassezia
dermatitis, 20 atopic dogs without Malassezia dermatitis
and 18 clinically normal dogs using Western
immunoblotting. Numerous IgG-binding proteins were
Introduction
Malassezia pachydermatis is a lipophilic, unipolar-
budding yeast that can be isolated from the skin and
ear canals of healthy dogs (Baxter, 1976; Gedek et al.,
1979; Bond et al., 1994, 1995; Bond & Anthony, 1995;
Kennis et al., 1996). However, since the early 1980s,
a dermatitis has been reported that is associated with
elevated cutaneous populations of M. pachydermatis
and shows a beneficial response to antifungal therapy
(Dufait, 1983; Larsson et al., 1988; Mason & Evans,
1991). The factors that have been suggested to cause
overgrowth of the organism are alterations in skin-
surface microclimate, such as increased temperature,
moisture and sebum production as well as defective
host immunity (Mason, 1992). Such changes may be
detected with sera from atopic dogs with Malassezia
dermatitis. Strong bands with molecular weights of 25,
29, 42, 45-51, 61, 82 and 90kDa were seen in more than
50% of the dogs. However, antigens of 28 30, 42, 45-51,
61, 82 and 90kDa were also recognised by most atopic
dogs without Malassezia dermatitis. Approximately half
of the normal dogs showed faint IgG binding to multiple
indistinct bands between 42 and 68kDa, but cleaiei
bands could be seen at 42, 45 and 82 kDa. These results
indicate that the majority of atopic dogs with Malassezia
dermatitis have a greater IgG response than normal dogs,
and show responses to an additional protein of 25 kDa.
This antigen may therefore be clinically important in cases
of Malassezia dermatitis associated with canine atopy.
associated with various underlying skin diseases,
including hypersensitivity disorders, bacterial skin
infections, keratinisation defects and endocrine dis¬
eases (Scott & Miller, 1989; Mason & Evans, 1991;
Mason, 1992; Morris, 1999).
Atopic dermatitis is one of the most common dis¬
eases associated with Malassezia overgrowth in dogs.
It has been demonstrated that some atopic dogs carry
higher numbers ofM. pachydermatis on the skin than
normal dogs (Bond 8( Sant, 1993; Bond et al., 1994;
White et al., 1996), and cytological evidence of
Malassezia overgrowth is a common finding in atopic
dogs in the authors' clinic (personal observations).
The interaction between M. pachydermatis and the
host's immune system has not been widely studied
either in normal or atopic dogs. Morris et al. (1998)
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showed that atopic dogs maymount an immunoglob¬
ulin E (IgE) response to M. pachydermatis, and
Nuttall showed that atopic dogs had elevated levels
of Malassezia-specific IgG (Nuttall, 1997) and IgE
(Nuttall, 1998) in their serum.
The aim of this study was to characterise further one
arm of the humoral immune response to M. pachy¬
dermatis by comparing IgG responses to individual
antigens of the yeast in atopic dogs with and without
Malassezia dermatitis and normal dogs, using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western immunoblotting.
Materials and methods
Serum samples
Serum samples were collected from 18 atopic dogs with
Malassezia dermatitis and 20 atopic dogs without
Malassezia dermatitis presenting to the dermatology
clinic at the Royal (Dick) School of Veterinary Stud¬
ies in Edinburgh. Sera of clinically normal dogs were
collected from 18 dogs presenting for euthanasia at a
rescue centre.
The diagnosis of atopic dermatitis was based on a
combination of consistent history and clinical signs,
exclusion of other causes of pruritic skin disease and
the presence of at least one positive intradermal skin-
test reaction. Coat brushings, skin scrapings and trial
therapy were used to eliminate ectoparasites. A 6 week,
home-cooked diet trial was conducted to eliminate
food intolerance. No anti-inflammatory medication
was given for at least 3 weeks before examination. The
intradermal skin tests were performed with 57 aller¬
gens using 0.05 ml of each allergen extract on the lat¬
eral flank after the dogs were sedated with 0.15 mg/kg
xylazine intramuscularly (i.m.) and clipped. Histamine
(1/100 000 w/v) and saline diluent were also injected
as positive and negative controls. Test sites were
assessed after 20 min and scored from 0 (negative con¬
trol) to 4 (positive control) compared with the con¬
trols. Reactions >2 were considered positive (Scott et
al., 2001).
Malassezia dermatitis was diagnosed by microscopic
observation of Diff-Quik® (Dade AG, Switzerland)
stained tape strips (Mason, 1992; Bond 8c Sant, 1993;
Charach, 1997). Samples were obtained from the
groin, axilla and interdigital web, and Malassezia
overgrowth was characterised as an average of five or
more Malassezia organisms per 400 X field. Malassezia
otitis was diagnosed by sampling the external ear canal
with a cotton swab and transferring the material to a
glass slide prior to heat fixing and staining. The cri¬
teria for demonstrating overgrowth were as described
for the tape strips.
Normal dogs had no history or clinical signs of
skin disease and had no lesions on dermatological exam¬
ination.
Culture of M. pachydermatis
An isolate ofM. pachydermatis was obtained from the
ear canal of a dog with Malassezia otitis. This was deemed
appropriate because previous studies have shown that
M. pachydermatis was the only Malassezia species iso¬
lated from the skin and external ear canal of dogs with
either otitis externa or skin infections, and all isolates
of M. pachydermatis had similar electrophoretic kary¬
otypes (Senczek et al., 1999). The sample was cultured
on Sabouraud Dextrose agar (Oxoid, Basingstoke, UK)
containing 20mg/ml chloramphenicol (Intramycetin®;
Parke-Davis Veterinary, Eastleigh, UK) for 48 h at 37°C,
and the colonies were identified asM. pachydermatis by
microscopic examination. The colonies were then sub-
cultured onto large numbers of plates to obtain enough
organisms for subsequent studies.
Extraction of M. pachydermatis proteins
Malassezia colonies were carefully harvested and
suspended in phosphate-buffered saline (PBS, pH 7.4)
for a washing procedure that consisted of three cycles
of centrifugation at 500 y for 5 min followed by removal
of the supernatant and resuspension in PBS. After
the last washing cycle, the cells were resuspended
in extraction buffer (pH 7.4) containing 125 mM
NH4HCO3 (Sigma, Poole, UK) and protease inhibitors
(20 mM e-aminocaproic acid, Sigma, UK; 5 mM ethyl-
enediaminetetraacetic acid, Sigma, UK; and 1 mM
phenylmethylsulfonyl fluoride, BDH, UK) (Jensen-
Jarolim et al., 1992; Morris et al., 1998).
Preliminary experiments were performed using
three different methods to determine the optimum
method for protein extraction. First, the Malassezia
colonies in the extraction buffer were mixed vigorously
with an equal volume of glass beads (0.4 mm, 40 mesh,
BDH, UK) on a vortex mixer for 10 min to disrupt
the cell membranes mechanically. A second suspension
of Malassezia organisms was subjected to three cycles
of freezing and thawing by alternately immersing the
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container in a dry ice-methanol mixture and warm tap
water. This was intended to fracture the cell mem¬
branes and allow release of cytoplasmic contents.
Thirdly, a Malassezia suspension was placed in an ultra¬
sonic water bath for 5 min to fragment the organisms
physically. Ten agar plates were prepared for each
method, and equal weights of colonies (3.07 g) were
added to 5 ml of extraction buffer. After extraction, the
cell suspensions were stored at 4°C overnight, then
centrifuged at 6000 £ for 5 min, and the supernatants
were collected. The amount of protein obtained from
each method was measured with BCA Protein Assay
Reagent (Pierce Chemical Company, Rockford, IL,
USA) and the extracts were analysed by SDS-PAGE.
The protein concentrations of the extracts obtained
from the three methods (glass beads, freeze-thaw cycles
and ultrasonification) were 16.35,0.58, and 0.22 mg/ml,
respectively. Figure 4.6.1 shows the Coomassie blue-
stained protein profiles of the three different extracts
on an SDS-PAGE gel. Much stronger protein bands
were seen in the extract obtained by glass bead
disruption. This method was therefore used in subse¬
quent studies.
SDS-PAGE and immunoblotting
The gel electrophoresis was performed according to
the method of Laemmli (1970) using 12% separating
polyacrylamide gel and 4% stacking gel in a discon¬
tinuous buffer system containing 0.025M Tris (Sigma,
UK), 0.2 M glycine (Fisher Scientific, Loughborough,
UK) and 0.1% SDS (Fisher Scientific, UK), pH 8.3. The
extracts and molecular weight standards were diluted
1:1 with reducing sample buffer (containing 5% (3-
mercaptoethanol; Sigma, UK) and heated at 95°C for
5 min. They were then added to the wells of the gel and
the electrophoresis was run at 200 V for 60 min.
The separated proteins and molecular weight stan¬
dards were transferred from the gel to a polyvinylidene
difluoride microporous membrane (Millipore Immo-
bilon™-P Transfer Membrane; Millipore Corporation,
Bedford, MA, USA) in a BioRad Trans-Blot® SD
Semi-Dry Electrophoretic Transfer Cell according to
Figure 4.6.1. Extracts of Malassezia pachydermatis obtained using three different methods in a Coomassie blue-stained sodium dodecyl sulfate—
pnlyarrylamide gel electrophoresis gel M: broad-range molecular weight standard; G: glass beads; F/T: three freeze thaw cycles; U: ultrasonification.
Molecular weights are shown in kilodaltons. The extract produced using glass bead disruption was selected for the immunoglobulin G study.
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the manufacturer's instructions. The transfer buffer
contained 10mM (cyclohexylamino)-l-propane sul¬
fonic acid (CAPS, Sigma, Poole, UK) and 10%
methanol (Fisher Scientific, UK) (LeGendre et al.,
1993). The transfer was run at 80 mA per minigel
for 1 h. The quality of transfer was checked by stain¬
ing gels and molecular weight standards blotted onto
the membrane with Coomassie brilliant blue R-250
(BDH, Poole, UK).
For detection of IgG binding proteins, one broad
well of Malassezia extract (123 pig, 150 pi of 1/20 dilu¬
tion) running across the top of the gel was used. This
allowed the membrane to be cut into narrow strips so
that they could be probed with individual sera. They
were then blocked for 1 h with 1% skimmed milk in
Tris-buffered saline (TBS) containing 0.02M Tris and
0.5M NaCl (Sigma, UK), pH 7.5. After washing with
TBS containing 0.05% Tween 20 (Fisher Scientific, UK)
(TTBS) for 15min (3 X 5min rinses), each strip was
incubated with 10 pi of dog serum diluted to 1 ml in
dilution buffer (1% skimmed milk in TTBS) for
30 min. The strips were then washed again in TTBS for
a further 15 min. Bound IgG was detected by incu¬
bating the strips for 1 h with horseradish peroxidase -
conjugated goat anti-dog IgG heavy and light chain
(Bethyl Laboratories, Montgomery, TX, USA) diluted
1:10 000 in dilution buffer. After further washing with
TTBS for 15 min, the strips were developed with 3,3'-
diaminobenzidine (DAB) peroxidase substrate (Vec¬
tor Laboratories, Burlingame, CA, USA) for about
1 min. The molecular weights of IgG binding proteins
were determined using standard curves generated by
analysing the position ofmolecular weight markers on
Coomassie blue-stained membranes.
Results
The IgG immunoblots of individual dog sera from the
three different groups are shown in Figure 4.6.2a-c.
The amount of staining seen in the normal dogs (Fig¬
ure 4.6.2a) was much weaker than that seen in the
atopic dogs with cytological evidence of Malassezia
overgrowth (Figure 4.6.2b). The binding pattern seen
in atopic dogs without Malassezia dermatitis was
between that of the other two groups (Figure 4.6.2c).
More than half of the normal dogs showed mul¬
tiple indistinct bands between 42 and 68kDa, but
clearer bands could be seen at 42 (in 83% of dogs), 45
(61%) and 82kDa (67%) (Figure 4.6.3a). Two dogs
showed relatively strong binding patterns (nos9 and 18)
and one dog had a prominent band at 27 kDa (no. 15).
In the atopic dogs with Malassezia dermatitis, there
was more intense staining of indistinct bands between
45 and 51 kDa. However, distinct IgG binding proteins
with molecular weights of 25 (78%), 29 (67%), 42
(94%), 61 (67%), 82 (89%) and 90 kDa (61%) were
recognised by more than 50% of the atopic dogs with
Malassezia dermatitis (Figure 4.6.3b). Some atopic
dogs also showed binding to various low molecular
weight proteins between 14 and 42 kDa. Antigens of
28-30 (55%), 42 (95%), 45-51 (80%), 61 (50%), 82
(65%) and 90 (55%) kDa were also recognised by more
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Figure 4.6.2. Immunoglobulin G-binding components
in extracts of Malassezia pachydermatis detected by
immunoblotting with dog sera from three different groups:
(a) normal dogs, (b) atopic dogs with Malassezia der¬
matitis, and (c) atopic dogs without Malassezia dermati¬
tis. The numbers along the bottom signify the strips probed
with individual dog sera. The molecular weight standards
on the left are 200, 66, 45, 31, 21.5 and 14.4kDa.
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(C) Figure 4.6.2. (Continued)
The blots of the three groups demonstrated that
most dogs showed IgG binding to multiple Malassezia
antigens. However, atopic dogs with Malassezia der¬
matitis had a much greater IgG response than the nor¬
mal dogs, and the majority showed binding to a protein
of 25 kDa which was not seen in most dogs of the other
two groups.
Discussion
The results of the immunoblotting with individual dog
sera indicate that most dogs have an IgG response to
multiple antigens of M. pachydermatis. Approxi¬
mately half of the normal dogs showed faint IgG bind¬
ing to multiple indistinct bands between 42 and
68 kDa, but clearer bands could be seen at 42, 45 and
82 kDa. These difficulties in distinguishing bands could
be overcome using two-dimensional SDS-PAGE and
immunoblotting (Onishi etal, 1999). Nevertheless, the
results suggest that the commensal population of
M. pachydermatis is recognised by the dogs immune
system, leading to an antibody response. Whether or
not this IgG response is protective in any way remains
to be determined.
The degree and intensityofstaining on the blots from
the atopic dogs with Malassezia dermatitis was much
greater than that seen in the normal dogs, indicating that
the majority of atopic dogs with Malassezia dermatitis
had a greater IgG response to M. pachydermatis. This
result is in accordance with a recent finding that dogs
with skin disease associated with M. pachydermatis
develop high serum titres ofM. pachydermatis-specific
IgG (Bond et al, 1998). Furthermore, more numerous
IgG binding proteins were observed on the blots from
the atopic dogs with Malassezia dermatitis than from the
normal dogs. Some of these proteins were the same in
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Figure 4.6.3. Percentage of dogs from three different groups showing immunoglobulin G binding to individual antigenic components in extracts
of Malassezia pachydermatis: (a) normal dogs, (b) atopic dogs with Malassezia dermatitis, and (c) atopic dogs without Malassezia dermatitis.
x-Axis: molecular weights of the bands detected on the strips; y-Axis: percentage of dogs reacting to these bands.
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both groups (molecular weights of 42, 45-51 and
82 kDa). However, an antigen of 25 kDa was recognised
by the majority ofatopic dogs with Malassezia dermatitis
but was not recognised by most dogs in the other two
groups. At this stage, the identity and function of this
protein are unknown, as is the significance of the IgG
response to this antigen in the atopic dogs. The IgG may
act as an opsonin to facilitate phagocytosis of
Malassezia antigens. This could have a protective func¬
tion but it could also activate the complement system
and exacerbate the underlying inflammation. It has been
shown that Malassezia furfur is capable of activating
both the classical and alternative complement pathways
(Belew et al, 1980; Sohnle 8c Collins-Lech, 1983). It has
also been suggested that zymogen in the cell wall ofM.
pachydermatis might activate complement, leading to
epidermal damage and inflammation (Mason, 1993).
Despite the uncertainty surrounding the role of this anti¬
gen, the IgG response seen in the atopic dogs with
Malassezia overgrowth but not in the normal dogs
suggests that it may have some clinical relevance in the
disease.
IgG binding components in extracts ofM. pachyder¬
matis have also been investigated with sera of healthy
dogs and non-atopic dogs with Malassezia dermatitis
(Bond & Lloyd, 1999). Proteins of 132, 66 and
50-54 kDa were recognised by most sera, but affected
dogs showed immunoreactivity mainly to proteins
of 219,110,71 and 42 kDa (Bond & Lloyd, 1999). Com¬
paring the relative positions of bands and molecular
weight standards, it may be inferred that some of these
results are likely to represent the same bands as those
seen in the present study. However, the 25 kDa antigen
was not recognised in the non-atopic dogs with
Malassezia dermatitis, again suggesting a degree of speci¬
ficity for this response in dogs with atopic dermatitis.
1 he pattern of IgG binding seen in the atopic dogs
without Malassezia dermatitis was between that of the
normal dogs and atopic dogs with Malassezia derma¬
titis. Most of these dogs also recognised antigens
of 28-30, 42, 45—51, 61, 82 and 90 kDa. Owing to the
difficulty in precisely resolving the molecular weight of
proteins on SDS-PAGE gels, it is possible that the bands
detected at 28 and 30 kDa are the same as the 29 kDa
antigen seen in the group with Malassezia overgrowth.
There are some possible explanations for this inter¬
mediate pattern.White et al. (1996) compared the car¬
riage ofM. pachydermatis on clinically normal skin of
the intradermal skin-test area in atopic dogs and
trunkal glabrous skin in healthy dogs. They found that
atopic dogs had significantly higher yeast culture scores
than healthy dogs. Hence, the atopic dogs without
Malassezia dermatitis could still have had elevated popu¬
lations of the yeast without having cytological evidence
of an overgrowth. In addition, some of the atopic dogs
in the present study may have had Malassezia dermatitis
in the past, leading to a residual IgG response. Finally,
the immune system of atopic dogs may be sensitized
to the normal population of the commensal through
their frequent scratching behaviour. It has been sug¬
gested that disruption of stratum corneum barrier
function by scratching may enhance exposure of the
skin immune system to yeast allergens (Morris et al.,
1998). However, the 25 kDa antigen was only seen in
less than 25% of the atopic dogs without Malassezia
overgrowth, suggesting that an IgG response to this pro¬
tein is clinically relevant in the disease.
In human beings, M. furfur is believed to be signifi¬
cant in the pathogenesis of atopic dermatitis, and
numerous IgE binding proteins have been identified
in crude extracts using immunoblotting techniques
(Johansson 8c Karlstrom, 1991; Jensen-Jarolim et al.,
1992; Zargari et al., 1994; Lintu et al., 1997). Further¬
more, type I hypersensitivity responses towards
intradermally injected extracts of M. pachydermatis
have been reported in atopic dogs with Malassezia
dermatitis (Morris et al., 1998). Hence, to complement
the IgG data presented in this paper, and to elucidate
further the role of M. pachydermatis in atopic
dermatitis, studies are currently underway to define the
IgE response to Malassezia antigens in atopic dogs.
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Identification of major allergens of Malassezia pachydevmatis
in dogs with atopic dermatitis and Malassezia overgrowth
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Abstract We have previously shown that both atopic and normal dogs generate an IgG response to antigens
of Malassezia paehydermatis. The aim of this study was to compare IgE responses to separated proteins of
M. pachydermatis in 28 atopic dogs with Malassezia dermatitis and 22 clinically normal dogs using Western
immunoblotting. Six different detection systems were evaluated in order to assess sensitivity and eliminate non¬
specific binding and cross-reactivity. The protocol yielding the best results utilized a monoclonal mouse antidog
IgE, an alkaline phosphatase conjugated goat antimouse IgG which had been passed through a canine IgG col¬
umn 3 times, a chemiluminescent substrate and a digital imaging system. Proteins of 45, 52, 56 and 63 kDa were
recognized by more than 50% of the atopic dog sera and thus represented major allergens. Only a minority of
normal dogs showed faint IgE binding to these proteins. The results indicate that themajority of atopic dogs with
Malassezia dermatitis have a greater IgE response than normal dogs, suggesting an IgE-mediated immune
response may be clinically important in the pathogenesis of the disease.
Keywords', atopic dermatitis, dogs, IgE, Malassezia
INTRODUCTION
Malassezia pachydermatis, a lipophilic, unipolar-
budding yeast is a commensal on canine skin and it
can be isolated from the skin and ear canals of healthy
dogs.1"6 However, a dermatitis associated with elevated
cutaneous populations of M. pachydermatis that shows a
beneficial response to antifungal therapy has been reported
in the last two decades,7-9 indicating that the organism
is an opportunistic pathogen. Several factors have
been suggested to cause overgrowth of the organism,
such as alterations in skin surface microclimate and
defective host immunity.10 These factors may be
associated with various underlying skin diseases includ¬
ing hypersensitivity disorders, bacterial skin infections,
keratinization defects and endocrine diseases.9"12
Atopic dermatitis is one of the most common dis¬
eases associated with Malassezia overgrowth in dogs,
and it has been demonstrated that some atopic dogs
carry higher numbers of M. pachydermatis on their
non-lesional and lesional skin than normal dogs.3'1314
Immediate hypersensitivity responses to intradermal
injections of M. pachydermatis extracts have been
demonstrated in atopic dogs with Malassezia over¬
growth,15 suggesting that allergens from the organism
may be involved in the pathogenesis of atopic dermatitis.
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Studies, Hospital for Small Animals, Royal (Dick) School of
Veterinary Studies, Easter Bush Veterinary Centre, Edinburgh EH25
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Previous reports have also shown that atopic dogs
have elevated levels of Malassezia-specific IgG and
IgE16 in their serum.
In human patients with atopic dermatitis, Malas¬
sezia furfur is known to be allergenic, and a number of
IgE-binding components in the range of 9-100 kDa
have been documented.17"20 Nine allergens of Malas¬
seziafurfur (Mai f 1-Mal f 9) have now been sequenced
and expressed as recombinant proteins,21"25 with
molecular weights of 37, 21, 20, 35, 18.2, 17.2, 16.2,
19.2 and 14 kDa, respectively.
We have recently shown that the majority of atopic
dogs with Malassezia dermatitis have a greater IgG
response to the yeast than normal dogs, and that an
antigen of 25 kDa appears to be clinically important.26
The aim of this study was to further characterize the
humoral immune response to M. pachydermatis by
comparing IgE responses to separated antigens of the




Serum samples were collected from 28 atopic dogs with
Malassezia dermatitis presented to the dermatology
clinic at the Royal (Dick) School of Veterinary Studies
in Edinburgh. Sera of clinically normal dogs were col¬
lected from 22 dogs presented for euthanasia at a
rescue centre.
© 2002 Blackwell Science Ltd 141
142 T.-A. Chen et al.
The diagnosis of atopic dermatitis was based on a
combination of consistent history and clinical signs,
exclusion of other causes of pruritic skin disease and
the presence of at least one positive intradermal skin
test reaction. Coat brushings, skin scrapings and trial
therapy were used to rule out ectoparasites. A 6-week,
home-cooked diet trial was conducted to rule out
adverse food reactions. No anti-inflammatory medica¬
tion was given for at least 3 weeks prior to examina¬
tion. The intradermal skin tests were performed with
57 allergens using 0.05 mL of each allergen extract on
the lateral flank after the dogs were sedated with
0.15 mg kg"1 xylazine intramuscularly and clipped.
Histamine (1/100 000 w/v) and diluent consisting of
buffered saline with 0.4% phenol as preservative were
also injected as positive and negative controls, respect¬
ively. Test sites were assessed after 20 min and scored
from 0 to +4 by comparison with the controls. Reac¬
tions > 2 were considered positive.27
Malassezia overgrowth was diagnosed by micro¬
scopic observation of Diff-Quik® (Dade AG, Switzer¬
land) stained tape strips.10'13'28 Samples were obtained
from the groin, axilla and interdigital web and Malas¬
sezia overgrowth was characterized as an average of 5
or more Malassezia organisms per 400x field.29'30
Involvement of Malassezia in cases of otitis externa
was assessed by sampling the external ear canal with a
cotton swab and transferring the material to a glass
slide prior to heat fixing and staining. The criteria for
demonstrating overgrowth were as described for the
tape strips.
Normal dogs had no history or clinical signs of
skin disease and had no lesions on dermatological
examination.
Culture o/M. pachydermatis
An isolate of M. pachydermatis was obtained from the
ear canal of a dog with Malassezia otitis. The use of a
single isolate was deemed appropriate because previ¬
ous studies have shown that M. pachydermatis was the
only Malassezia species isolated from the skin and
external ear canal of dogs with either otitis externa or
skin infections, and all isolates of M. pachydermatis
had similar electrophoretic karyotypes.31 The sample
was cultured on Sabouraud Dextrose agar (Oxoid,
UK) containing 20 mg mL"1 chloramphenicol (Intramy-
cetin®, Parke-Davis Veterinary, UK) for 48 h at 37 °C,
and the colonies were identified as M. pachydermatis
by microscopic examination. The colonies were then
subcultured onto large numbers of plates in order to
obtain enough organisms for subsequent studies.
Extraction ofM. pachydermatis proteins
Malassezia colonies were carefully harvested and sus¬
pended in phosphate-buffered saline (PBS) (pH 7.4)
for a washing procedure that consisted of 3 cycles of cen-
trifugation at 500 g for 5 min followed by removal of
the supernatant and resuspension in PBS. After the last
washing cycle, the cells were resuspended in extraction
buffer (pH 7.4) containing 125 mm NH4HC03 (Sigma,
UK) and protease inhibitors (20 mm e-aminocaproic
acid, Sigma, UK; 5 mm ethylenediaminetetra-acetic
acid, Sigma, UK; and 1 mm phenylmethylsulphonyl
fluoride, BDH, UK).15'18 The Malassezia colonies
in the extraction buffer were then mixed vigorously
with an equal volume of glass beads (0.4 mm, 40 mesh,
BDH, UK) on a vortex mixer for 10 min to mechan¬
ically disrupt the cell membranes. After extraction,
the cell suspensions were stored at 4 °C overnight, cen-
trifuged at 6000 g for 5 min and the supernatants
were collected. The amount of protein obtained was
measured with BCA Protein Assay Reagent (Pierce
Chemical Company, Rockford, IL, USA).
SDS-PAGE and electrophoretic transfer
Gel electrophoresis was performed according to the
method of Laemmli32 using 10% separating polyacry-
lamide gel and 4% stacking gel in a discontinuous
buffer system containing 0.025 m Tris (Sigma, UK),
0.2 m Glycine (Fisher Scientific, UK) and 0.1% sodium
dodecyl sulphate (Fisher Scientific, UK), pH 8.3. The
extract (60 pg) and molecular weight standards were
diluted 1:1 with reducing sample buffer (containing 5%
P-Mercaptoethanol, Sigma, UK) and heated at 95 °C
for 5 min. The extract was then added to one broad
well across the top of the gel and the electrophoresis
was run at 200 V for 40 min. Fig. 1 shows the protein
profile of M. pachydermatis extracts on a 10% separat¬
ing polyacrylamide gel.
The separated proteins and molecular weight stand¬
ards were transferred from the gel to a polyvinylidene
difluoride microporous membrane (Millipore Immo-
bilon™-P Transfer Membrane, Millipore Corpora¬
tion, Bedford, MA, USA) in a Bio-Rad Trans-Blot®
SD Semi-Dry Electrophoretic Transfer Cell according
to the manufacturer's instructions. The transfer buffer
contained 25 mm Tris (Sigma, UK), 192 mm Glycine
(Fisher Scientific, UK) and 20% methanol (Fisher Scien¬
tific, UK), pH 8.3. The transfer was run at 80 mA per
minigel for 1 h. The quality of transfer was checked by
staining gels and molecular weight standards blotted
onto the membrane with Coomassie Brilliant Blue
R-250 (BDH, UK).
Optimization ofmethodology to detect IgE binding
proteins on the Malassezia pachydermatis immunoblots
Various methodologies and reagents were evaluated to
detect IgE binding proteins in M. pachydermatis (sum¬
marized in Table 1). Two methods were investigated to
allow the immunoblot membrane to be probed with
individual dog sera: cutting the membrane into narrow
strips or placing the whole membrane into a mul¬
tichannel miniblotter (Immunetics Inc., Cambridge,
MA, USA). The blocking reagents that were evaluated
included 5% skimmed milk, casein solution (Vector
Laboratories Inc., Burlingame, CA, USA), Tween 20
(Fisher Scientific, UK), Tween 80 (Sigma, UK), and an
avidin/biotin blocking kit (Vector Laboratories Inc.,
Burlingame, CA, USA). The following IgE-specific
reagents were evaluated: a polyclonal epsilon chain
© 2002 Blackwell Science Ltd, Veterinary Dermatology, 13, 141-150










Figure 1. Coomassie Brilliant Blue stained M. pachydermatis
extracts on a 10% separating polyacrylamide gel. Lane 1: molecular
weight markers; lane 2: Malassezia extract.
specific goat antidog IgE conjugated with horseradish
peroxidase (HRP) (Bethyl Laboratories, Montgomery
TX, USA); two monoclonal mouse antidog IgE anti¬
bodies (D9#3116, kindly donated by Dr D. J. Deboer,
University of Wisconsin, USA and E6-71Al, Custom
Monoclonals International, W. Sacramento, CA,
USA); and a biotinylated recombinant human IgE
receptor alpha chain (kindly donated by Dr C. McCall,
Heska Corporation, Fort Collins, USA). For visualiza¬
tion of binding, the following conjugates labelled with
either alkaline phosphatase (AP) or HRP were used: a
monoclonal mouse antigoat IgG-AP (Sigma, UK); a
monoclonal bovine antimouse IgGl-HRP (Serotec,
UK); two polyclonal goat antimouse IgG antibodies
labelled either with HRP (Sigma, UK) or AP (South¬
ern Biotechnology Associates Inc., USA); and two
avidin reagents (Vectastain® Elite ABC kit, Vector
Laboratories Inc., Burlingame, CA, USA and Extravi-
din®-peroxidase, Sigma, UK). Two different detection
systems were evaluated: substrate colour change and
chemiluminescence. For standard blots, DAB (3,3'-
diaminobenzidin. Vector Laboratories Inc., Burlingame,
CA, USA) and 5-bromo-4-chloro-3-indolyl phosphate/
nitro blue tetrazolium (BCIP/NBT, Sigma, UK) were
used to detect HRP- and AP-labelled reagents, respect¬
ively. For chemiluminescent blots, ECL™ (Amersham
Pharmacia Biotech, UK) was used for HRP-labelled
reagents and CDP-Star™ (Tropix Inc., Bedford, USA)
for AP-labelled reagents (Table 1).
Assessment of reagent specificity
Purified dog IgG (Sigma, UK), dog IgE (Bethyl Labo¬
ratories, Montgomery TX, USA) and mouse IgG Ik
(Sigma, UK) were used to test the specificity of rea¬
gents. The purified antibodies were diluted 1:1 with
nonreducing sample buffer (in view of the sensitivity of
dog IgE to 2-mercaptoethanol33), and the gel electro¬
phoresis performed as described above. They were then
transferred from the gel to a membrane, blocked with
5% skimmed milk in Tris-buffered saline containing
0.02 m Tris, 0.5 m NaCl and 0.1% Tween 20 (TTBS),
pH 7.5 for 1 h and sequentially incubated with the
various combinations of IgE-specific reagents and
secondary antibody conjugates summarized in Table 1.
The antibody conjugate used in protocol 6 had pre¬
viously been shown to exhibit cross-reactivity between
mouse IgGl and canine IgG (data not shown). To
eliminate this cross-reactivity, the conjugate had been
further purified using affinity chromatography. Briefly,
purified dog IgG (10 mg) dissolved in 0.15 m NaCl
(Sigma, UK) was exchanged with sodium hydrogen
carbonate buffer (0.2 m NaHC03 and 0.5 m NaCl, pH 8.5)
using HiTrap Desalting (Amersham Pharmacia Biotech,
UK) and coupled to cyanogen bromide (CNBr)-activated
Sepharose™ 4B (Amersham Pharmacia Biotech, UK).
The remaining active sites in the Sepharose were
blocked with 1 m ethanolamine (Sigma, UK), and the
gel was then packed into a column. The AP-labelled
goat antimouse IgG (Southern Biotechnology Associ¬
ates Inc., USA) was then passed through the canine
IgG column on three occasions using an FPLC® sys¬
tem (Amersham Pharmacia Biotech, UK). Antibodies
that did not bind to canine IgG were collected. The
specificity of solution passed through the column was
checked after each run using the method described
above. After three passages through the column, the
AP-labelled goat antimouse IgG did not bind to either
dog IgE without the presence of monoclonal mouse
antidog IgE or to dog IgG with orwithout the presence
of antidog IgE antibody (Fig. 2). For long-term stor¬
age, the final solution collected was concentrated using
Centriplus™ concentrators (Amicon Inc., Beverly, USA)
and the antibody concentration was measured with a
spectrophotometer. The concentrated solution was diluted
1:1 in glycerol (BDH, UK) to a final concentration of
0.29 mg mL"1.
Immunoblotting
Evaluation of the various reagents and protocols
revealed that an immunoblot membrane cut into strips
and protocol 6 (Table 1) yielded the best result. The
miniblotter did not produce repeatable results, and
© 2002 Blackwell Science Ltd, Veterinary Dermatology, 13, 141-150
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Reagents IgE-specificReagent GoatantidogIgE-epsilon chainspecific,HRP (BethylLaboratories) GoatantidogIgE-epsilon chainspecific,HRP (BethylLaboratories) Monoclonalmouse antidogIgE (DrD.J.eboer) Monoclonalmouse antidogIgE (DrD.J.eboer) Biotinylatedrecombinant humanIgEreceptoralpha chain (Heska) Monoclonalmouseantidog IgEE6-71A1 (CustomMonoclonals International)
Secondaryd velopingreagent
Substrate
Monoclonalantigo tIgG,AP (Sigma) GoatantimouseIgG,HRP (Sigma) BovineantimouseIgGl,HRP (Serotec) Vectastain®Eli eABCk t (VectorLabora ries) Extravidin®-peroxidase (Sigma) GoatantimouseIgGl,AP (SouthernBiotec nologyAsso iates) beforeandfterpassingthrough acanineIgGolumnthreetim s
DAB BCIP/NBT ECLT ECLT ECLT CDP-Star
Detection Colourchangeblots Colourchangeblots Chemiluminescence detectedonX-rayfilms (Hyperfilm™ECL™, AmershamLifeSc ence) Chemiluminescence detectedonX-rayfilms Chemiluminescence detectedonX-rayfilms Chemiluminescence detectedusingKodak DigitalScience™Image Station440CF






HRP:horseradishperoxidase;AP:alk linephosphatase:DAB3,3'-diaminobenzidin;BCIP/N T:5-bromo-4-chloro-3-in olylphosphate/ itroblutetraz lium.











Figure 2. Examination of reagent specificity in protocol 6 to detect IgE-binding proteins in Malassezia pachydermatis. Purified dog IgE (lanes
1 and 2) and IgG (lanes 3 and 4) were diluted with nonreducing sample buffer, separated in 10% SDS-PAGE (0.2 pg per lane), and transferred
to a membrane. The membranes were then sequentially incubated with monoclonal mouse antidog IgE (E6-71A1) diluted 1:500 in dilution
buffer (1% skimmed milk in TTBS), the secondary developing reagent which had been passed through a canine IgG column three times (1:2000
dilution) and the substrate (lanes 1 and 3). For the control groups (lanes 2 and 4), the antidog IgE antibody was replaced with the dilution buffer.
protocols 1-5 were rejected due to lack of sensitivity or
specificity. The individual serum samples were therefore
analysed using the following conditions. The strips were
blocked for 1 h with 5% skimmed milk in TTBS. After
washing with TTBS for 15 min (3x5 minute rinses),
each strip was incubated with individual dog serum
diluted 1:5 in dilution buffer (1% skimmed milk in
TTBS) for 1 h. The strips were then washed again in
TTBS for a further 15 min. Bound IgE was detected by
incubating the strips for 1 h with monoclonal mouse
antidog IgE E6-71A1 (diluted 1:500). After further
washing with TTBS for 15 min, the strips were incu¬
bated with AP-labelled goat antimouse IgGl (diluted
1:2000) for 1 h. The strips were washed again with
TTBS for 15 min, and then rinsed with detection buffer
containing 0.1m Tris-HCl, 0.1m NaCl and 5 mM
MgCl2 (BDEI, UK), pH 9.5. The strips were devel¬
oped by incubating them with a chemiluminescent sub-
stract, CDP-Star™, for 5 min. After draining off excess
liquid, the strips were wrapped in cling film and placed
on a Kodak Digital Science™ Image Station 440CF
along with Coomassie blue stained molecular weight
markers. The membrane was exposed for 15 min, and
blots were visualized on the computer screen. Kodak
Digital Science™ ID Image Analysis Software was
used to detect the bands on the blots and to determine
the molecular weight of bands by analysing their posi¬
tions relative to molecular weight markers.
To confirm that the major bands on the blots rep¬
resented IgE-binding proteins, a pooled serum sample
was generated from all the atopic dogs and from all
the normal dogs. The pooled samples were analysed
by SDS-PAGE and immunoblotting as described above
both before and after heating to 56 °C for 2, 4 and 8 h.
RESULTS
Immunoblotting with individual dog sera
The IgE immunoblots of individual dog sera from the
two groups are shown in Fig. 3(a and b). The intensity
of binding seen in normal dogs (Fig. 3a) was much
weaker than that seen in the atopic dogs with Malassezia
dermatitis (Fig. 3b).
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Figure 3. IgE-binding proteins in extracts of M. pachydennatis detected by immunoblotting with dog sera from 2 groups: (a) normal dogs; and
(b) atopic dogs with Malassezia dermatitis. The images of blots were captured by a digital imaging station and printed out directly from the
computer. The numbers along the bottom signify the strips probed with individual dog sera. The molecular weight markers on the left are 200,
116, 97, 66,45,31 and 21.5 kDa.
The intensity of binding in atopic dogs with Malassezia
dermatitiswas strongest between 45 and 63 kDa. IgE bind¬
ing proteins with molecular weights of 45 (61% of dogs),
52 (50%), 56 (61%) and 63 (68%) kDa were recognized in
more than 50% of the dogs (Fig. 4). Strong bands were
also detected at 26 (29%), 48 (39%) and 60 (18%) kDa.
Approximately one-third of the normal dogs showed
faint binding to proteins between 45 and 63 kDa, but
clearer bands at 45 (in 18% of dogs), 52 (36%), 56 (32%)
and 63 kDa (36%) were detected by the image analysis
software (Fig. 4). Furthermore, one dog had a promin¬
ent band at 26 kDa (No. 9) (Fig. 3a).
In order to confirm that the bands detected on the
blots were IgE-binding proteins, a pooled serum
sample was prepared from the atopic dogs with
Malassezia dermatitis and from the normal dogs.
The pooled serum samples were heat treated at
56 °C for 2, 4 and 8 h to detect the heat lability of
binding reactions (Fig. 5). The binding patterns seen
in the two serum pools were very similar to those seen
in the corresponding individual serum samples. As with
the individual blots, the binding intensity seen in the
atopic dog serum pool was much stronger than that
in the normal dogs. Between 45 and 63 kDa, the
binding intensity declined dramatically over the period
when serum pools were heated. Gradually decreasing
binding activity was also seen on one single band at
26 kDa. Accordingly, bands of 26 kDa and any bind¬
ing detected between 45 and 63 kDa on the strips
from the individual dogs were regarded as IgE specific.
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Figure 4. The percentage of dogs from the two groups showing IgE
binding to individual proteins in extracts of M. pachydermatis. The
bands on the blots shown in Fig. 3 were detected using Kodak
Digital Science™ ID Image Analysis Software and the molecular
weight of bands generated by the software was used to calculate the
percentage of dogs reacting to individual bands. Filled columns:
atopic dogs with Malassezia dermatitis; open columns: normal dogs,
x-axis: molecular weights of the bands detected on the strips; _y-axis:






Figure 5. Heat-lability of binding detected in two serum pools: one
from atopic dogs with Malassezia dermatitis and one from normal
dogs. AM: atopic dogs with Malassezia dermatitis; N: normal dogs;
C: control (dilution buffer: 1% skimmed milk in TTBS). The
numbers represent the length of heat treatment. 0: nonheated serum
pool; 2,4, and 8: after heating for 2,4 and 8 h, respectively. Note the
decrease in staining intensity seen in bands at 26 and 45-63 kDa
after heating.
DISCUSSION
In this study, we have shown that Malassezia dermatitis
in atopic dogs is associated with an IgE response to the
organism (compare Fig. 3a and b). This result con¬
firms the findings of previous studies that have demon¬
strated elevated concentrations of Ma/asserta-specific
IgE in atopic dogs with Malassezia overgrowth by
ELISA16 and positive responses following intradermal
injection of Malassezia extracts.15 Furthermore, we
have demonstrated that the IgE response is predom¬
inantly targeted against proteins with molecular
weights of 45, 52, 56 and 63 kDa. As these proteins
were recognized in over 50% of the atopic dogs with
Malassezia dermatitis, but only recognized by a minor¬
ity of normal dog sera, they can be classified as major
allergens. Strong bands were also detected with molecu¬
lar weights of 26, 48 and 60 kDa, but as these were
recognized in less than half of the atopic dogs they can
be regarded as minor allergens. Weak IgE binding was
also seen in some normal dogs between 45 and 63 kDa.
The cause of this weak IgE binding in normal dogs
is unknown. It has been shown that extracts of
M. pachydermatis at high concentrations are capable of
inducing wheal and flare responses in normal dogs.15
This could be an irritant reaction or an IgE response
present to commensal populations of the yeast. The
latter is certainly the case with IgG responses as shown
in previous studies.16,26
Of all the allergens detected, those with molecular
weights of 45 and 48 kDa seemed to be the most relev¬
ant because they were recognized by most atopic dogs
with Malassezia overgrowth but only a few normal
dogs (Fig. 4). Further studies are required to deter¬
mine the identity of these proteins using protein puri¬
fication and N-terminal sequencing. They may
represent two different proteins or a single protein with
variable glycosylation.
In contrast to the low molecular weight allergens
of Malassezia furfur (Mai f 1-Mal f 9) recognized by
humans, dogs recognized higher molecular weight
allergens in this study. Similar findings have been docu¬
mented with Dermatophagoides allergens. Most
human atopic sera have high IgE titres to group 1 and
group 2 allergens of Dermatophagoides34'35 which are
low molecular weight proteins, whereas in dogs the
most important Dermatophagoides allergens are high
molecular weight proteins greater than 90 kDa.36 38
Whilst optimizing the methodology to detect IgE
binding proteins in M. pachydermatis, we had to over¬
come problems of lack of sensitivity and specificity
(summarized in Table 1). Protocols 1 and 2 were
rejected because there were no visible bands, even with
the amplification step introduced in protocol 2. To
increase the sensitivity, various chemiluminescent pro¬
tocols were investigated (protocols 3-6). Luminescent
detection methods are believed to provide several
advantages over traditional chromogenic procedures,
such as generally increasing the sensitivity of both
HRP and AP systems, rapid detection and long-lasting
signals permitting multiple exposures.39 To increase
the specificity of the chemiluminescent methods,
monoclonal antibodies and an IgE receptor reagent
were used. In protocols 3 and 4, the secondary anti¬
bodies cross-reacted with canine IgG and they were
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abandoned due to lack of specificity. This problem is
confounded by the fact that levels of allergen-reactive
IgG may be several thousandfold higher than levels of
IgE in normal and atopic animals.40 The results of our
previous study obtained using a less sensitive substrate
(DAB) to detect Malassezia-specific IgG verified that
the levels of antigen-specific IgG were much higher
than levels of IgE. The high levels of Malassezia-
specific IgG in dog sera could enhance the IgG signals
and eclipse the IgE reaction.
The high-affinity receptor for IgE, FceRI, is a
requisite for the IgE-mediated immediate hypersensit¬
ivity reaction and the interaction between IgE and FceRI
is highly specific.41 In spite of offering absolute speci¬
ficity for IgE, the FceRI receptor reagent used in pro¬
tocol 5 was not successful because the avidin reagents
bound to Malassezia proteins. This could stem from
endogenous protein-bound biotin or lectins in the
extracts, as these contained a crude mixture of both
cytoplasmic and cell wall components.
In protocol 6, a combination of reagents that had
previously been used successfully to detect IgE binding
in ELISA assays (unpublished observations) was
assessed. In this protocol, the cross-reactivity of the
secondary antibody was removed by immunoabsorp-
tion through a canine IgG column. Although protocol
6 proved to be successful, it is possible that the use of
the cross-absorbed secondary reagent with other prim¬
ary antibodies could also be suitable. With this pro¬
tocol, we also used a digital imager to resolve the
bands, rather than assessment of X-ray films. We found
that X-ray films produced previously reported prob¬
lems such as weak bands being overshadowed by adja¬
cent strong signals, broad diffuse images resulting from
overexposure and film saturation. We found that the
image station and image analysis software provided
better resolution of the bands detected and enabled
more accurate determination of theirmolecular weights
than traditional chemiluminescent methods. It is
important to note that chemiluminescent blots are not
visible to the naked eye and can only be visualized on
X-ray film or on a computer screen (when using digital
imaging). Furthermore, the bands on chemilumines¬
cent blots are not as clear and distinct as those seen on
normal chromogenic blots. However, the use of imag¬
ing software allows the bands to be resolved without
investigator bias.
Despite the various problems associated with lack of
specificity, we believe that there are three lines of evid¬
ence that confirm that we have detected Malassezia-
specific IgE. First, using protocol 6 we demonstrated
that the reagents did not cross-react with canine IgG
(see Fig. 2). Secondly, the IgE binding to the major
allergens was shown to be heat labile (Fig. 5). Thirdly,
the antigens detected in this study were different from
those detected in our previous study using reagents to
detect IgG.
In summary, we have demonstrated that M. pachy-
dermatis allergens of 45, 52, 56 and 63 kDa appear to
be clinically relevant in atopic dogs. However, further
characterization of these allergens is needed before
they could potentially be used in intradermal testing or
allergen immunotherapy in affected dogs.
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Resume Nous avons demontre precedemment que les chiens atopiques comme les chiens normaux
synthetisaient des IgG en reponse a un stimulus par des antigenes de Malasseziapachydermatis. Le but de cette
etude etait de comparer la synthese d'IgE vis a vis de differentes proteines de M. pachydermatis chez 28 chiens
atopiques presentant une dermatite a Malassezia et chez 22 chiens cliniquement sains. Six systemes differents
de detection ont ete evalues afin d'ameliorer la sensibilite et d'eliminer les reactions non specifiques ou les
reactivites croisees. Le protocole donnant les meilleurs resultats etait celui avec un antilgE monoclonal de souris,
un systeme de phosphatases alcalines conjuguees avec des IgG antisouris de chevre, qui ont ete passees trois fois
sur une colonne d'IgG canines, un substrat de chimioluminescence et un systeme d'imagerie digitale. Des pro¬
teines de 45, 52, 56 et 63 kDa ont ete reconnues par plus de 50% des serums de chiens atopiques, et doivent done
considerees comme des allergenes majeurs. Seule une minorite des chiens normaux ont presente une reactivite
IgE faible a ces proteines. Les resultats de cette etude indiquent que la majorite des chiens souffrant de dermatite
a Malassezia ont une reponse IgE plus elevee que les chiens normaux, suggerant que la reponse immunitaire
mediee par les IgE soit importante cliniquement dans la pathogenie de la maladie.
Resumen En estudios anteriores hemos demostrado que tanto perros atopicos como normales generan una
respuesta de IgG a antigenos de Malassezia pachydermatis. El objetivo de este estudio fue comparar las
respuestas de IgE a proteinas separadas de M. pachydermatis en 28 perros atopicos con dermatitis por Malas¬
sezia y 22 perros clinicamente normales, utilizando Western inmunoblotting. Se evaluaron seis sistemas difer-
entes de deteccion con el fin de evaluar la sensibilidad y eliminar las uniones inespecificas y la reactividad cruzada.
El protocolo con losmejores resultados utilizaba una IgEmonoclonal de raton anti-canina, una IgG caprina anti-
murina conjugada con fosfatasa alcalina pasada por una columna de IgG canina 3 veces, un substrato quemi-
luminescente y un sistema de imagen digital. Las proteinas de 45, 52, 56 y 63 kDa fueron reconocidas por mas
del 50% de sueros de perros atopicos, representando por tanto los principales alergenos. Solo una minoria de
perros normales mostraban una union debil de IgE a estas proteinas. Los resultados indican que la mayoria de
los perros atopicos con dermatitis por Malassezia tienen una respuesta de IgE mayor que los perros normales,
sugiriendo que una respuesta inmune mediada por IgE puede ser clinicamente importante en la patogenesis de
esta enfermedad.
Zusammenfassung Wir haben in der Vergangenheit nachgewiesen, dass normale Hunde und Hunde mit
atopischer Dermatitis gegen Malassezia pachydermatis-Antigene eine IgG Antwort entwickeln. Das Ziel
dieser Studie war, die mittels Western Blot gemessene IgE Antwort gegen Proteine von M. pachydermatis bei
28 atopischen Hunden mit Ma/assez/a-Dermatitis und 22 klinisch normalen Hunden zu vergleichen. Sechs
verschiedenen Entdeckungssystemen wurden untersucht, um die Sensitivitat zu bestimmen und nicht-spezifische
Bindungen und Kreuzreaktionen zu eliminieren. Das Protokol mit den besten Ergebnissen benutzte einen
monoklonalen, gegen Hunde-IgE gerichteten Mausantikorper, einen mit alkalischer Phosphatase konjugierten
Ziegenantikorper gegen Maus IgG, der dreimal durch die Saule mit Hunde IgG geschickt wurde, ein
chemilumeszentes Substrat und ein digitales Bildsystem. Proteine mit einer Masse von 45, 52, 56 und 63 kDa
wurden von mehr als der Halfte der atopischen Hundeseren gebunden und reprasentierten daher wichtige
Allergene. Eine Minderheit der normalen Hunde zeigte schwache IgE Bindung an diese Proteine. Die Resultate
deuten daraufhin, dass die Mehrheit der atopischen Hundemit Malassezia-Dermatitis im Vergleich zu normalen
Hunden eine erhohte IgE Immunantwort zeigen und dass eine IgE-mediierte Immunantwort klinisch in der
Pathogenese der Erkrankung wichtig sein konnte.
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Failure of extracts from Malasseziapachydermatis to stimulate
canine keratinocyte proliferation in vitro
TAI-AN CHEN, RICHARD E. W. HALLIWELL and PETER B. HILL
Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, The University of
Edinburgh, UK
(Received 29 June 2002; accepted 31 August 2002)
Abstract Epidermal hyperplasia is one of the major histopathological features seen in dogs with Malassezia
dermatitis. The aim of this study was to investigate the effects of extracts and culture supernatants from Malassezia
pachydermatis on the proliferation of canine keratinocytes. Keratinocyte cultures were established from normal
dog skin, and cell monolayers were co-cultured with Malassezia extracts (prepared either with orwithout protease
inhibitors) and supernatants derived from organisms grown in liquid culture. The proliferation of keratinocytes
was measured using a colourimetric assay. Neither the culture supernatants nor the Malassezia extracts had
significant effects on the proliferation rate of canine keratinocytes, regardless of whether protease inhibitors were
present or not. The results indicate that the epidermal hyperplasia seen in Malassezia dermatitis is unlikely to be
caused directly by secretion of products from the organism.
Keywords', canine, keratinocytes, Malassezia, proliferation assays.
INTRODUCTION
Malassezia dermatitis is a disease that is increasingly
recognized in dogs and its clinical features have been well
documented.1 Skin biopsy samples from affected dogs
generally show superficial perivascular-to-interstitial
dermatitis, with hyperkeratosis, irregular hyperplasia
of the epidermis and follicular infundibula, epidermal
spongiosis and lymphocyte exocytosis.4-8 Scott and
Miller4 described a hyperplastic dermatosis associated
with secondary Malassezia pachydermatis infection in
West Highland White Terriers. More recently, the
epidermal dysplasia in two West Highland White
Terriers was reported to be reversible after treatment,
including antifungal therapy.9
A preliminary report has demonstrated a significant
increase in a cellular proliferation marker in cultured
canine keratinocytes infected with M. pachydermatis
compared to noninfected cells.10 However, the mecha¬
nisms by which Malassezia might induce keratinocyte
proliferation are not understood. One hypothesis for the
epidermal hyperplasia seen in Malassezia dermatitis is
that a product within, or secreted from, the organism
may have a direct stimulatory effect on keratinocyte
proliferation.
The aim of this study, therefore, was to evaluate the
direct effects of extracts and culture supernatants from
M. pachydermatis on the proliferation rate of cultured
canine keratinocytes.
Correspondence: P. B. Hill, Department of Veterinary Clinical Studies,
Hospital for Small Animals, Royal (Dick) School of Veterinary




A strain of M. pachydermatis originating from the ear
canal of a dog with Malassezia otitis was cultured on
Sabouraud Dextrose agar (Oxoid, Basingstoke, UK)
containing 20 mg mL~' chloramphenicol (Intramycetin;
Parke-DavisVeterinary, Pontypool, UK) for 48 h at 37 °C.
Malassezia colonies were then carefully harvested and
suspended in phosphate-buffered saline (PBS, pH 7.4).
After three washing cycles with PBS, the cells were
resuspended in extraction buffer (pH 7.4) comprising
125 mM NH4HC03 (Sigma, Poole, UK) with or with¬
out protease inhibitors [20 mM e-aminocaproic acid
(Sigma); 5 mM ethylenediaminetetraacetic acid, (Sigma);
and 1 mM phenylmethylsulphonyl fluoride, (BDH,
Poole, UK)] for extraction of Malassezia proteins.11'12
The Malassezia colonies in the extraction buffer were
then mixed vigorously with an equal volume of glass
beads (0.4 mm, 40 mesh; BDH) on a vortex mixer for
10 min to mechanically disrupt the cell membranes.
After extraction, the cell suspensions were stored at
4 °C overnight, centrifuged at 6000 g for 5 min and the
supernatants were collected. The extracts were steri¬
lized by passing through syringe filters with a 0.8, 0.45
and 0.2 pm pore-size serially. A 50-pL aliquot of the fil¬
tered extracts was inoculated on Sabouraud Dextrose
agar (Oxoid) and the plate was incubated for 3 days at
37 °C to check its sterility. No growth of any organisms
was observed after the 3-day incubation. The amount
of protein obtained was measured with BCA Protein
Assay Reagent (Pierce Chemical Company, Rockford, IL,
USA). The protein profiles of Malassezia extracts with
or without protease inhibitors were demonstrated
© 2002 Blackwell Science Ltd 323


















Figure 1. Coomassie Brilliant Blue stained SDS-PAGE gel. (a)
Extracts of Malassezia pachydermatis. Lane 1, Malassezia extracts
produced with protease inhibitors. Lane 2, Malassezia extracts
produced without protease inhibitors, (b) Protein profile of culture
supernatants from M. pachydermatis. Lane 1, culture supernatants
from Malassezia; faint bands are visible. Lane 2, sterile Sabouraud
liquid medium; no bands are visible.
using sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE) with reducing sample
buffer containing 10% (3-Mercaptoethanol (Sigma) and
are shown in Fig. 1(a).
Culture supernatants p/'Malassezia pachydermatis
Culture supernatants of M. pachydermatis were pre¬
pared by growing the organisms in Sabouraud liquid
medium (Mast Laboratories Ltd, Merseyside, UK) for
3 days. The cell suspension was then centrifuged and
the supernatant collected. It was concentrated using
Centriplus concentrators (Millipore Corporation,
Bedford, MA, USA) to a final volume of 2 mL and
passed through syringe filters with a 0.2-pm pore size.
Sterile medium was also incubated and concentrated in
parallel to act as a control. The protein profile of the
culture supernatants was checked using an SDS-PAGE
gel as described above (Fig. lb).
Keratinocyte culture
Healthy skin was taken immediately post-mortem
from dogs presented for euthanasia from a dog rescue
centre. The flank of dogs was shaved and scrubbed with
Hibiscrub, painted with Povidone-Iodine and wiped
with 70% ethanol. Full-thickness skin was removed
and dipped in Povidone-Iodine/PBS solution (1:5) for
10 s and then washed with PBS containing Penicillin
(100 units mL-1), Streptomycin (100 pg mL"1), and
Fungizone (2.5 pg mL"1) (PSF; Life Technologies, Paisley,
UK). The skin was then immersed in Dulbecco's
Modified Eagle Medium (DMEM; Life Technologies)
containing PSF.
Canine keratinocyte culture was established using a
modification of a protocol published previously.13
Briefly, the subcutaneous tissue and fat were removed
by trimming and the skin was cut into small pieces.
The pieces were then incubated overnight at 4 °C in
William's Medium E (WME; Life Technologies) contain¬
ing lOmgmL"1 dispase (Life Technologies) and PSF.
The epidermis was carefully stripped off the dermis
and placed in a solution of trypsin/EDTA (0.1%/
0.04%) (Life Technologies) at 37 °C for lOmin. The
enzymatic effect of trypsin was abolished by adding
an excess of WME supplemented with 10% foetal
calf serum (FCS; Sigma), 0.1 nM cholera toxin (CT;
Sigma), lOngmL"1 murine epidermal growth factor
(mEGF; Life Technologies), and PSF (complete
medium). The cell suspension was filtered with a cell
strainer to remove hair and cell debris. It was then cen¬
trifuged at 700 g for 10 min and the cells were resus-
pended in complete medium. For primary cultures,
tissue culture flasks coated with fibronectin (kindly
provided by Dr R. C. McKenzie, University of Edin¬
burgh, UK) at a concentration of 1 pg cm"2 were used.
Cells of passages 2-5 were utilized in the following
experiments.
The morphological and cytoskeletal characteristics
of the keratinocytes were verified using an immunos-
taining technique with monoclonal antibroad spectrum
keratin and monoclonal antivimentin antibodies
(EURO/DPC Ltd, Gwynedd, UK). Briefly, the cells
were cultured in chamber slides to form a monolayer
and then fixed with 4% paraformaldehyde in PBS for
20 min. After washing with PBS three times, cells were
treated with 1% H202 in methanol for 20 min to block
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endogenous peroxidase activity followed by another
wash. They were then incubated with 1% SDS in PBS
for 5 min as an antigen retrieval step to enhance stain¬
ing. The slides were rinsed with PBS and blocked with
horse serum for 1 h (Vector Elite ABC mouse IgG
kit; Vector Laboratories Ltd, Peterborough, UK). An
antikeratin or antivimentin antibody was added as the
primary antibody and allowed to react for a further
1 h. The reagents in the IgG kit, including a bioti-
nylated horse antimouse IgG and avidin/biotinylated
peroxidase complex, were then used according to the
manufacturer's instructions and each incubation step
lasted for 30 min. The slides were developed using
DAB (3, 3'-diaminobenzidine; Vector Laboratories
Ltd) and counterstained with Mayer's haemotoxylin
(Sigma). Ligure 2 shows the keratinocytes stained with
antikeratin and antivimentin antibodies. Keratinocytes
reacted to antikeratin antibody and exhibited brown
staining (Lig. 2a). In contrast, they stained negatively
with antivimentin antibody (Lig. 2b).
10 pm
Figure 2. Cytoskeleton staining in canine keratinocytes (x500).
(a) Anti-keratin antibody stained keratinocytes showing dark brown
staining, (b) Keratinocytes appear unstained with antivimentin
antibody. Scale bars = 10 pm.
Validation of a cell proliferation assay to detect
keratinocyte proliferation
Cells harvested from tissue culture flasks were resus-
pended in WME and counted in a haemocytometer.
Various combinations of supplements, including ECS,
cholera toxin, and murine epidermal growth factor,
were added to the concentrations of 10%, 0.1 nM, and
lOngmL"1, respectively. The cells were then plated
into 96-well plates in quadruplicate (lOOpL/well,
2xl04 cells cm"2), and the plates were cultured at
37 °C with 5% CO-, in air for up to 7 days. Cells from
the same passage were also plated in flasks to be used
for generating a standard curve in the cell proliferation
assay.
A colourimetric assay reagent (Celltiter 96 AQueous
One Solution Cell Proliferation Assay; Promega,
Southampton, UK) was used to determine the number
of viable keratinocytes. Lor the standard curve, cells
grown in the flasks were trypsinized, washed and
counted in a haemocytometer. A volume of 100 pL of
cell suspension (containing twofold dilutions from
2 x 105 to 3125 cells per well) was added in triplicate to
empty wells on the day of the assay. Wells with 100 pL
of medium only were included as a background con¬
trol. Twenty microliters of Celltiter 96 AQueous One
Solution reagent was then added to all wells and the
plates were incubated for a further 3 h. The absorbance
of the reaction was evaluated using an ELISA reader
(Dynatech MR5000, Dynatech Laboratories Ltd,
Billingshurst, UK) at a wavelength of 490 nm and a
reference wavelength of 630 nm. Optimum plating cell
densities in tissue culture plates and assay conditions
were established in preliminary experiments (data not
shown).
A linear correlation was found between the absorbance
and cell number per well (between 2x 105 and 3125
cells per well) when both parameters were transformed
to logarithms (Pig. 3). Therefore, this assay was judged
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Figure 3. Correlation between cell numbers and absorption in the
Celltiter 96 colourimetric assay. The absorbance is proportional to
cell number between 2 x 105 and 3125 when both x- and y-axes are
transferred to logarithmical scales. Data shown are the mean of
triplicates, but the error bars are so small they cannot be displayed
on the figure. ,v-axis, cell number per well; y-axis, absorbance at
490 nm with a reference wavelength of 630 nm.
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Culture of keratinocytes with extracts and culture
supernatantsfrom M. pachydermatis
Keratinocytes were seeded into 96-well plates at 2 x 104
cells cm"2 in complete medium, as well as into flasks to
be used for generating a standard curve in the cell pro¬
liferation assay. After 24 h, the medium was changed in
order to remove nonadherent cells. Fresh medium and
Malassezia extracts made with and without protease
inhibitors were added into wells at a final concentra¬
tion of 5 x 10"'-5 x 10"5mgmL"1. Wells containing
medium alone and PBS served as controls. Concen¬
trated Malassezia culture supernatants and sterile
Sabouraud liquid medium were diluted 10-fold with
PBS and used at final dilutions of 1/10 to 1/10 000. All
wells were plated in at least quadruplicate for each
experiment, and the plates were incubated for 3 days.
Wells were washed and filled with 100 pL of fresh
medium on the day of the assay and the number of
viable cells in each well was measured using the colouri-
metric cell proliferation assay described above. Results
of repeated experiments were combined to give more
replicates for each group in subsequent analyses.
Data analysis
Results were expressed as the number of cells per well.
The number of keratinocytes cultured with or without
Malassezia extracts was compared using one-way
anova (Prism; Graphpad Inc., San Diego, USA). T-
tests (Prism) were used to compare the cell numbers of
keratinocytes incubated with culture supernatants of
Malassezia and sterile medium for each dilution ratio.
Significance was set at P < 0.05.
RESULTS
Effects of growth factors on keratinocyte proliferation
To verify that the culture conditions for keratinocytes
were optimal, the cell proliferation assay was used to
investigate the effects of growth factors on cell prolif¬
eration. Cells were cultured inWME alone; withWME
and FCS; with WME, FCS and CT; with WME, FCS
and mEGF; and with WME, FCS, CT, and mEGF
(Fig. 4). Fewer cells were detected in wells containing
only unsupplemented WME in comparison to the
other four groups. Cells grown in the complete medium
(containing FCS, CT, and mEGF) had the highest pro¬
liferation rate, with more cells detected than the other
groups in all three assays performed during the 7-day
incubation. The findings are in accordance with those
of an earlier study using manual counting with a
haemocytometer.13
Effects of Malassezia extracts on keratinocyte
proliferation
In order to examine the role of proteases in keratinoc¬
yte proliferation as well as other proteins in the Malas¬
sezia extracts, the extracts were made using buffer
both with and without protease inhibitors. There was
no significant difference in cell numbers between any
group of keratinocytes cultured with 5 x 10_1-5 x 10~5
mg mL"1 of extracts, either with or without protease
inhibitors, or PBS, which was the negative control
(P > 0.05) (Fig. 5a,b).
Effects of culture supernatantsfrom M. pachydermatis
on keratinocyte proliferation
The results of culturing keratinocytes with culture
supernatants from Malassezia are shown in Fig. 6. No
significant difference was found between each group
of cells incubated with culture supernatants from M.
pachydermatis at the four dilutions compared to the
individual negative controls (P > 0.05).
DISCUSSION
The purpose of this study was to determine if extracts
and culture supernatants from Malassezia pachyder¬
matis could induce proliferation of canine keratinoc¬
ytes. This was suggested by a previous study using live
organisms.10 Our findings, however, showed that Malas¬
sezia extracts did not affect keratinocyte proliferation
with extracts produced either with or without protease
inhibitors. These results suggest that products from M.
pachydermatis do not contribute directly to the epider¬
mal hyperplasia seen in Malassezia dermatitis.
Similarly, the proliferation of keratinocytes was
not affected by coculturing keratinocytes with culture
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Medium type
Figure 4. Comparison of the proliferation
rate of keratinocytes cultured in William's
Medium E with and without supplementation.
Each bar represents the mean and standard
error of the mean of quadruplicates. Shaded
bars, day 3; open bars, day 5; black bars, day
7. WME, William's medium E; FCS, foetal
calf serum; CT, cholera toxin; mEGF, murine
epidermal growth factor.
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Figure 5. Dose-response of canine keratinocytes to Malassezia
extracts, (a) Extracts produced using buffer containing protease
inhibitors, (b) Extracts without protease inhibitors. Data shown are
the combination of five separate experiments and the differences
between groups were analysed using one-way anova. No significant
difference was found between groups.
100 000 n
1/10 1/100 1/1000 1/10 000
Dilution
Figure 6. Dose-response of keratinocytes to culture supernatants
from Malassezia pachydermatis. Data shown are the combination of
four experiments and the differences between cells cultured with
supernatants and sterile medium were analysed using /-tests. There
was no significant difference between the two groups at any dilution.
Open bars, sterile medium; black bars, culture supernatants from
Malassezia.
showed that proteins with molecular weights between
66 and 45 kDa (Fig. lb) were generated in the liquid
medium or released from Malassezia during culture.
It is unclear what these products are without further
purification and analysis. However, protease activity has
been demonstrated in yeast-free supernatants when M.
pachydermatis was cultured in liquid medium.14 It is
likely therefore that the culture supernatants used in
this study also contained proteases. Enzyme secretion
is one of the virulence factors possessed by many
micro-organisms. Protease is an important virulence
factor of candidiasis in humans,15'16 and a keratinolytic
protease of Candida albicans has been shown to digest
human stratum corneum in vitro.11 Enzymes produced
by Malassezia are generally considered to be potential
pathogenic factors. Coutinho and Paula18 demon¬
strated that all the strains of Malasseziapachydermatis
they studied isolated from dogs with otitis and derma¬
titis showed protease activity. Protease released by
Malassezia was proposed as the mediator of itch at
free nerve endings in the skin and a contributer to the
prominent pruritus seen in affected dogs.2 However,
little work has been undertaken looking at the role
of proteases in the pathogenesis of histopathological
changes associated with Malassezia dermatitis. We
found no difference in the growth rate of keratinocytes
cultured with Malassezia extracts produced either with
or without protease inhibitors and keratinocytes cul¬
tured with supernatants from M. pachydermatis com¬
pared to sterile medium. These results indicate that
proteases or other proteins secreted by the organism do
not cause changes in keratinocyte proliferation in vitro.
If Malassezia can induce keratinocyte proliferation
directly, it is likely that cell-to-cell interaction is required
between the whole organism and the keratinocyte. This
hypothesis requires further study.
This study was performed using healthy dog skin.
It is important to consider the possibility that there
may a difference in proliferation rate in response to
M. pachydermatis between normal and Malassezia-
infected skin. Higher thymidine incorporation has
been demonstrated in basal cells of Candida-infected
skin compared to normal skin of guinea pigs.19
Whether this is the case in dogs with Malassezia der¬
matitis remains to be investigated. It is also possible
that skin from dogs with atopic dermatitis might
exhibit different proliferative responses to those of
normal dogs, although this awaits further study.
In conclusion, the present study has shown that
Malassezia extracts, either with or without protease
inhibitors, do not cause keratinocyte proliferation in
vitro. Likewise, culture supernatants from Malassezia
had no effect on the growth rate of keratinocytes. It
seems likely therefore that the excessive epidermal
proliferation associated with Malassezia dermatitis is
induced by other mechanisms.
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Resume L'hyperplasie epidermique est un des aspects majeurs observe a l'examen histopathologique de chiens
atteints de dermatite a Malassezia. Le but de cette etude etait d'evaluer les effets d'extraits et de surnageants de
cultures de Malassezia pachydermatis sur la proliferation keratinocytaire. Des cultures de keratinocytes ont ete
realisees a partir de la peau de chiens sains, et des monocouches cellulaires ont ete incubees avec des extraits de
Malassezia (prepares avec ou sans inhibiteurs de proteases) et le surnageant obtenu a partir d'organismes cultives
en phase liquide. La proliferation keratinocytaire a ete mesuree par une technique de colorimetrie. Ni les sur¬
nageants de culture, ni les extraits de Malassezia n'ont presente un effet sur le taux de proliferation des keratino¬
cytes, que ce soit en presence ou en absence d'inhibiteurs de proteases. Ces resultants indiquent que fhyperplasie
epidermique observee dans les dermatites a Malassezia n'est probablement pas liee a des produits de secretion
des levures.
Resumen Epidermal hyperplasia es una de las caracteristicas histopathological principales vistas en perros con
el dermatitis de Malassezia. La punteria de este estudio era investigar los efectos extractos y los supernatants de
la cultura de los Pachydermatis de Malassezia en la proliferacion de keratinocytes caninos. Las culturas de Kerat¬
inocyte con fueron establecidas de piel normal del perro, y los monolayers de celula co-fueron cultivados los
extractos de Malassezia (preparados con o sin los inhibidores del protease) y los supernatants derivados de los
organismos crecidos en cultura llquida. La proliferacion de keratinocytes fue medida usando un analisis colour-
imetric. Ni los supernatants de la cultura ni los extractos de Malassezia tenian efectos significativos en el indice
de la proliferacion de keratinocytes caninos, sin importar si los inhibidores del protease estaban presentes o no.
Los resultados indican que la hiperplasia epidermica vista en el dermatitis de Malassezia es poco probable ser
causado directamente por la secrecion de productos del organismo.
Zusammenfassung Epidermale hyperplasia ist eine der wesentlichen histopathologischen Veranderungen
der Malassezia-Dermatitis beim Hund. Das Ziel dieser Studie war es, die Wirkung von Extrakten und vom
Kulturiiberstand auf die Proliferation von Hundekeratinozyten zu untersuchen. Keratinozyten von normaler
Hundehaut wurden kultiviert und Zellmonoschichten wurden mit Malassezia-Extrakten (entweder mit oder
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ohne Proteasehemmer zubereitet) und mit Kulturiiberstand von in flussiger Kultur gewachsenen Organismen
geziichtet. Die Keratinozytenproliferation wurde mittels eines kolorimetrischen Assays gemessen. Weder der
Kulturiiberstand noch die Malassezia-Extrakte (unabhangig von der Anwesenheit eines Proteinasehemmers)
hatten signifikanten Einfluss auf die Proliferationsrate der Keratinozyten. Diese Ergebnisse deuten darauf hin,
dass die bei Malassezia-Dermatitis gesehene epidermale Hyperplasie wahrscheinlich nicht direkt durch
Sekretionsprodukte des Organismus verursacht wird.
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